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As in previous years, this 11thth national report 
on the drug situation in Norway has been drawn 
up in accordance with the reporting guidelines 
common to all member states in the EMCDDA. 
In addition to the annual report, we have sub-
mitted separately a number of standardised ta-
bles, mainly epidemiological data, as well as sev-
eral comprehensive questionnaires in the fields 
of demand reduction and policy. SIRUS wishes 
to express its gratitude to all public institutions 
that have provided relevant information. Our 
thanks go in particular to the co-authors who 
have made textual contributions and to the au-
thors of the two selected topics.
Oslo, December 2011
Odd Hordvin
Head of Focal Point
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Summary. Main findings – Part A
Legal framework
In 2011, the Act relating to municipal health and 
care services replaced the Act relating to the mu-
nicipal health services and the Social Services 
Act. It clarifies the municipalities’ overall respon-
sibility for ensuring health and care services, but 
without requiring the municipalities to organise 
the services in a particular manner. The munici-
palities have the same duties, but they are formu-
lated in more general and professionally neutral 
terms. The act does away with the legal distinc-
tion between health services and care services. 
The new act aims to ensure better coordination 
within the municipality and between the special-
ist health service and municipal health and care 
services.
Amendments were also adopted to the Road 
Traffic Act in 2011. The amendments concern 
the Road Traffic Act’s provisions concerning 
driving under the influence, mainly related to 
driving under the influence of substances other 
than alcohol. The primary purpose of the legisla-
tive amendments is to improve traffic safety and 
reduce the number of traffic injuries and fatali-
ties. The amendments also aim to create greater 
correspondence between the provisions on drink 
driving and the regulation of driving under the 
influence of other substances.
Consultation on alternatives to punishment
In June 2011, a working group submitted the re-
port Alternative reactions to less serious drug of-
fences, intervention programmes and motivational 
interviews to the Ministry of Justice and the 
Police and the Ministry of Health and Care 
Services. It proposed that persons arrested for 
minor drug offences be offered motivational in-
terviews or a more long-term intervention pro-
gramme as a special condition fora conditional 
waiver of prosecution or a conviction. The reac-
tion will normally not be registered in the per-
son’s criminal record. The target group primarily 
consists of young people, but no upper age limit 
is proposed. The purpose is rehabilitation. The 
Minister of Justice and the Police underlines that 
‘the proposals do not entail any form of legalisa-
tion, decriminalisation or lessening of criminali-
sation of drug offences. It is more a question of 
punishing people in a way that works, by tailor-
ing a reaction that addresses the cause of the 
crime/ drug use’. The report and the proposals 
have been distributed for consultation.
White paper in progress
A white paper on drug and alcohol policy, origi-
nally scheduled for presentation in 2011, has 
been postponed until 2012. The white paper will 
summarise experience of the Action Plan (2008–
12) and identify the main challenges and strate-
gies for the drug and alcohol policy in future. 
Prevention, comprehensive and coordinated ser-
vices and emphasis on the role of the municipali-
ties will be guiding principles in relation to the 
contents of the report. The white paper will deal 
with alcohol, drugs, medicinal drugs and doping 
outside organised sport. The provision of servic-
es for older people with drug and alcohol prob-
lems will be assessed, including palliative treat-
ment and care in the final phase of life. User 
participation and the situation of next-of-kin 
will be emphasised.
The question of introducing heroin-assisted 
treatment
In June 2009, the Storting asked the Government 
to organise a so-called consensus conference at 
which both expert communities and user organ-
isations could discuss professional, ethical and 
priority-related aspects of offering heroin-assist-
ed treatment to drug addicts in Norway. On as-
signment for the Ministry of Health and Care 
Services, the Research Council of Norway or-
ganised a conference of this kind in June 2011. 
The appointed panel submitted its report to the 
Ministry in September. It recommended 
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not initiating a trial scheme for heroin-assisted 
treatment. The panel concluded that the overall 
knowledge basis for introducing heroin-assisted 
treatment in Norway is still too weak. The 
Ministry will make a recommendation on this is-
sue in the coming white paper.
Decline in the use of cannabis
The most recent survey among the general popu-
lation was carried out in 2009. The survey showed 
that the proportion of respondents who an-
swered that they had ever tried cannabis had 
fallen from approx. 16 per cent in 2004 to less 
than 15 per cent in 2009. What was more sur-
prising was the relatively strong decrease since 
2004 in the proportion that had used cannabis 
during the last 30 days in the under-35 age group. 
In 2004 it was 4.5 per cent, while in 2009 it was 
reduced to less than the half. Furthermore,  the 
last-year prevalence had also decreased in the 
15–34 age group, from  a proportion of 9.6 per 
cent in 2004 to seven per cent in 2009. 
In another survey addressing young adults that 
was conducted in 2010, preliminary analyses 
show that lifetime prevalence for the use of can-
nabis is declining in the 21–30 age group com-
pared with the 2006 survey for the same age cat-
egory. The decline found among the general 
population thus seems to be confirmed by this 
survey.
The 2010 survey, which included people aged 
18–30 years, showed that cannabis is still the il-
legal drug that most young people report having 
tried (29 %). Significantly fewer have tried am-
phetamine and cocaine (approx. 6 % for both). 
Ecstasy and sniffing have been tried by nearly 
four and three per cent, respectively, while 
around one per cent of this age group report ever 
having used LSD, GHB and heroin.
Injecting users – stable situation
The number of injecting users in Norway has 
probably been quite stable since 2003.In 2009, it 
was estimated to be between 8,800 and 12,500. 
The figure includes all injecting use. Heroin is 
still the most common drug injected, but, for 
around 17 per cent, amphetamines are the main 
drug injected.
Problem users of cocaine
SIRUS has in 2010/2011 participated in a project 
in which the amount of cocaine used in Oslo was 
calculated using three different methods. The 
Norwegian Institute for Water Research has car-
ried out measurements of cocaine in wastewater, 
while the Norwegian Institute of Public Health 
has carried out measurements of cocaine among 
drivers suspected of driving under the influence. 
SIRUS has used a method based on the reporting 
of the frequency of cocaine use in four different 
surveys, both population-based and among in-
mates in prisons and injecting users. The results 
of the surveys have not yet been published, 
however.
In the questionnaire surveys, the respondents 
were also asked how often they used cocaine. It is 
thus possible to calculate an annual average 
number of cocaine users and the number of per-
sons who used the drug more than once a week 
or more (problem users). On average for 2000–
2009, there were approximately 1,800 problem 
users of cocaine per year in Oslo and 10,200 oth-
ers who used the drug more rarely. The majority 
of the cocaine users, almost 50 per cent, were ex-
perimental users who had only used the drug 
one to four times during the last 12 months, 
while 35 per cent were recreational users (limited 
use). No corresponding estimates have been car-
ried out so far at the national level.
Drug-related treatment
During the first half of the 2000s, extensive ad-
ministrative and organisational changes took 
place with regard to the treatment of drug and 
alcohol problems. Through the hospital reform 
of 2002 and the Administrative Alcohol and 
Drugs Treatment Reform of 2004, responsibility 
was assigned to the state-run specialist health 
service. This reorganisation has led to increased 
focus on diagnostics, medication and the use of 
commercial principles in the treatment context. 
This change has been criticised in several differ-
ent quarters. It has been argued, for example, 
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that the reorganisation threatens to undermine 
the diversity of treatment options. Resources ap-
pear to be increasingly channelled to so-called 
evidence-based interventions, the establishment 
of outpatient clinics, shorter treatment pro-
grammes and more medication. There now 
seems to be a tendency to prioritise short-term 
measures and substitution treatment in tender 
criteria at the expense of social-pedagogical 
long-term measures and aftercare.
One new set of guidelines, For pregnant women 
in opioid substitution treatment (OST) and follow-
up of families until the children reach school age, 
entered into force in the course of 2011.
The goal is to provide clear, knowledge-based 
recommendations for the treatment and follow-
up of OST patients during pregnancy and while 
in hospital in connection with the birth, and for 
follow-up /treatment of the child and the family 
until the child reaches school age. The target 
group consists of women in OST during preg-
nancy, their partners, children who have been 
exposed to methadone or buprenorphine at the 
foetal stage, and their families. The guidelines 
address all professional groups in the municipal-
ities and in the specialist health service that have 
responsibility for following up these patients. 
This applies to the health services, but also to so-
cial services, child welfare services, kindergar-
tens and the school psychological service.
Treatment provision
In a report for 2009, the Directorate of Health 
describes the health services offered to patients 
in interdisciplinary specialised drug or alcohol 
treatment by the sector itself and by the mental 
health care service for adults. The data basis con-
sists of information reported by the institutions 
about patients who have received treatment in 
the interdisciplinary specialist treatment sector. 
In all, 40 per cent of the patients in this sector 
received in-patient treatment in 2009, more men 
than women. Drug problems caused by the use 
of cannabinoids were more often treated on an 
outpatient basis, while problems caused the by 
the use of tranquillisers and depressants, 
stimulants or multiple substances were more of-
ten treated through admission.
Psychiatric and somatic co-morbidity
Very many patients in mental health care in 
Norway have drug or alcohol problems, and very 
many patients in interdisciplinary specialised 
treatment for drug or alcohol use have psychiat-
ric and somatic disorders.
Counts of patients in mental health care for 2010 
show that 23 per cent of those who are admitted 
to mental health care, have or are given a drug or 
alcohol diagnosis. This is a decline from 2007, 
when the proportion was 29 per cent. The pres-
ence of drug or alcohol problems in addition to 
another primary condition increases the likeli-
hood of readmission to mental health care. 
Although they are readmitted more often, pa-
tients with concurrent drug or alcohol problems 
and mental health problems nonetheless spend 
fewer days in treatment than other patients. 
These patients make more use of in-patient treat-
ment than other patients in mental health care 
and less use of outpatient services. Behaviour 
disorder is the most common psychiatric diag-
nosis among those who are readmitted with con-
current psychiatric and drugs or alcohol-related 
diagnoses.
The treatment period is shorter and the contact 
with specialists in mental health problems more 
sporadic for these patients than for others. This 
makes it difficult to establish the patient’s needs 
and how drug/alcohol treatment and mental 
health care can be integrated to provide better 
treatment.
New patient register in force
The Norwegian National Patient Register (NPR) 
is authorised by the regulations of 2009 to collect 
personally identifiable information about pa-
tients in the specialist health service. The pur-
pose is to facilitate quality development and 
management of treatment provision, and to 
strengthen evaluation and research activities. 
The personally identifiable register also enables 
NPR to quantify the number of patients who 
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receive treatment in the specialist health service. 
The ‘new’ way of counting patients is based on 
encrypted personal identification numbers, not 
just institution numbers and patient numbers. 
This means that the new calculation method 
avoids patients being counted more than once.
All entities that offer interdisciplinary specialised 
treatment are required to report to the NPR. The 
reporting of activity data from entities that offer 
interdisciplinary specialised treatment has been 
mandatory since 1 January 2009, and it also in-
cludes registering the patient’s situation at the 
start of treatment. Patient data for interdisciplin-
ary specialised treatment are still incomplete. 
Deviations between patient data and overall re-
ports to Statistics Norway indicate that some ar-
eas remain to be clarified. This also applies to 
under-reporting, which is most common in the 
outpatient sector.
HIV stable– high incidence of HCV
The incidence of HIV among injecting drug us-
ers has remained at a stable, low levelfor many 
years, with about 10 to 15 cases reported per 
year. The reason for this is not entirely clear, but 
a high level of testing, great openness regarding 
HIV status within the drug user community, 
combined with a strong fear of being infected 
and strong internal justice in the milieu, are as-
sumed to be important factors. However, the 
high incidence of hepatitis C shows that there is 
still extensive needle sharing among this group.
Drug-related deaths. Large proportion 
caused by other opioids than heroin
In 2009, 285 persons died of drug-related causes 
in Norway, an increase of 22 compared to 2008. 
Of the total number that were recorded by 
Statistics Norway,255 deaths involved opioids 
with or without additional drugs, 137 were 
deaths due to heroin, 39 deaths were recorded 
with methadone poisoning as the underlying 
cause, and 61 with other opioids, either as poi-
soning or dependency. Thirty-nineof the deaths 
were coded as suicides, which is probably a con-
servative estimate of the suicide rate.
The proportion of drug-related deaths among 
those over the age of 30 has increased steadily. In 
2009, this age group accounted for 76 per cent of 
the deaths. The proportion over the age of 50 ap-
pears to have increased as well. In 2009, this age 
group accounted for 25 per cent of the total num-
ber of deaths. Five of the deaths were in the 65 
years or more age group. The youngest age 
groups’ proportion of deaths has remained rela-
tively stable, but nine deaths under the age of 20 
years in 2009 is the highest number ever 
registered.
Drug markets
The number of cases and seizures has increased 
to record levels in 2010. However, with the ex-
ception of GHB and GBL, the big increase in 
cases has not led to seizures of record amounts of 
drugs.
The number of seizures of heroin is the highest 
since 2003. The number is far lower, however, 
than in the period 1995–2003. Moreover, the pu-
rity of heroin base has sunk to a historically low 
level, 21 per cent in 2010 on average, declining 
further to 17 per cent in first half of 2011.
The total seized amount of all cannabis products 
is not particularly high, which can be explained 
by the relatively small amount of hash seized. On 
the other hand, the number of cultivation cases 
and the number of seizures of marijuana have 
again increased strongly. Both the quantities and 
the number of seizures substantially exceed those 
in the years 2007 and 2008, which were regis-
tered as record years until 2010.
In total, the number of seizures of amphetamine 
and methamphetamine has increased relatively 
strongly in 2010 compared with the period 
2006–2009.
Although 2007 is the only year in which more 
seizures of cocaine were made than in 2010, co-
caine nonetheless appears to have a somewhat 
smaller market share during the last three years 
compared with seizures of other drugs.
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The seizure figures are very low for ecstasy, both 
in terms of the amount seized and the number of 
seizures. Among tablets with logos, MDMA has 
largely been replaced by other drugs, primarily 
mCPP (1,3-chlorphenylpiperazine).
Both the number of seizures and the number of 
tablets of benzodiazepines have increased since 
2008, a trend that was reinforced in 2010. Only 
in two previous years have greater quantities 
been found and more seizures made than in 
2010. It is clonazepam (Rivotril) and diazepam 
(e.g. Valium) in particular that dominate the user 
market.
Of the new stimulants that were introduced to 
the user market in 2010, it is mainly PMMA that 
stands out, According to the National Institute of 
Public Health, PMMA has so far (end of 
September 2011) been linked to 20 overdose cas-
es with fatal outcomes.
The customs service is uncovering an increasing 
amount of drugs sent in the post and by courier. 
This applies in particular to narcotic tablets or-
dered online. As regards tranquillising narcotic 
tablets, the smuggling of Rivotril and Subutex 
appears to have increased in particular.
The customs service has also registered an in-
crease in the smuggling of new drugs. New ver-
sions of synthetic cannabinoids and other syn-
thetic substances are being uncovered all the 
time. The challenge is that many of these sub-
stances are difficult to stop as they are not yet on 
the list of narcotic substances. Eight synthetic 
cannabinoids were listed with effect from 21 
December 2011, however.
PART A
New Developments and Trends
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1.  Drug policy: legislation, strategies and 
economic analysis
See also information in Structured Questionnaire 
32.
1.1 Legal framework
In 2011, two new acts were passed and amend-
ments were made to one act, all of which have a 
bearing on drug and alcohol policy.
The Norwegian Act relating to municipal health 
and care services1 replaces the Act relating to the 
municipal health services and the Social Services 
Act. It clarifies the municipalities’ overall respon-
sibility for ensuring health and care services, but 
without requiring the municipalities to organise 
the services in a particular manner. The munici-
palities have the same duties, but they are formu-
lated in more general and professionally neutral 
terms. The act does away with the legal distinc-
tion between health services and care services. 
Patient and user rights relating to municipal 
health and care services are continued, but they 
are now set out in the Patients’ Rights Act. This 
entails more unambiguous and comprehensive 
rights for patients and users. The new act aims to 
ensure better coordination within the munici-
pality and between the specialist health service 
and municipal health and care services.
The Norwegian Act relating to public health work 
(the Public Health Act)2 replaces, among other acts, 
1  Act relating to municipal health and care services. 
Proposition 91 L (2010-2011) to the Storting, Recom-
mendation 424 L (2010-2011) to the Storting, Legislative 
decision 63 (2010-2011).
2  The Act relating to public health work. Proposition 90 
L (2010-2011) to the Storting, Recommendation 423 
L (2010-2011) to the Storting, Legislative decision 64 
(2010-2011).
the Act concerning the county municipalities’ pub-
lic health duties and certain provisions of the Act 
relating to the municipal health services. The act is 
intended to contribute to developing society in a 
manner that promotes public health and evens out 
social differences in health and living conditions. 
The municipalities’ responsibility for maintaining 
an overview of health conditions and impact fac-
tors is specified, thus providing the individual mu-
nicipalities with a clearer picture of local health 
challenges.
Amendments to the Norwegian Road Traffic 
Act.3 The amendments concern the Road Traffic 
Act’s provisions concerning driving under the 
influence, mainly related to driving under the in-
fluence of substances other than alcohol. The 
primary purpose of the legislative amendments 
is to improve traffic safety and reduce the num-
ber of traffic injuries and fatalities. The amend-
ments also aim to create greater correspondence 
between the provisions on drink driving and the 
regulation of driving under the influence of oth-
er substances.
Alternatives to punishment
A working group has looked more closely at the 
question of alternative reactions to less serious 
drug-related crime. In June 2011, the working 
group submitted the report Alternative reactions 
to less serious drug offences, intervention pro-
grammes and motivational interviews to the 
Ministry of Justice and the Police and the 
3  Amendments to the Road Traffic Act concerning driving 
under the influence. Proposition 9 L (2010-2011) to the 
Storting, Recommendation 105 L (2010-2011) to the 
Storting, Legislative decision 26 (2010-2011).
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The allocations for the Action Plan have so far 
increased by more than EUR 125 million4 (NOK 
1 billion) during the course of the plan period. In 
the proposal for the national budget for 2012, the 
allocation is continued at the same level as in 
2011 in the Ministry of Health and Care Services’ 
budget. Strengthening the municipalities’ financ-
es and the basic allocations to the four regional 
health authorities come in addition. This is in-
tended to contribute to the continuation and 
strengthening of services for drug addicts and al-
coholics. The Action Plan has helped to increase 
the focus on prevention, competence and quality 
in the municipalities and in specialised interdis-
ciplinary drug and alcohol treatment.
A white paper on drug and alcohol policy was 
originally scheduled for presentation in 2011, 
but it has been postponed until 2012. The white 
paper will summarise experience of the Action 
Plan, follow up the Stoltenberg Committee’s5 re-
port and identify the main challenges and strate-
gies for the drug and alcohol policy in future. 
Prevention, comprehensive and coordinated ser-
vices and the emphasis in the Coordination 
Reform6 on the role of the municipalities will be 
guiding principles in relation to the contents of 
the report. The white paper will deal with alco-
hol, drugs, medicinal drugs and doping outside 
organised sport. The provision of services for 
older people with drug and alcohol problems 
will be assessed, including palliative treatment 
and care in the final phase of life. User participa-
tion and the situation of next-of-kin will be 
emphasised.
4  Conversion rate 1 EUR = NOK 8.00
5  In spring 2009, the Government appointed a commit-
tee that was tasked with assessing how drug addicts and 
alcoholics most in need of help can receive better help 
– the so-called ‘Stoltenberg Committee’. The committee 
submitted its report in June 2010. It contained 22 con-
crete proposals ranging from prevention to treatment. 
A narrow majority of the committee’s members support 
carrying out a trial project whereby treatment with 
heroin will be included in OST.
6  Proposition no 47 (2008-2009) to the Storting. The 
Coordination Reform. The right treatment in the right 
place at the right time.
Ministry of Health and Care Services. It pro-
posed that persons arrested for minor drug of-
fences be offered motivational interviews or a 
more long-term intervention programme, as a 
special condition in a conditional waiver of pros-
ecution or a conviction. The reaction will nor-
mally not be registered in the person’s criminal 
record. The target group primarily consists of 
young people, but no upper age limit is proposed. 
The purpose is rehabilitation. The Portugal mod-
el of dedicated commissions has been a source of 
inspiration.
Motivational interviewing (one to three sessions) 
is intended for persons who have only used drugs 
a few times. The idea is that the interviews will 
have a preventive effect. The intervention pro-
gramme (three to six months) is intended for ad-
dicts or persons in danger of becoming addicted. 
If the arrested person does not consent, or re-
peatedly violates the conditions for the alterna-
tive reactions, he/she may risk fines or imprison-
ment, which is the current practice.
The Minister of Justice and the Police underlines 
that the proposals ‘do not entail any form of le-
galisation, decriminalisation or lessening of 
criminalisation of drug offences. It is more a 
question of punishing people in a way that works, 
by tailoring a reaction that addresses the cause of 
the crime/ drug use’. The report and the propos-
als has been distributed for consultation in au-
tumn 2011.
1.2  National action plan, 
strategy, evaluation and 
coordination
The Government’s overriding goal for its drug 
and alcohol policy is to reduce the negative con-
sequences of drug and alcohol use for individu-
als and for society as a whole. The policy, for 
which the Ministry of Health and Care Services 
has overall responsibility and which it coordi-
nates, is enshrined in the National Action Plan 
on Alcohol and Drugs 2008–2012, hereinafter 
called the Action Plan.
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the Norwegian Centre for Addiction Research 
(SERAF) at the University of Oslo. In spring 
2011, the Research Council concluded an evalu-
ation of the centre’s activities. The evaluation 
recommended that SERAF be granted funds for 
a new period. A preliminary summary has also 
been produced of existing knowledge in the proj-
ects in the programme. The main impression is 
that the quality of the projects is generally good, 
and that there is great variation in research ques-
tions and methods.
Other important research communities in the 
drugs and alcohol field are the Norwegian 
Institute for Alcohol and Drug Research (SIRUS), 
the Institute of Public Health and important 
treatment institutions in the health authorities.
The Directorate of Health is in the process of pre-
paring a series of guidelines and guides for the 
drugs and alcohol field, with the aim of contribut-
ing to more knowledge-based practice. The seven 
regional drugs and alcohol competence centres 
and the county governors are tasked with main-
taining, developing and disseminating expertise 
in the field, and with initiating and implementing 
government measures in the individual regions. 
The competence centres collaborate with the 
county governors on measures adapted to the 
needs in the municipalities, among other things 
by providing continuing and further education, 
interdisciplinary networks/arenas in the regions 
and courses to raise the level of basic knowledge 
about drug and alcohol problems.
Quality shall also be raised in the public and vol-
untary sector through making the grant schemes 
more performance-oriented. In addition, con-
tinuous efforts are being made to develop better 
statistics for municipal services for persons with 
drug or alcohol problems and better reporting of 
treatment data from the Norwegian National 
Patient Register.
The Directorate of Health has been tasked with 
assessing systems for relevant reporting on drugs 
and alcohol-related work and mental health care 
in the municipalities. The goal is to obtain good 
1.2.1  Status of implementation of the 
Action Plan
The plan has five main goals:
• a clear public health perspective
• better quality and increased competence
• more accessible services and greater social 
inclusion
• more binding cooperation
• increased user influence and greater 
attention to the interests of children and 
family members.
The plan includes 147 concrete and relatively ex-
tensive measures that address the challenges in 
the drugs and alcohol field. Almost all the mea-
sures have been initiated.
A clear public health perspective
A public health perspective in the drug and alco-
hol policy is considered crucial. The extent of 
negative social and health-related consequences 
increases in step with the use of drugs and alco-
hol. It is therefore a challenge that alcohol con-
sumption is increasing among adults. On the 
other hand, surveys show a certain decline in the 
use of alcohol and cannabis among young 
people.
Grants for drug prevention projects and activi-
ties are awarded annually, as well as operating 
grants for drug and alcohol policy organisations. 
The Directorate of Health runs information cam-
paigns and engages in attitude-building work.
Better quality and increased competence
One of the goals of the Action Plan is to strength-
en research and teaching in the field of drug and 
alcohol problems, to initiate measures to en-
hance the quality of preventive work and services 
and to raise employees’ competence.
One main focus is the Research Council of 
Norway’s drug and alcohol research programme. 
The programme’s overriding goal is to contribute 
to the development of new relevant knowledge 
and to promote research in the drugs and alco-
hol field. An important instrument is funding of 
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23 with mental health problems and/or drug or 
alcohol problems. The waiting list guarantee 
means that all assessments must be made within 
ten working days and that all treatment must 
have commenced within 65 working days. This 
has resulted in more people receiving treatment 
within the deadline.
The voluntary sector has also been strengthened 
(see Chapter 1.3). Activities cover the whole 
range of measures, with the main emphasis on 
rehabilitation, follow-up/motivation and social 
participation /aftercare. Grants are also awarded 
to a number of projects and organisations run by 
and for users.
The correctional service has adopted a compre-
hensive drugs and alcohol strategy to ensure bet-
ter rehabilitation and treatment of inmates and 
convicted persons with drug or alcohol prob-
lems. The strategy and the measures are de-
scribed in more detail in Chapter 11.
Through the Action Plan, the collaboration be-
tween the correctional service, the health servic-
es and other services has been strengthened. The 
number of inmates serving their sentence in an 
institution, either in the specialist health service 
or in other institutions, is increasing. Work is 
also under way on strengthening coordination 
between the services upon release, cf. the 
Government’s return-to-society guarantee, and 
on increasing the number of people who receive 
an individual plan and on the trial scheme of 
suspended sentences with drug courts. The 
scheme is currently being evaluated by SIRUS.
In 2010, 511 persons were transferred to serving 
sentences pursuant to the Execution of Sentences 
Act section 12. It is an express goal that far more 
inmates shall receive this offer than today. The 
individual measures in the prisons are described 
in Chapter 11.
Binding cooperation
The Directorate of Health has allocated grant 
funding for the testing of models that ensure a 
continuous and coherent treatment 
data on the service recipients, assistance and ser-
vice needs, and the use of resources in municipal 
work on drug and alcohol problems.
The Uni Rokkan Centre has carried out an evalu-
ation of the provisions on forced treatment in 
the Social Services Act in relation to drug ad-
dicts and alcoholics.7 The report addresses the 
question of whether it is necessary to change the 
rules, and it points out that a need to revise the 
rules on certain points has been identified. The 
Directorate of Health has been tasked with fol-
lowing up the evaluation.
More accessible services and greater social 
inclusion
In 2011, grants totalling EUR 50.88 million 
(NOK 407 million) were awarded to municipal 
drug and alcohol work to around 300 
municipalities.
The Action Plan is intended to contribute to im-
proving services for people with drug and alco-
hol problems and to support the work on the 
Coordination Reform. The goal is to provide the 
users with comprehensive services characterised 
by quality and accessibility. In line with the 
Coordination Reform, the services and the mu-
nicipalities’ competence in early identification of 
drug and alcohol problems and early interven-
tion, especially in relation to children and young 
people, must be improved. See Chapter 3 for a 
more detailed description of measures. The ca-
pacity of the services for people with drug and 
alcohol problems has increased, both in the spe-
cialist health service and in the municipalities. In 
2010, around 23,000 patients received interdisci-
plinary specialised drug and alcohol treatment. 
The figure includes both patients with alcohol 
problems and patients with drug problems.
A waiting list guarantee was introduced in 2008 
for children and young people under the age of 
7  The use of force in relation to drug addicts and alco-
holics. Evaluation of the Act relating to social services 
sections 6-2, 6-2a and 6-3 (June 2010).
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in grant schemes, and the county governors and 
the competence centres are working together 
with the user organisations to develop measures/
projects.
Self-organised self-help is an important focus 
area. In 2010, the nodal point for self-help, 
Selvhjelp Norge, focused on the drugs and alco-
hol field in particular. The strategy is regarded as 
being a success, and the drugs and alcohol field 
will be an integrated part of the work on self-or-
ganised self-help in the years ahead.
1.3  Work organised by voluntary 
organisations etc.
In 2011, EUR 20.6 million (NOK 165 million) 
was awarded to 103 measures. The allocation 
covers grants for the follow-up, care and reha-
bilitation of people with drug/alcohol addiction 
and/or with experience of prostitution, organised 
by voluntary and charitable organisations. Self-
help groups and interest groups and work with 
next-of-kin will also receive funding.
The purpose of the funding is to support the 
work of voluntary and charitable organisations 
in relation to people with drug or alcohol prob-
lems. The intention is that the initiatives that re-
ceive funding will supplement public services 
and contribute to improving and coordinating 
the overall efforts aimed at the target groups. 
Emphasis will be placed on the organisations’ 
ability to document cooperation with the mu-
nicipality, and on the establishment of a system 
for user participation.
The grant recipients cover the whole range of 
measures, with the main emphasis on rehabilita-
tion, follow-up/motivation and social participa-
tion /aftercare. Grants are also awarded to a 
number of projects and organisations run by and 
for users. The grant scheme was evaluated in 
2010 by the International Research Institute of 
Stavanger . The evaluation recommended draw-
ing a clearer distinction when allocating funding 
between operating grants for institutions that 
and rehabilitation process. Grants have also been 
allocated to mapping/raising competence in re-
lation to coordination problems and different 
target groups’ need for comprehensive services 
and interdisciplinary cooperation between 
health and care services and other sectors. Work 
and activity have been emphasised in particular. 
The use of individual plans must be increased in 
order to ensure more coordinated services for 
users.
Municipal drug and alcohol policy action plans 
are intended to help to ensure better coordina-
tion of drug and alcohol policy. About three-
quarters of the Norwegian municipalities have 
now drawn up such action plans. In 2011, SIRUS 
conducted a study in selected municipalities to 
investigate the effect of these plans. The report 
emphasises the importance of political involve-
ment and support, but it points out that much 
work remains to be done before the intentions 
behind the action plans have been achieved (see 
also Chapter 3.1.1).
Next-of-kin, and especially children, are a vul-
nerable group whose problems will be better ad-
dressed through the Action Plan. In 2011, the 
Institute of Public Health has established that 
many children live in families in which there is 
mental illness and/or drug or alcohol problems, 
and studied the consequences of this.
Children as next-of-kin of problem drug and al-
cohol users have been given a stronger entitle-
ment to follow-up. The child welfare service has 
been strengthened, and several conferences have 
been held on the topic of children as next-of-kin. 
In 2011, the Directorate of Health established an 
online next-of-kin portal containing informa-
tion about services for and the rights of next-of-
kin and, if relevant, users. A training package 
will also be produced for services that target 
next-of-kin.
The user perspective is important in all work in 
the drugs and alcohol field, and the user organi-
sations have been strengthened through the 
Action Plan. User participation is a requirement 
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1.4  The question of introducing 
heroin-assisted treatment
In June 2009, the Storting asked the Government 
to organise a so-called consensus conference at 
which both expert communities and user organ-
isations could discuss professional, ethical and 
priority-related aspects of offering heroin-assist-
ed treatment to drug addicts in Norway.8
On assignment for the Ministry of Health and 
Care Services, the Research Council of Norway 
organised a conference of this kind in June 2011. 
The appointed panel submitted its consensus re-
port to the Ministry in September. It recom-
mended not initiating a trial scheme for heroin-
assisted treatment. The panel concluded that the 
knowledge basis for introducing heroin-assisted 
treatment in Norway is weak, especially because 
of the following factors:
‘A large proportion of those who constitute the 
intended target group for heroin-assisted treat-
ment are not included in the international stud-
ies of such treatment. The intended target group 
consists of problem users of heroin who do not 
make use of other treatment and who are capable 
of adapting to the stringent regime that heroin-
assisted treatment represents. Little knowledge is 
available about how this group might benefit 
from an offer of heroin-assisted treatment. A 
clearer definition of the target group for a mea-
sure of this type is in any case required, so that 
the treatment is adapted to the patients, and not 
the other way round.
The panel finds that the effects of heroin-assisted 
treatment are only moderately better than the ef-
fects of other substitution treatment (with meth-
adone or buprenorphine). International studies 
show a high drop-out rate in the course of a few 
years of the treatment. There are indications that 
the drop-out rate is greatest among patients with 
a weak social network, poor health and poor 
8 Document no 8:93 (2008/2009), cf. Recommendation no 
326 (2008/2009) to the Storting.
provide in-patient treatment and more short-
term projects and measures. This will be achieved 
by adopting different grant regulations for the 
different target groups. Further follow-up of the 
evaluation will also be a topic addressed in the 
upcoming white paper.
Regional competence centres for the drugs 
and alcohol field
For 2011, a total of EUR 16 million (NOK 128 
million) was allocated to the seven regional drug 
and alcohol competence centres. The grants aim 
to strengthen organisation, competence and 
quality development in the drugs and alcohol 
field. The grants will be used:
• to stimulate the development of preventive 
measures in the municipalities
• for competence-building in the 
municipalities and the specialist health 
service
• to develop national areas of expertise.
Each competence centre has been assigned re-
sponsibility for one or two national areas of ex-
pertise. In 2010/2011, the centres have focused 
on three priority areas in particular:
• better coordination of the municipalities’ 
work in the drugs and alcohol field based on 
drugs and alcohol policy action plans,
• boosting the municipalities’ competence in 
relation to local preventive measures,
• raising competence in early intervention.
A number of method development projects were 
carried out in the period 2007–2010. The proj-
ects target children of parents with mental health 
problems and drug or alcohol problems, at-risk 
youth, pregnant women, employees at work, stu-
dents in schools, patients at GPs and in hospitals. 
The projects will be reviewed and experience 
communicated to other regions. See also Chapter 
3. An evaluation of the competence centres will 
be completed by the turn of the year 2011/2012.
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justifiable to stipulate a more specific amount be-
fore a reliable calculation model exists.
The Norwegian welfare model is largely based on 
universal design, rights and integrated solutions. 
Drug and alcohol problems and costs relating to 
such problems are difficult to isolate, and com-
ing up with a figure that only relates to drugs and 
alcohol is very difficult in practice. It is common 
to describe drug and alcohol problems as com-
plex and to say that they must be seen in con-
junction with other closely-related areas. This 
applies to both prevention and treatment. For 
example, early intervention will address the in-
cipient stages of drug or alcohol use and form 
part of a broader preventive strategy that does 
not limit itself to drug and alcohol prevention 
alone. The same applies to the treatment of ad-
diction, which often involves somatic health care, 
psychiatry and social issues.
social functioning. There is much to indicate that 
the effects of heroin-assisted treatment are weak-
est for those in the target group who are in great-
est need of an alternative or extended offer of 
substitution treatment.’
The Ministry will follow up the question of hero-
in-assisted treatment in the coming white paper 
on drugs and alcohol policy.
1.5 Economic analysis
It has proven difficult to calculate the costs to so-
ciety of drug and alcohol use. This is partly be-
cause problems caused by use and abuse of alco-
hol and drugs are difficult to translate into 
monetary terms, and partly because of different 
views of what cost components should be in-
cluded in such a cost estimate. Calculations that 
have been carried out vary with respect to what 
costs are included, and the studies are not very 
comparable. Over and above establishing that 
the costs are significant, we do not find it 
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the relatively strong decrease since 2004 in the 
proportion that have used cannabis during the 
last 30 days in the under-35 age group. In 2004 it 
was 4.5 per cent, while in 2009 it was reduced to 
2.1 per cent. This percentage seems to have in-
creased among those over the age of 35. 
Furthermore,  the last year prevalence has also 
decreased in the 15–34 age group, from a pro-
portion of 9.6 per cent in 2004 to seven per cent 
in 2009. The decline in the youngest group could 
also be a sign of a change in the longer term and 
it may be a contributory factor to the above-
mentioned observed decline in lifetime preva-
lence at the population level (Figure 1).
For the other drugs, the lifetime prevalence has 
been more stable and at a relatively low level. In 
2009 the prevalence for amphetamine is highest, 
almost four per cent, followed by cocaine at 2.5 
per cent. The figures are very small, however, 
which means chance can result in relatively large 
changes. In 2009 the prevalence of any drugs, ex-
cept for cannabis did not exceed one per cent.
Table 1: Percentage of the population between the 
ages of 15 and 64 that have used cannabis: ever, 
during the last year and during the last 30 days, 
respectively.
Used  
cannabis 1985 1991 1994 1999 2004 2009
 .. ever 8.5 9.6 13.1 15.4 16.2 14.6
 .. last year 2.2 3.0  4.4  4.5  4.6  3.8
 .. last 30 days -* -  1.9  2.5  2.2  1.6
*- = no data available
Source: SIRUS
2.1  Drug use in the general 
population
SIRUS has conducted surveys of the Norwegian 
population’s use of alcohol and drugs since 1968. 
The surveys are normally carried out every five 
years. The most recent survey was carried out in 
autumn 2009, and the data were presented in the 
National report for 2010, Chapter 2. The drugs 
questionnaire was part of a more comprehensive 
survey that was mainly concerned with alcohol 
consumption and attitudes to alcohol policy is-
sues. Data collection in these surveys is carried 
out in the form of face-to-face interviews, but 
the questions about drugs were answered on a 
separate sheet that the respondent gave to the in-
terviewer in a sealed envelope. The data concern-
ing drugs were later linked to the other data from 
the interview survey. Main features from the 
2009 survey:
The proportion of respondents who answered 
that they had ever tried cannabis had fallen from 
approx. 16 per cent in 2004 to less than 15 per 
cent in 2009 (Table 1). The fact that lifetime 
prevalence has fallen during the past five years is 
somewhat surprising given the cumulative na-
ture of the variable.
Lifetime prevalence is highest in the 25–34 age 
group, while both the proportion that have taken 
cannabis during the last year and the last 30 days 
is highest in the 15–24 age group. This applies to 
both 2004 and 2009. What is more surprising is 
2.  Drug use in the general population and 
among specific targeted groups
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2011). The 2010 survey has been changed on two 
points, however: 1) the age group was extended 
to include people aged 18–20 years, and 2) a 
sample of 2,005 persons recruited via TNS 
Gallup’s web panel for the relevant age group was 
included in addition to the ordinary sample. 
Some minor changes were also made to the 
questionnaire.
The sample consists of 4,956 persons in total. 
Unless otherwise stated, the findings are based 
on the whole sample, i.e. 18, 19 and 20-year-olds 
are included. This means that the results here are 
not directly comparable with the previous three 
surveys. A report based on comparable data 
(corresponding sample type and age group), 
which focuses on changes over time in particu-
lar, is being prepared and is expected to be com-
pleted by the end of 2011. Preliminary analyses 
show that lifetime prevalence for the use of can-
nabis is declining in the 21–30 age group, com-
pared with the 2006 survey for the same age cat-
egory. The decline found among the general 
population thus seems to be confirmed by this 
survey.
2.2.1 Data
Figure 2 shows the proportion of young adults 
who say that they have used various illegal sub-
stances ever and during the last six months prior 
to completing the questionnaire. As in previous 
studies, cannabis is the illegal drug that most 
young people report having tried (28.8  %). 
Significantly fewer have tried amphetamine and 
cocaine (approx. 6 % for both). Ecstasy and sniff-
ing have been tried by 3.8 and three per cent, re-
spectively, while around one per cent of this age 
group report ever having used LSD, GHB and 
heroin.
Figure 1: Percentage in different age groups in 2004 
and 2009 who have taken cannabis: ever, during the 
last year and during the last 30 days, respectively.
Source: SIRUS
2.2  Drug use among young 
adults.
Main findings of a questionnaire survey 
conducted in 2010 in the 18–30 age group.
Every four years since 1998, SIRUS has conduct-
ed questionnaire surveys on the use of drugs 
among young adults in the age group 21–30 
years. The results for the years 1998, 2002 and 
2006 were published in the national report for 
2007, Chapter 2.2.2. Both the age categories and 
intervals (here: ever used, used during the last 
six months) deviate from the EMCDDA’s system 
(ever used, used during the last year, used during 
the last 30 days). The data cannot therefore be 
presented in the standardised table that the 
EMCDDA uses as the basis for its trend 
analyses.
Methodology and sampling
The 2010 survey, which forms the basis for the 
results that are presented here, was conducted in 
a corresponding manner to previous surveys, 
based on systematic samples of the population 
register with the aim of ensuring a representative 
sample for this age group (Bretteville-Jensen, 
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Figure 3: Frequency of use among those who report 
having tried different substances, as a percentage, 
aged 18–30
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Gender and age distribution
More men than women state that they have tried 
different drugs(Figure 4). The difference between 
women and men is statistically significant for 
cannabis, amphetamine, cocaine, ecstasy and 
LSD. This means that the gender differences are 
greater than can be ascribed to random differ-
ences resulting from our using samples instead 
of total population figures. Nine percentage 
points more men than women report having 
used cannabis, and almost twice as many men as 
women report having used amphetamine and 
cocaine.
Figure 4: The proportion aged between 18 and 30 
years who report having tried different substances 
in Norway, among women and men
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Figure 5 clearly shows that persons in the oldest 
age category (26–30 years) have more experience 
Figure 2: The proportion who report having tried 
different substances, ever and during the last six 
months, aged 18–30
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As Figure 2 shows, the number reporting more 
recent use is significantly lower than the number 
who have ever tried the different substances. 
About a third of those who report having experi-
ence of the different types of drugs, report that 
they have used them during the last six months. 
Nine per cent of the entire sample report rela-
tively recent use of cannabis, less than two per 
cent have used amphetamine or cocaine and less 
than one per cent of the respondents report that 
they have used the other substances during the 
last six months.
Frequency of use
Although almost 30 per cent of the sample re-
port having tried at least one illegal substance, 
the data show that the majority only try this drug 
a few times (Figure 3). The proportion who have 
used the different substances once or just a few 
times is highest for heroin and lowest for canna-
bis, but even here, 46 per cent of the cannabis us-
ers report having used the drug one to four times 
and 63 per cent report having used it ten times 
or less. Two out of ten cannabis users report hav-
ing used the drug more than 50 times during 
their lives. Heroin deviates somewhat from the 
other drugs in that more than 30 per cent of 
those who report use state that they have tried 
the drug more than 50 times. The number of 
persons who report heroin use is nonetheless 
very small (n=45).
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Debut age
The lowest average debut age in this age group is 
found for the sniffing of solvents, namely 14.6 
years, followed by cannabis (17.7), amphetamine 
(18.2) and ecstasy (18.4). It is only for the latter 
two that there is a statistically significant differ-
ence between the genders, with women starting 
somewhat earlier than the men who try these 
drugs. LSD has the highest average debut age (21 
years), followed by cocaine (19.7). The average 
debut ages for GHB and heroin are 19.0 and 18.1, 
respectively (Figure 6).
Figure 6: Debut age for different substances, for 
men and women separately. Age group 18–30 years
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of drug use than the younger age groups. This is 
to be expected, as the former have had more 
years to try drugs. For cannabis, for example, we 
see that, while 20 per cent of the youngest age 
group (18–21) report having tried the drug, the 
proportion is 31 per cent among those aged 22 to 
25, and 34 per cent in the oldest age category. 
The difference between the youngest cannabis 
users and the slightly older ones is nonetheless 
so great (11 and 14 percentage points, respec-
tively), that it may indicate that the younger us-
ers have a lower tendency to try the drug. This is 
in line with other surveys that show declining 
cannabis use in the youngest age group (Vedøy & 
Skretting, 2009, Hibell et al., 2007). It is only in 
relation to the sniffing of solvents and use of her-
oin that the proportion among those aged be-
tween 22–25 is somewhat higher than in the 
other age groups, but these differences are not 
statistically significant.
Figure 5: The proportion who report having tried 
different substances in Norway, in different age 
groups
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individuals and society. One important goal is to 
coordinate and strengthen local prevention ef-
forts. Competence-raising measures target key 
personnel in the municipalities (administrative 
decision-makers, politicians, relevant sector 
managers, the retail and licensed trades, the po-
lice, health personnel, local school managers, 
teachers, parents/guardians and voluntary 
organisations).
One example of local competence-raising mea-
sures is PREMIS, a programme for coordinating 
drug and alcohol prevention work that was initi-
ated by a regional competence centre in Central 
Norway. The programme is linked to the inter-
sectorial partnership in health in two of the 
counties in Central Norway. It aims to contribute 
to raising competence in the municipalities, the 
implementation of knowledge-based measures 
and network-building between the municipali-
ties. The main goals of PREMIS are:
- To reduce the incidence of binge drinking 
among youth
- To raise the debut age for alcohol use
- To reduce the use of drugs among young 
people
All the municipalities in the region are invited to 
join PREMIS for a period of three years. The pro-
gramme has certain fixed, overriding elements re-
lating to the implementation of the process, but 
the participating municipalities are free to organ-
ise the local work themselves and to choose pre-
ventive measures based on local needs. Each mu-
nicipality appoints a local interdisciplinary 
working group and a coordinator. The municipali-
ties are offered free courses, access to a ‘toolbox’ of 
methods and measures, professional guidance and 
follow-up, and opportunities for network building 
with other municipalities. The programme was 
first developed, implemented and evaluated as a 
pilot project in the period 2006–2008.
Introduction
Preventive work in Norway is based on a long-
term, continuous perspective. In recent years, 
prevention in Norway has been rooted in the 
Government’s Action Plan. The plan includes ef-
forts to raise professional standards in preventive 
work in Norway. One of the five main goals is a 
clear focus on public health. Information work 
will be strengthened, with more targeted infor-
mation and more participation by young people 
and parents. Knowledge must be increased and 
attitudes changed in order to reduce harmful ef-
fects. Public support of the voluntary sector will 
continue as part of the effort to improve quality. 
Preventive measures will be coordinated and 
work on drug and alcohol prevention in the 
workplace will be intensified. It is a goal that pre-
ventive work in the drugs and alcohol field (and 
in mental health) shall be a natural part of the 
municipalities’ work on health promotion. The 
Norwegian Directorate of Health’s task is to con-
tribute to local implementation of preventive 
measures that are in line with official policy. The 
seven regional competence centres for alcohol 
and drug tasks are key partners in coordinating 
and improving local prevention in the munici-
palities. Preventive work of various kinds and on 
a varying scale is ongoing in all municipalities.
3.1 Universal prevention
3.1.1 Community
Competence-raising in the municipalities
The Directorate of Health and the seven regional 
drug and alcohol competence centres cooperate 
with the aim of increasing the municipalities’ 
competence in drug and alcohol prevention work 
in general. The county governors also contribute 
to this work. The municipalities are responsible 
for quality assuring and developing a local drugs 
and alcohol policy that helps to reduce the nega-
tive consequences of drug and alcohol use for 
3. Prevention
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the 430 Norwegian municipalities now have 
drugs and alcohol policy action plans, compared 
with about a third in 2004. In other words, there 
has been a considerable increase in the number 
of municipalities with such plans.
On assignment for the Directorate of Health, 
SIRUS has carried out an in-depth study consist-
ing of qualitative interviews, participatory ob-
servation at meetings and document analyses in 
eight selected municipalities in order to shed 
light on the importance of such plans (Baklien & 
Krogh, 2011). The report covers both the process 
in connection with the plan, the actual plan itself 
and what effects the action plans seem to have 
had.
The evaluation points out that, for those in-
volved, the plan processes generate enthusiasm, 
increase awareness and knowledge, and put the 
topic of drugs and alcohol on the agenda. When 
the plan gets as far as to the municipal council, 
however, the outcome is often that not very much 
happens. To the extent that there is debate, it 
usually concerns sales and licensing hours. Care 
and rehabilitation initiatives are seldom the sub-
ject of political debate. How far politicians feel 
ownership to the plans varies a great deal. It is 
the practitioners who feel the clearest ownership 
to the plans and who use them actively. As a 
whole, the plans have probably failed to have the 
big and noticeable effect on municipal drugs and 
alcohol policy that was hoped for. There is basi-
cally not much politics involved in the processes, 
products and consequences. This indicates that a 
lot remains to be done for the intention behind 
the drugs and alcohol policy action plans to be 
realised.
The selection of municipalities was based on in-
cluding different regions, municipalities of dif-
ferent sizes and political colour, that varied in 
terms of organisation and the degree of involve-
ment of the competence centres. Questions can 
nonetheless be raised about representativeness, 
since the study only covers a small minority of 
the municipalities that have prepared such ac-
tion plans.
In order to learn from experience of this way of 
working, the evaluation focused on how the 
work was carried out in the municipalities. The 
evaluation did not focus on measuring the ef-
fects of the measures.
Different disciplines and agencies have been rep-
resented in the local PREMIS groups. This has 
helped to give those involved greater insight into, 
understanding of and respect for each other’s 
work situations. An important success criterion 
for the work on PREMIS was good backing from 
the municipality, i.e. support at different levels in 
a municipality, from both politicians and experts. 
This was important in order to win acceptance 
for preventive measures.
The evaluation indicated that PREMIS has con-
tributed to raising the competence of people in 
the municipalities, strengthened interdisciplin-
ary/inter-service cooperation, helped with the 
systematisation of existing measures and, not 
least, laid a foundation for further work on drugs 
and alcohol prevention. Four out of five pilot 
municipalities are still running measures that 
were implemented when they participated in 
PREMIS, three years after the end of the PREMIS 
period. Since its start-up in 2005, 24 municipali-
ties have participated or are participating in 
PREMIS.
Action plans in the field of drugs and 
alcohol policy
Pursuant to the Norwegian Alcohol Act, the mu-
nicipalities are required to prepare alcohol policy 
action plans. Several other laws also assign the 
municipalities tasks in the drugs and alcohol 
field. Based on the intentions of the act and the 
municipalities’ own needs, the municipalities are 
encouraged to pursue a coherent drugs and alco-
hol policy, and to have a plan for this work in 
which drugs and alcohol policy challenges are 
seen in conjunction with licensing arrangements, 
other preventive efforts and rehabilitation. The 
Directorate of Health, the regional competence 
centres and the county governors assist the mu-
nicipalities in the development and implementa-
tion of such plans. Just under three-quarters of 
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adapting it to Norwegian conditions. Various lo-
cal projects have also been initiated in several 
municipalities to strengthen the work.
3.1.3 School
For several decades, drug and alcohol prevention 
work has been based on various documents gov-
erning the school sector, such as legislation, na-
tional curricula and subject-specific curricula. 
Based on recent relevant research in the field, the 
Directorate of Health and the Directorate for 
Education and Training will publish a new, elec-
tronic guide in autumn 2011 for schools’ preven-
tive work in the drugs and alcohol field.
The guide is intended to help to spread new 
knowledge about how schools can best contrib-
ute to drugs and alcohol prevention work and to 
provide national recommendations for the whole 
country. The guide focuses on important ele-
ments that form the basis for coherent, knowl-
edge-based prevention: a good learning environ-
ment, cooperation between the home and school, 
adapted tuition, social competence, methods 
that activate pupils and authoritative classroom 
leadership. The efforts that are implemented 
must be theoretically well-grounded, have a clear 
implementation strategy and a long-term per-
spective. The guide is linked to the national cur-
riculum, which, in some subjects and for selected 
years, contains clearly defined competence goals 
relating to drugs and alcohol. The home/parents 
and the school health service are key partners.
3.2  Selective prevention, at-risk 
groups and settings
Pursuant to the Government’s Action Plan, ser-
vices shall be available to children and young 
people who are particularly at risk of developing 
drug or alcohol problems.
Six measures in the plan are intended to contrib-
ute to early intervention and greater accessibility 
of services for children and young people:
The municipalities’ control of the sale and 
serving of alcohol
Norwegian legislation relating to alcohol con-
tains many provisions aimed at limiting accessi-
bility, including a licensing requirement, age 
limits for the sale and serving of alcohol, sales 
and licensing hours, and restrictions on serving/
selling alcohol to people who are clearly under 
the influence of alcohol or drugs. It is the mu-
nicipalities’ responsibility to enforce the provi-
sions of the law in this context. Surveys show 
that municipal control of the sale and serving of 
alcohol is not good enough. On the basis of a 
project carried out by the Directorate of Health 
in collaboration with the regional competence 
centres in 2009/2010, the directorate is now pre-
paring a guide to inspections aimed at munici-
palities and sales and licensed premises inspec-
tors. One of the goals is to establish a national 
norm/standard for good inspections and proce-
dures. The guide is being developed in collabora-
tion with the National Police Directorate. A 
number of competence-raising measures have 
also been carried out for the municipalities.
3.1.2 Family
Parents’ role in drug prevention
One important aim of the Action Plan 2008–
2012 is to raise the general public’s level of 
knowledge and to make people aware of the link 
between the age at which people start drinking 
and alcohol consumption in adult life. The initial 
target group is young people and parents, who 
are to be given a more active role as contributors 
and mediators in local preventative work. One 
important goal is to help develop good, safe local 
communities.
One of the regional competence centres is dedi-
cated to collecting more information and know-
how about this topic. The centre follows a five-
year plan for this work. Conferences, seminars 
and various programmes will contribute to 
spreading information and involving parents 
more in preventive work. During the past year, 
the competence centre has, among other things, 
worked on translating the Swedish Örebro 
Prevention Programme into Norwegian and 
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drug and alcohol users and parents with mental 
illness, and early intervention in relation to preg-
nant women and parents of infants and small 
children. Work is currently under way on sum-
marising the results of the project, which will be 
used to identify ‘best practice’.
Continuation of the ‘Ut av tåka’ (Out of the 
fog) quit smoking hash course in Oslo
The course is a continuation of the Outreach 
Service’s quit smoking hash course in Oslo in 
2006/2007. See NR 2010 Chapter 3.2.1. It is based 
on intersectorial support and cooperation, and 
on the systematic development of local method-
ological competence based on experience from 
Sweden and Denmark. There are two target 
groups: youth aged between 15 and 25 who are 
motivated to stop using cannabis, and first-line 
employees in the city wards whose day-to-day 
work involves contact with these young people. 
The initiative has helped professionals to develop 
their competence so that they are able to offer 
young people in their ward an opportunity to 
stop on a group and individual basis. Young peo-
ple are reached earlier than before.
The Outreach Service, the Oslo Drug and Alcohol 
Addiction Service Competence Centre and the 
SaLTo secretariat (SaLTo – Model for collabora-
tion between the City of Oslo and Oslo Police 
District on crime-prevention work among chil-
dren and youth) have produced a description of 
an initiative outlining an offer to young people 
with an addictive relationship to cannabis. It in-
cludes the ‘Ut av Tåka’ programme. The offer is 
comprehensive and is based on high accessibility 
to the target group and unbureaucratic referral 
procedures.
• Raising competence in the municipalities, for 
example through guidance by expert teams 
in the child welfare service
• Improving competence in early identification 
and early intervention among staff who come 
into contact with children and young people 
at risk
• Strengthening the municipalities’ low-
threshold services and outreach activities
• Introducing a specific waiting-time 
guarantee for children and young people 
with mental health problems and young 
alcoholics and drug addicts under the age of 
23
• Ensuring that GPs have the tools they need 
to assess problem alcohol use among patients
• Studying the prevalence of mental health 
problems and drug and alcohol problems 
among children and young people and their 
treatment and follow-up needs.
Work on all the measures is under way. Among 
other things, a training package has been devel-
oped for staff in relevant services. The guide Fra 
bekymring til handling (From Concern to Action) 
(see NR 2010 Chapter 3.3.1) was launched in au-
tumn 2009. It makes an important contribution 
to early intervention efforts by providing guid-
ance for service staff and managers.
The waiting-time guarantee will ensure that chil-
dren and young people under the age of 23 with 
drug and alcohol problems or mental health 
problems do not have to wait for more than ten 
days for their application for help to be consid-
ered, and no more than 65 days for treatment.
A study was carried out in 2010 of the prevalence 
of mental health and drug and alcohol problems 
among young people and their further treatment 
and follow-up needs. The final report is expected 
to be completed by the end of 2011.
3.2.1 At-risk groups
About 30 methodology development projects 
have been initiated in different municipalities. 
The projects largely target at-risk young people 
aged between 11 and 23, children of problem 
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3.2.2 At-risk families
Children of parents with drug or alcohol prob-
lems and/or mental health problems and chil-
dren who have been exposed to violence or trau-
matic experiences are particularly at risk of 
developing drug or alcohol problems themselves. 
It is important to ensure that everyone who is at 
particular risk of developing such problems and 
people with incipient drug or alcohol problems 
are discovered at an early stage and that they are 
offered the correct help as early as possible. Early 
intervention in relation to children often involves 
intervening in relation to the adults in the child’s 
life, while early intervention in relation to youth, 
adults and older people is often about getting to 
grips with risky alcohol consumption.
The guide ‘Fra bekymring til handling’ (From 
Concern to Action) has been implemented in 
many municipalities during 2010. See the de-
scription in NR 2010 Chapter 3.3.1. The recom-
mendations in the guide are followed up by com-
petence-raising initiatives in the municipalities 
organised by the regional competence centres. 
Link:
(http://www.helsedirektoratet.no/vp/multime-
dia/archive/00334/IS- 1742_Engelsk_
Eng_334559a.pdf)
Competence raising
In collaboration with the regional competence 
centres, the Directorate of Health contributes to 
raising competence in use of the ‘early interven-
tion’ method in the municipalities and the spe-
cialist health service, among other things through 
increased use of mapping tools with follow-up 
conversations (mini-interventions).
In 2010, the Directorate of Health and the 
Directorate for Children, Youth and Family 
Affairs developed a national training programme 
that provides training in mapping tools (TWEAK 
– uncovering risky consumption of alcohol, and 
depression and violence in close relationships) 
and conversation methods targeting pregnant 
women and parents of small children. The pro-
gramme is offered to the municipalities free of 
The goal is to:
• Establish an offer for young problem users of 
cannabis
• Establish and develop an intervention in all 
interested city wards
• Spread knowledge about the method, the 
initiative and cannabis addiction
• Seek contact with Norwegian and Swedish 
networks in the prevention and 
rehabilitation of problem cannabis use.
Great demand has been registered for know-how 
about cannabis and the treatment of cannabis 
problems. There is reason to believe that courses 
aimed at weaning people off cannabis reach 
young people who would not otherwise seek 
help for their drug problems. Increased focus on 
and knowledge about cannabis in the help ser-
vices will also help more young people to seek 
help for their problems at an earlier stage.
Measures aimed at immigrant youth’s use of 
drugs and alcohol
In cooperation with the City of Oslo’s Health and 
Welfare Service, the Oslo Drug and Alcohol 
Addiction Service Competence Centre has car-
ried out a project where ICDP groups focus on 
the topic of drugs and alcohol (described in more 
detail in NR 2010 Chapter 3.2.1). The aim of 
ICDP (the International Child Development 
Programme) is to influence the carer’s positive 
experience of the child/youth in order to get the 
carer to more readily identify and empathise 
with him or her. The ICDP courses have been 
completed and the report is in preparation. The 
feedback from ICDP counsellors indicates that 
the project has produced good results in terms of 
participation and a mutual increase in knowl-
edge. There were challenges during the start-up 
phase relating to the recruitment of participants, 
but there were no drop-outs once the course got 
started. The preliminary conclusion is that the 
courses seem to have had a positive effect on the 
participants in relation to network building, 
strengthening of the role of parent and increas-
ing knowledge about society and drug 
problems.
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with friends, relatives or colleagues. The course/
self-help is not suitable for persons with a long 
history of problem drug or alcohol use.
Links: The Bergen Clinics Foundation/ the Bergen 
Drug and Alcohol Addiction Service Competence 
Centre: Online self-help programmes, alcohol, can-
nabis and cocaine.
http://www.bergenclinics.no/index.asp?strUrl=1
001996i&topExpand=&subExpand
AKAN’s Balance, Alcohol:
https://program.changetech.no/ChangeTech.ht
ml?Mode=Trial&P=H8V8X8&C=HJ04HX
3.3.2 Outreach work
There is long-standing tradition for outreach 
work targeting young people. It is an important 
part of the preventive efforts in Norway. The 
main focus is on early intervention. In this con-
text, early intervention means reaching youth in 
high-risk milieus as early as possible. While out-
reach work among young people is part of the 
municipality’s general responsibilities, it is not a 
statutory responsibility.
Outreach workers work on secondary preven-
tion amongst children and youth. The main prin-
ciple for the method used is to actively reach out 
to youth in need of support or help. These indi-
viduals are often not being reached, or not suffi-
ciently, by other parts of the public support sys-
tem. The intention is to establish contact with 
young people at the earliest possible stage and to 
motivate them for alternative activities, help or 
counselling.
The Norwegian Association for Outreach Work 
With Youth (LOSU) represents most of the coun-
try’s 60 outreach workshops, counting some 250 
street educators. Link: http://www.losu.no/in-
dex.php?option=com_content&view=category&
layout=blog&id=102&Itemid=55
charge. The training programme is being tested 
in five municipalities (one municipality in each 
region – North, Central, Eastern, Southern and 
Western Norway) and it is offered to relevant 
employees/services (doctors, midwives and 
health visitors, kindergartens/schools/NAV). 
The training programme is approved by the 
Norwegian Medical Association as conferring 
formal competence. The training programme is 
being evaluated by SIRUS. The report will be 
available in 2012.
Website
The Norwegian Electronic Health Library runs a 
website on behalf of the Directorate of Health 
and the Directorate for Children, Youth and 
Family Affairs: Screening and mapping tools for 
use in work with parents, pregnant women and 
children of parents with mental health problems 
and/or drug or alcohol problems.
http://www.helsebiblioteket.no/microsite/
Kartleggingsverktøy
3.3. Indicated prevention
3.3.1 Early intervention
From 2010, all the competence centres in the 
drugs and alcohol field have three trained in-
structors in MI (motivational interviewing), 
which is a knowledge-based method (for change). 
They will contribute to competence-raising in 
municipalities that work on early intervention in 
particular. The interviewing method is suitable 
in many contexts when it is desirable to encour-
age another person to change his/her behaviour 
and it is very suitable for conversations about 
lifestyle changes in the health and care sector.
Self-help programmes
There are many digital self-help programmes 
aimed at people who wish to change their use of 
or addiction to alcohol, cocaine or cannabis. The 
programmes are freely available on the internet. 
Self-help programmes are aimed at people with 
mild to moderate drug or alcohol problems, who 
live in stable living conditions and have contact 
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on tacit know-how in their work. Both services 
have given lectures on the method both in 
Norway and abroad – often in collaboration with 
the Oslo Drug and Alcohol Addiction Service 
Competence Centre. Part of the method consists 
of reflecting team sessions being held ‘live’, linked 
to a specific situation that the field workers or 
others bring with them from their work.
Motivational interviewing as a method in 
outreach work
In 2010–2011, the Oslo Drug and Alcohol 
Addiction Service Competence Centre carried 
out a pilot group project with the aim of system-
atically testing the use of motivational interview-
ing (MI) in outreach work. Ten former students 
with further education in outreach social work 
who now work in six different outreach services 
were given the chance to take part in a guidance 
group in which experience of the use of MI in 
outreach work was to be reviewed and further 
developed. The evaluation of the pilot group in-
dicates that MI is a highly expedient approach to 
outreach work, but it also seems to be the im-
pression that implementing MI requires relative-
ly extensive training and support in the process 
of changing one’s own practice. The Oslo Drug 
and Alcohol Addiction Service Competence 
Centre is starting a new guidance group in MI 
for outreach services staff this autumn. There is 
great interest in participating.
Further education at university college level
Topics relating to outreach work are now part of 
further education programmes at several univer-
sity colleges. At the university colleges in Oslo 
and Akershus counties, the Oslo Drug and 
Alcohol Addiction Service Competence Centre 
has established a dedicated further education 
programme in outreach social work (street-
based youth work). To be eligible for participa-
tion, the students must have a relevant education 
from a university or university college and be 
employed in an outreach service. The study pro-
gramme lasts for one year and is worth 30 cred-
its. This year’s class consists of 26 students, 14 of 
whom are Norwegian field workers, while the 
In 2010, LOSU has, among other things:
• Organised four regional conferences for 
outreach services in Norway to strengthen 
the professional preventive approach in 
outreach methodology
• Prepared and distributed a professional 
guide for small outreach services
• Prepared and distributed a professional 
guide for outreach social work on the 
internet
• Contributed to the development of an 
international methodology textbook for 
outreach social work
• Had close contact with central authorities 
concerning social and legal challenges 
relating to unaccompanied minor asylum 
seekers and young people who are victims of 
human trafficking
• Taken part in international cooperation. 
LOSU is a key member of the global 
association for outreach social work, 
Dynamo International, which is based in 
Brussels
• Helped to organise a big international 
conference in Oslo. The topic was 
‘Perspectives on Outreach Work in Europe’. 
Plans are under way for a new conference in 
2012. These conferences are organised under 
the auspices of the Oslo Drug and Alcohol 
Addiction Service Competence Centre.
The biggest outreach services come together in a 
dedicated network twice a year to exchange in-
formation and experiences from work in the big 
cities and towns in Norway. Bergen Outreach 
Service has adapted the Rapid Assessment & 
Response method as an analytical approach to 
social issues in outreach work. The method was 
originally developed by the World Health 
Organisation (WHO). The use of this method is 
on the increase in the outreach field.
Work on tacit know-how and the use of so-called 
reflecting teams is now well established in the 
outreach services in Oslo and Bergen. Reflecting 
teams are a method whereby the members of the 
outreach team are given an opportunity to focus 
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rest are field workers employed in Swedish and 
Finnish municipalities.
The European Correlation Network
A report from the network on early intervention 
is currently in preparation This is a European 
collaboration network in which one of the focus 
areas is how to reach at-risk youth at an early 
stage. The report and the project will be complet-
ed in autumn 2011. The Oslo Outreach Service 
and outreach workers in two city wards have 
been part of the project, which has also involved 
collaboration with partners in several European 
countries.
Online registration tool
With support from the Directorate of Health, the 
Oslo Drug and Alcohol Addiction Service 
Competence Centre has worked during 2010 
and 2011 on creating a new online registration 
tool for outreach services. The programme, 
which will be tested in ten municipalities, could 
lead to new procedures for the documentation of 
practice in outreach services. At the same time, it 
results in better information security in connec-
tion with the registration of personal data (pa-
tient records etc.), and the submission of statis-
tics to local and central authorities, and it creates 
new possibilities for improved registration and 
handling of governing data for the development 
of the services. During 2011, the new registra-
tion tool will be introduced in ten pilot munici-
palities throughout Norway. The project is to be 
evaluated in 2012–2013, and the possible con-
tinuation and wider introduction of the tool in 
more municipalities will be considered in this 
connection.
3.4  National and local media 
campaigns
No recent media campaigns have been aimed at 
the use of drugs in particular. There have been 
several extensive national information cam-
paigns in connection with alcohol, however. 
These campaigns were described in the national 
report for 2009. They were continued in 2010.
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Work is being done to calculate how many prob-
lem users we have according to the general defi-
nition. Figures from the Norwegian National 
Patient Register for the number of persons who 
have started treatment for drug-related diagno-
ses will be a new source of data. See more details 
in Chapter 5.
Calculating the number of injecting drug 
users
Table 2 shows estimates of the number of inject-
ing users in Norway, calculated using the 
Mortality Multiplier. The estimates include fig-
ures for overdose fatalities from the Norwegian 
Cause of Death Register supplied by Statistics 
Norway and from the National Crime 
Investigation Service (Kripos) up until 2009. 
Provisional calculations for 2009 from last year’s 
report have been adjusted upwards to the same 
level as in 2008. The estimated number of inject-
ing users in Norway increased from the 1970s 
until 2001, followed by a reduction up until 2003. 
The figure has since remained stable.
Table 2: Ranges for the number of injecting drug 
users in Norway 2002–2009, calculated using the 
Mortality Multiplier*
Year Lower limit – upper limit
2002 10,500 – 14,000
2003 9,200 – 12,800
2004 8,700 – 12,200
2005 8,900 – 12,400
2006 8,400 – 11,700
2007 8,600 – 12,000
2008 8,800 – 12,500
2009 8,800 – 12,500
*Round figures
Source: SIRUS.
The figures include all injecting use. Heroin is 
still the most common drug injected, but, for 
some, amphetamine is the main drug injected. 
The proportion of injecting users in Oslo who 
inject amphetamine has been increasing and it 
4.1  Prevalence and incidence 
estimates of PDU
See data in Standard tables 07 and 08.
Definitions
The EMCDDA defines problem use as ‘Injecting 
use of drugs or prolonged/regular use of opiates, 
cocaine and/or amphetamines’. Opioids is used as 
a generic term for natural opiates (such as opium, 
dolcontin), semi-synthetic opiates (heroin) and 
synthetic opioids (such as methadone, buprenor-
phine). This means that everyone undergoing sub-
stitution treatment who is prescribed methadone 
and Subutex are problem users according to the 
EMCDDA’s definition. Including such groups can 
appear strange in Norway, where the intention of 
opioid substitution treatment (OST) is to get peo-
ple who have used heroin for a prolonged period 
to begin a life without using illegal drugs, subject 
to follow-up and rehabilitation.
In the Norwegian context, however, it might be 
natural to look at a subgroup of patients in OST 
as problem users. Around 12 per cent of OST pa-
tients report using morphine substances in addi-
tion to OST medication during the last 30 days, 
and 17 per cent have been found to use stimu-
lants. There has also been an increase in the 
number of persons who move in and out of OST, 
and who thus may have periods of heroin use be-
tween treatment periods (Waal et al., 2011).
In addition to the general definition of problem 
use, the EMCDDA also uses two underlying def-
initions: injecting drug users and problem users 
of opioids or heroin.
In Norway, we primarily have figures for the 
group that injects drugs, but the number of prob-
lem users of heroin in the period 2000 to 2008 
has also been estimated (see NR 2009 Chapter 
4.2.1 and Bretteville-Jensen & Amundsen, 2009). 
4. Problem drug use
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was around 17 per cent in the period 2000–2004 
(Bretteville-Jensen, 2005).
Problem users of cocaine
SIRUS has participated in a project in which the 
amount of cocaine used in Oslo was calculated 
using three different methods. The Norwegian 
Institute for Water Research (NIVA) has carried 
out measurements of cocaine in wastewater, 
while the Norwegian Institute of Public Health 
has carried out measurements of cocaine among 
drivers suspected of driving under the influence. 
SIRUS has used a method based on the reporting 
of the frequency of cocaine use in four different 
surveys, both population-based and among in-
mates in prisons and injecting users.9 The results 
of the surveys have not yet been published (Reid 
et al.). SIRUS’s work on this project can also be 
used to estimate the number of problem users of 
cocaine.
The EMCDDA’s definition of problem users of 
cocaine includes persons who have used cocaine 
or crack over a prolonged period and regularly. 
SIRUS chooses to define ‘prolonged and regu-
larly’ to mean having used cocaine at least once a 
week for at least six of the last 12 months. Recent 
use of cocaine (during the last six or twelve 
months) seems to have changed little during the 
2000s, and average figures from several different 
surveys have therefore been used to ensure low 
statistical uncertainty.
In the questionnaire surveys, the respondents 
were also asked how often they used cocaine. It is 
thus possible to calculate an annual average 
number of cocaine users and the number of per-
sons who used the drug more than once a week 
or more (problem users). The results for Oslo for 
the period 2000–2009 are shown in Table 3. On 
9  The following surveys were used: Surveys of the 15-20 
age group in 2006-2008; the 21-30 age group in 2006 
and 2010; the population aged 15 and older in 2004 
and 2009. In addition, the results are based on a survey 
conducted among prison inmates in 2002 and among 
injecting drug users in 2000-2004.
average, there were approximately 1,800 (inter-
val 1,600–2,000) problem users of cocaine per 
year in Oslo and 10,200 (9,100–11,300) others 
who used the drug more rarely.
The majority of the cocaine users, almost 50 per 
cent, were experimental users who had only used 
the drug one to four times during the last 12 
months, while 35 per cent were recreational us-
ers (limited use). Overall, it was thus estimated 
that 15 per cent of a total of 12,000 persons 
(10,700–13,300) were problem users of cocaine.
Some marginalised users who use little cocaine 
may be big consumers of other hard drugs and 
therefore be included in the general definition of 
problem users, but on the basis of their use of 
other substances. No corresponding estimates 
have been carried out so far at the national level.
Table 3: Last-12-months cocaine users in Oslo. 
Annual average 2000–2009
Problem 
users 
Other users Total 
Number 
of cocaine 
users
1,600–2,000 9,100–11,300 10,700–13,300
Source: SIRUS
Table 4: Last-12-months cocaine users in Oslo. 
Annual average 2000–2009. Percentage of the 
population 15–64 years old
Problem 
users 
Other  
users
Total 
15–30  
years old 1
0.4 4.3 4.7(4.3–5.2)
31–64  
years old 2
0.3 1.3 1.7 (0.6–2.8)
Marginalised 
users 3
0.1 0.1 0.2 (0.0–0.4)
Total 0.4 2.5 2.9 (2.6–3.2)
1 Based on population surveys among 15 to 20-year-olds in 
2006–2008 and among 21 to 30-year-olds in 2006 and 2010
2 Based on population surveys among persons aged 15 year and 
older in 2004 and 2009
3 Based on sample surveys among prison inmates in 2002 and 
among injecting drug users in 2000–2004
Source: SIRUS
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grammes and more medication. There now 
seems to be a tendency to prioritise short-term 
measures and substitution treatment in tender 
criteria at the expense of social-pedagogical 
long-term measures and aftercare.
5.2 Quality assurance
Two guidelines have entered into force in the 
course of 2010/2011:
National guidelines for pregnant women in 
opioid substitution treatment (OST) and 
follow-up of families until the children 
reach school age
On assignment for the Ministry of Health and 
Care Services, the Directorate of Health has pro-
duced professional guidelines for pregnant wom-
en in OST and for the follow-up of families until 
the children reach school age. The guidelines en-
tered into force in May 2011.
The goal is to provide clear, knowledge-based 
recommendations for the treatment and follow-
up of OST patients during pregnancy and while 
in hospital in connection with the birth, and for 
follow-up /treatment of the child and the family 
until the child reaches school age.
The guidelines contain recommendations relat-
ing to the whole course of a patient’s develop-
ment. The treatment includes several different 
areas in both the first-line service (health, social 
and child welfare services) and the specialist 
health services (obstetrics, neonatal medicine, 
child and youth psychiatry and drug and alcohol 
treatment), and the roles and responsibilities of 
these services are described in the guidelines.
Additional information can be found in 
Structured Questionnaire 27, Treatment pro-
grammes, Standard table 24, Access to treatment, 
and in Standard table 34 Treatment Demand 
Indicator.
5.1 Strategy/policy
During the first half of the 2000s, extensive ad-
ministrative and organisational changes took 
place with regard to the treatment of drug and 
alcohol problems. Through the hospital reform 
of 2002 and the Administrative Alcohol and 
Drugs Treatment Reform of 2004,10 responsibili-
ty was assigned to the state-run specialist health 
service. This reorganisation has led to increased 
focus on diagnostics, medication and the use of 
commercial principles in the treatment context. 
This change has been criticised in several differ-
ent quarters. It has been argued, for example, 
that the reorganisation threatens to undermine 
the diversity of treatment options. Resources ap-
pear to be increasingly channelled to so-called 
evidence-based interventions, the establishment 
of outpatient clinics, shorter treatment pro-
10  The state, represented by the regional health authori-
ties (RHAs), took over responsibility for the treatment 
of problem drug and alcohol users from 1 January 2004 
(the Administrative Alcohol and Drugs Treatment 
Reform). Through this reform, 74 treatment units/in-
stitutions (in-patient institutions as well as out-patient 
units) were transferred to the state as represented by 
the RHAs. Forty-two of them were privately owned and 
run, while the other 32 were public. These institutions 
comprised both in-patient and out-patient units. As a re-
sult of the hospital reform effected from 1 January 2002, 
approximately 30 per cent of the intervention services 
had already been transferred before 2004, (psychiatric 
out-patient clinics, drug and alcohol clinics and certain 
in-patient institutions).
5.  Drug-related treatment: treatment 
demand and treatment availability
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specialised treatment is organised differently in 
the different regions. In one of the regions (Central 
Norway), the treatment is organised in a separate 
health enterprise, while in the other three regions, 
the treatment is divided between different health 
enterprises to a varying extent. About half of the 
in-patient treatment capacity is provided by pri-
vate non-profit organisations.
Several of the entities that offer treatment for 
drug and alcohol problems are organised as part 
of the mental health care service. The two sectors 
are closely linked organisationally. There may be 
professional, organisational or resource-related 
reasons for this, such as access to professionals. 
However, not all patients who receive treatment 
for their drug or alcohol problems are treated in 
the interdisciplinary specialist treatment sector. 
Care-based services and low-threshold services 
are largely defined as a municipal responsibility. 
On the other hand, there are also patients in the 
interdisciplinary specialist treatment sector who 
receive treatment for a mental health problem 
that is not related to drugs or alcohol.
The Norwegian National Patient Register (NPR), 
which is a department in the Directorate of 
Health, is authorised by the regulations of 2009 
to collect personally identifiable information 
about patients in the specialist health service. 
The purpose is to facilitate quality development 
and management of treatment provision, and to 
strengthen evaluation and research activities. 
The personally identifiable register also enables 
NPR to quantify the number of patients who re-
ceive treatment in the specialist health service. 
The ‘new’ way of counting patients is based on 
encrypted personal identification numbers, not 
just institution numbers and patient numbers. 
This means that the new calculation method 
avoids patients being counted more than once.
5.3.1  Treatment provision for patients in 
interdisciplinary specialised drug or 
alcohol treatment
A report for 2009 (the Directorate of Health, 
2011) describes the health services offered to pa-
tients in interdisciplinary treatment by the sector 
The target group consists of women in OST dur-
ing pregnancy, their partners, children who have 
been exposed to methadone or buprenorphine at 
the foetal stage, and their families.
The guidelines address all professional groups in 
the municipalities and in the specialist health ser-
vice that have responsibility for following up these 
patients. This applies to the health services, but 
also social services, child welfare services, kinder-
gartens and the school psychological service.
National guidelines for opioid substitution 
treatment of opioid dependency
The guidelines entered into force in February 
2010 and were described in NR 2010 Chapter 
11.2. The aim is to provide advice and recom-
mendations in connection with substitution 
treatment for persons who are addicted to heroin 
or other opioids.
The guidelines and pertaining regulations re-
place the framework that was developed when 
substitution treatment was established as a na-
tionwide service in 1998. The objective is to nor-
malise OST and integrate it with the general 
health service, to ensure that OST patients re-
ceive comprehensive treatment, and, as far as 
possible, to help to ensure that the treatment of-
fered is the same throughout the country. The 
guidelines have been prepared on the basis of 
collated international research on substitution 
treatment and on clinical experience from 
Norway.
5.3  Treatment systems and 
organisation
Treatment for drug and alcohol problems became 
part of the state specialist health service in 2004. It 
was designated ‘Interdisciplinary specialised treat-
ment for problem drug and alcohol use’. This type 
of treatment is either provided as part of the spe-
cialist health service in the four regional health au-
thorities or at private drug and alcohol institutions 
that have an agreement with the health authorities 
for the provision of such services. Interdisciplinary 
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specialised treatment accounted for as many as 
ten per cent of all in-patients treated by the men-
tal health care service, but, because their stays 
were short, they accounted for a somewhat 
smaller proportion of in-patient days. Overall, 
patients in interdisciplinary specialised treat-
ment accounted for about five per cent of pa-
tients treated by the mental health care service in 
2009.
All entities that offer interdisciplinary specialised 
treatment are required to report to the NPR. The 
reporting of activity data from entities that offer 
interdisciplinary specialised treatment has been 
mandatory since 1 January 2009, and it also in-
cludes registering the patient’s situation at the 
start of treatment (situation data). Personal ID 
numbers were reported in almost all cases in 
both 2009 and 2010 (99.6  % and 99.4  %, 
respectively).
Patient data for interdisciplinary specialised 
treatment are still incomplete. Deviations be-
tween patient data and overall reports to Statistics 
Norway indicate that some areas remain to be 
clarified. This also applies to under-reporting, 
which is most common in the outpatient sector.
5.3.2 Waiting times
The Norwegian National Patient Register pub-
lishes statistics every four months of waiting 
times for treatment and violations of treatment 
guarantees. In interdisciplinary specialised treat-
ment, the average waiting time was 76 days for 
patients who were entitled to prioritised medical 
help in 2010, a reduction of two days from 2009, 
but five days more than in 2008. In the waiting 
list statistics, a patient can be referred several 
times since the patients are referred to different 
discipline areas. This means that the same patient 
is counted more than once, which leads to the 
NPR registering more referrals than the number 
of patients.
itself and by the mental health care service for 
adults. The presentation of the treatment offered 
is based on the level of care, and a distinction is 
drawn between in-patient treatment and outpa-
tient contact.
The data basis consists of information reported 
by the institutions about patients who have re-
ceived treatment in the interdisciplinary special-
ist treatment sector. In all, 40 per cent of the pa-
tients in this sector received in-patient treatment 
in 2009. More men than women received in-pa-
tient treatment. Drug problems caused by the 
use of cannabinoids were more often treated on 
an outpatient basis, while problems caused the 
by the use of tranquillisers and depressants, 
stimulants or multiple substances were more of-
ten treated through admission.
Patient data for interdisciplinary specialised 
treatment for 2009 showed that about 60 per cent 
of completed in-patient stays were followed by 
outpatient contact. Half of these contacts took 
place in the course of the first two weeks follow-
ing discharge, and two-thirds had started outpa-
tient follow-up within 30 days.
In all, 30 per cent of the interdisciplinary specia-
lised treatment patients were also treated by the 
mental health care service for adults. As regards 
in-patients, more than 40 per cent were treated 
by both sectors. It was the youngest patients in 
particular who were treated by both sectors. 
While 45 per cent of the patients aged 18–22 
were treated in both sectors, the proportion was 
less than 20 per cent for the oldest patients.
Patients in interdisciplinary specialised treat-
ment who were treated by the mental health care 
service were younger and more predominantly 
male than other patients in mental health care. 
More than 40 per cent of patients in interdisci-
plinary specialised treatment who were treated 
by the mental health care service were admitted, 
while the rest only had outpatient contact with 
this sector. More drugs/alcohol patients were 
treated at hospitals when they were admitted to 
mental health care. Patients in interdisciplinary 
The Drug Situation in Norway 201136
The incidence of HIV among injecting drug us-
ers has for many years remained at a stable, low 
level, with about 10 to 15 cases reported per year. 
The reason for this is not entirely clear, but a high 
level of testing, great openness regarding HIV 
status within the drug user community, com-
bined with a strong fear of being infected and 
strong internal justice in the milieu, are assumed 
to be important factors. In addition, many of the 
sources of infection in the milieu have disap-
peared due to overdose deaths or have been re-
habilitated through substitution therapy or other 
forms of rehabilitation. However, the extensive 
outbreaks of hepatitis A and B in the late 1990s 
and early 2000s, and the high incidence of hepa-
titis C, show that there is still extensive needle 
sharing among this group.
6.1.2 Hepatitis
During the nationwide outbreak of hepatitis A 
from 1996 to 2000, 1,360 drug users were identi-
fied as having acute hepatitis A. Since then, only 
sporadic, individual cases of hepatitis A have 
been reported among injecting drug users. 
6.1.  Drug-related infectious 
diseases
See data in Standard table 09.
6.1.1 HIV and AIDS
In 2010, 258 cases of HIV infection were report-
ed to the Norwegian Surveillance System for 
Communicable Diseases (MSIS). Eleven of the 
cases were among injecting drug users: eight 
men and three women. The median age was 38 
years (26 to 52 years). Five of the eleven who 
were diagnosed as HIV positive in 2010 were 
persons of foreign origin. They had probably 
been infected abroad before coming to Norway 
for the first time.
As of 31 December 2010, a total of 575 persons 
had been diagnosed as HIV positive with inject-
ing use as a risk factor. This amounts to 12 per 
cent of all reported cases of HIV since 1984. 
Development into AIDS has been reported in 
153 of the cases (Table 5). No information is 
available regarding how many of the HIV-
positive injecting drug users are still alive.
6. Health correlates and consequences
Table 5: Notifications of HIV infection and AIDS, Norway 1984–2010. Percentage of injecting drug users by 
year of diagnosis
HIV total HIV injecting 
drug use
Percentage HIV 
injecting drug 
use
AIDS total AIDS injecting 
drug use
Percentage  
AIDS injecting 
drug use
1984–99 2,018 442 22 % 675 112 17 %
2000 175 7 4 % 35 5 14 %
2001 157 8 5 % 33 8 24 %
2002 205 16 8 % 34 4 12 %
2003 238 13 5 % 53 6 11 %
2004 251 15 6 % 36 4 11 %
2005 219 20 9 % 32 4 13 %
2006 276 7 3 % 32 4 13 %
2007 248 13 5 % 11 0 0 %
2008 299 12 4 % 18 2 11 %
2009 282 11 4 % 18 1 6 %
2010 258 11 4 % 22 3 13 %
Total 4,626 575 12 % 999 153 15 %
Source: Norwegian Surveillance System for Communicable Diseases (MSIS), Norwegian Institute of Public Health
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Since 2002, small-scale prevalence surveys have 
been carried out in connection with needle dis-
tribution in Oslo in order to register the preva-
lence of several infectious diseases among inject-
ing drug users. These surveys are the only 
prevalence surveys that are carried out regularly 
among a sample of drug users in Norway. The 
2010 survey showed that 70 per cent of the IDUs 
tested had experienced a hepatitis A infection or 
had been vaccinated against the disease, 34 per 
cent had had a hepatitis B infection and 67 per 
cent had experienced a hepatitis C infection. 
Twenty-seven per cent had hepatitis B markers 
indicating that they had been vaccinated against 
hepatitis B.
6.1.3 Bacterial infections
In the period 2000–2010, six cases of botulism 
have been notified among injecting drug users. 
In addition, one case of anthrax and one case of 
Clostridium noyvi were reported in injecting 
drug users in the same period. In recent years, 
five to ten cases of methicillin resistant 
Staphylococcus aureus (MRSA) have been re-
ported annually among drug users. There are in-
sufficient data about the incidence of other bac-
terial infections among drug users in Norway. 
Tuberculosis is very rarely seen in drug users in 
Norway.
6.2  Other drug-related health 
correlates and consequences
6.2.1 Psychiatric and somatic co-morbidity
Very many patients in mental health care in 
Norway have drug or alcohol problems, and very 
many patients in interdisciplinary specialised 
treatment for drug or alcohol use have psychiat-
ric and somatic disorders.
Studies from Norwegian emergency psychiatric 
services show a prevalence of drug or alcohol 
problems of between 20 and 47 per cent (Vaaler 
et al., 2006, Mordal, 2010). Biological tests show 
that many patients have taken more than one 
drug upon admission. Potentially addictive 
medication was found in about 50 per cent of the 
Hepatitis A vaccine has been offered to IDUs 
free of charge since 2000.
In the period 1995–2008, a considerable increase 
in hepatitis B among drug users nationwide was 
reported to the Norwegian Surveillance System 
for Communicable Diseases. In 2010, only 5 of a 
total of 27 reported cases of acute hepatitis B in-
volved injecting drug users. During the period 
1995–2010, the total number of reported cases of 
acute hepatitis B among injecting drug users was 
1 952. Hepatitis B vaccine has been offered to 
IDUs free of charge since the mid-1980s.
The monitoring of hepatitis C in Norway was in-
tensified from 1 January 2008. The notification 
criteria were changed so that all laboratory-con-
firmed cases of hepatitis C must now be reported 
to MSIS. Previously, only acute illness had to be 
reported, and this resulted in a very inadequate 
overview of the real incidence of the disease in 
the country. In 2010, 1,792 cases of hepatitis C 
(both acute and chronic cases) were reported. In 
about half of the reported cases, no information 
was provided about the presumed mode of trans-
mission, but in the cases where the mode of 
transmission is known, 85 per cent were infected 
through the use of needles. For the time being, 
data from MSIS cannot distinguish between cas-
es involving new infection with hepatitis C and 
cases where the infection occurred many years 
ago. It is therefore not known whether new in-
fection with hepatitis C has declined or increased 
among drug users in recent years.
Among OST patients, the status survey for 2010 
from the Norwegian Centre for Addiction 
Research shows that, for the country as a whole, 
59 per cent of the clients were hepatitis C anti-
body positive, roughly the same proportion as in 
2009. This is lower than expected, and the expla-
nation is probably that the percentage with un-
known status was as high as 16 per cent. In two 
regions where the percentage with unknown sta-
tus was low, the proportion of hepatitis 
C-infected was almost 70 per cent.
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Services Act in 2009 had a concurrent mental 
health problem, but this represents a relatively 
low number of patients (Lundeberg et al., 2010).
Persons with concurrent drugs/alcohol and men-
tal health problems receive illness-triggered so-
cial benefits, such as disability benefit, less often 
than other patients, and they often lack daily ac-
tivation measures (Gråwe and Ruud ,2006). The 
group has a high risk of experiencing homeless-
ness. In the most recent survey of homelessness 
in Norway (2008), over 6,000 persons were regis-
tered as homeless. Twenty-three per cent – i.e. 
almost 1,500 persons – are assumed to have con-
current drug or alcohol problems and a mental 
health problem. (Dyb and Johannessen, 2009). 
This is an increase of 15 per cent from a corre-
sponding survey ten years earlier. The increase 
may be related to the fact that treatment facilities 
have poor discharge procedures, and to the 
downscaling of in-patient provision that is tak-
ing place in the mental health care sector with-
out a corresponding increase in residential and 
follow-up services in the municipalities (Skog 
Hansen & Øverås, 2007). Surveys of homeless 
persons with concurrent drug or alcohol prob-
lems and mental health problems show that they 
are often more ill, more down-at-heel and have a 
longer history of living in marginalised environ-
ments than other homeless people.
A Norwegian follow-up survey among 482 cli-
ents at 20 different treatment facilities for drug 
users that was carried out during the treatment 
and ten years later (SIRUS, 2003) showed a stable 
and substantial reduction in the clients’ drug/al-
cohol problems, but less experienced improve-
ment in mental health. This may indicate that 
many people who receive treatment for drug or 
alcohol problems have under-diagnosed chronic 
physical and mental problems and that they are 
therefore not receiving adequate treatment. The 
problems can become more noticeable as they 
stop using drugs/alcohol to the same extent as 
before.
patients, alcohol in 10 per cent and illegal sub-
stances in 30 per cent. Findings/traces of illegal 
substances are most common among men aged 
18–36, with amphetamine being found in 40 per 
cent. (Mordal, 2010).
Counts of patients in mental health care for 2010 
(the Directorate of Health, 2011) show that 23 
per cent of those who are admitted to mental 
health care have or are given a drug or alcohol 
diagnosis. This is a decline from 2007, when the 
proportion was 29 per cent. The presence of drug 
or alcohol problems in addition to another pri-
mary condition increases the likelihood of read-
mission to mental health care. Although they are 
readmitted more often, patients with concurrent 
drug or alcohol problems and mental health 
problems nonetheless spend fewer days in treat-
ment than other patients. These patients make 
more use of in-patient treatment than other pa-
tients in mental health care and less use of outpa-
tient services. Behaviour disorder is the most 
common psychiatric diagnosis among those who 
are readmitted with concurrent psychiatric and 
drugs or alcohol-related diagnoses.
The treatment period in mental health care is 
shorter and the contact with specialists in mental 
health problems more sporadic for these patients 
than for others. This makes it difficult to estab-
lish the patient’s needs and how drug/alcohol 
treatment and mental health care can be inte-
grated to provide better treatment.
Reports for 2010 show that in 17 per cent of all 
decisions to forcibly commit people to mental 
health care institutions, pursuant to the provi-
sions on compulsory mental health care in the 
Norwegian Mental Health Care Act, the patients 
had a drugs or alcohol-related diagnosis. In total, 
there are 1,200 forcible admissions annually of 
persons with drugs or alcohol-related disorders 
in the mental health care sector (the Directorate 
of Health, 2011). There is also an option pursu-
ant to social services legislation of detaining 
people with drug or alcohol problems without 
their consent. Forty per cent of those who were 
forcibly committed pursuant to the Social 
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criterion that had been used until then. In the 
period since 1996, Statistics Norway’s figures 
have been consistently higher than the figures 
from Kripos. However, if suicide (by using 
drugs) and drug deaths among elderly people 
above the age of 65 are eliminated from Statistics 
Norway’s statistics, the difference is smaller, al-
though still considerable in some years. The 
trends are largely identical in both series of fig-
ures, however.
The WHO revised its coding of causes of deaths 
relating to drugs and alcohol in 2002. The cor-
rected figures from 2003 onwards show a higher 
estimate than previously reported by Statistics 
Norway.
Situation and development
Table 6 shows that the figures from both Statistics 
Norway and Kripos peaked in 2000/2001. In the 
ensuing years, there has been a considerable re-
duction in the number of registered drug deaths. 
6.3  Drug-related deaths and 
mortality of drug users
See data in Standard tables 05 and 06.
Methodological considerations
In Norway, there were two bodies that registered 
drug-related deaths, Statistics Norway and 
Kripos (the National Crime Investigation 
Service). Kripos based its figures on reports from 
the police districts, while Statistics Norway pre-
pared figures on the basis of medical examiners’ 
post-mortem examination reports and death 
certificates in accordance with the WHO’s ICD 
10 codes. Kripos has unofficially announced that 
it will stop releasing figures for drug-related 
deaths. Hence, the 2009 figures will probably be 
the last year of reporting from that source.
With effect from 1996, Statistics Norway’s figures 
have been based on EMCDDA’s definition of 
drug deaths. This broadened the inclusion 
Table 6: Drug-related deaths 1991–2009. Total number of deaths and broken down by gender. Figures from 
Kripos and Statistics Norway (underlying cause of death).
1991–2009 Number of deaths according to Kripos Number of deaths according to Statistics Norway
Men Women Total Men Women Total
1991 74 22 96 66 22 88
1992 78 19 97 81 23 104
1993 77 18 95 76 17 93
1994 102 22 124 105 19 124
1995 108 24 132 114 29 143
1996* 159 26 185 173 31 204
1997 149 28 177 160 34 194
1998 226 44 270 228 54 282
1999 181 39 220 191 65 256
2000 264 63 327 302 72 374
2001 286 52 338 327 78 405
2002 166 44 210 240 67 307
2003** 134 38 172 193 62 255
2004 168 55 223 220 83 303
2005 146 38 184 176 58 234
2006 152 43 195 187 64 251
2007 162 38 200 217 58 275
2008 148 31 179 210 53 263
2009 146 38 184 222 63 285
2010 n.a n.a  n.a *** *** ***
*The figures from 1996 onwards have been classified in accordance with a new revision. Hence the figures before and after 1996 are 
not directly comparable. Suicides in which narcotic substances were used are included from 1996.
** STATISTICS NORWAY’s figures from 2003 onwards are based on WHO’s revised coding of causes of death.
***Figures for 2010 are not yet available.
Source: Kripos and Statistics Norway
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In 2009, Kripos recorded 184 deaths, 11 of which 
were of non-Norwegian citizens. This was the 
same level as the year before. Many of these 
deaths are believed to be due to extensive multi-
ple-drug use. In 60 per cent of the deaths, the 
heroin-specific metabolite monoacetylmorphine 
was detected, and morphine was found in a fur-
ther 15 per cent of the deaths. Methadone was 
detected in 16 per cent of the deaths, while am-
phetamines and/or methamphetamines and/or 
cocaine were detected in 28 per cent of the 
deaths.
In 2009, there were 5,383 patients in opioid sub-
stitution treatment (OST) in Norway, 56 per cent 
of whom were on methadone and 44 per cent on 
buprenorphine. The 39 deaths due to methadone 
in 2009, is a somewhat higher number than in 
2008 (31). The majority of methadone-related 
deaths occur among persons not enrolled in the 
OST programme, and multiple drugs were typi-
cally involved. This fact illustrates that it is nec-
essary to strike a balance between access to OST 
and the need for control measures to limit the 
‘leakage’ of methadone from the OST pro-
gramme. Additionally, it is generally a challenge 
to differentiate between deaths caused by metha-
done and deaths where methadone was present 
in the blood at the time of death, but not neces-
sarily the cause of death.
Age -increasing
Figure 8 shows that the proportion of drug-relat-
ed deaths among those over the age of 30 has in-
creased steadily. In the 1990s, it had reached 60 
per cent according to Statistics Norway statistics. 
The Statistics Norway statistics show that, for the 
years 2000 to 2009, the proportion of drug deaths 
in the 30-plus age group was approximately 70 
per cent on average. In 2009, this age group ac-
counted for 76 per cent of the deaths (217 per-
sons). During the same period, the proportion 
over the age of 50 appears to have increased. In 
2009, this age group accounted for as many as 25 
per cent of the total number of deaths (71 per-
sons). Five of the deaths were in the 65 years or 
more age group. The youngest age groups’ pro-
portion of deaths has remained relatively stable, 
The reduction since the turn of the millennium 
is most probably due to the strong increase in the 
number of clients on opioid maintenance treat-
ment. Both the Statistics Norway figures and the 
Kripos figures appear to indicate that, after the 
reduction following the peak years of 2000 and 
2001, a certain stabilisation of the number of 
mortalities has occurred. The number of mor-
talities remains high, however.
Concerning the 285 drug-related deaths in 2009 
that were recorded by Statistics Norway, 255 
deaths involved opioids with or without addition-
al drugs (Figure 7), 137 were deaths due to heroin 
(X42, X44, X62, X64 + T401), 39 deaths were re-
corded with methadone poisoning as the underly-
ing cause (X42, X44, X62 + T403), and 61 with 
other opioids, either as poisoning or dependency 
(X42, X44, X62, X64 + T402, F112). The remain-
ing 48 deaths broke down as follows: 18 other syn-
thetic narcotics (X42, X44, X64 + T404), four 
other/unspecified psychodysleptics (X42 + T409), 
seven psychostimulants (X41, X44, X61 + T436), 
three unspecified narcotics (X42, X44 + T406), 16 
dependence other stimulants and dependence 
multiple/other (F152,F192), and no deaths from 
cocaine (X44 + T405).
In 2009, 39 (14 %) of the deaths were coded as 
suicides, which is probably a conservative esti-
mate of the suicide rate.
Figure 7: Drug-related deaths in 2009 broken down 
by specific death. Numbers
0
20
40
60
80
100
120
140
He
ro
in
Ot
he
r o
pio
ds
Me
th
ad
on
e
Sy
nt
he
tic
Ps
yc
hs
tim
.
Ps
yc
ho
dy
sl.
Co
ca
ine
De
pe
nd
en
.
De
p:
Mu
ltip
l.
Un
sp
ec
ifie
d
Source: SIRUS and Statistics Norway
Annual report to the European Monitoring Centre for Drugs and Drug Addiction – EMCDDA 41
but nine deaths under the age of 20 years in 2009 
is the highest number ever registered.
Figure 8: Drug-related deaths broken down by age 
group 1997–2009. Per cent
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Gender distribution -stable
In 2009, 222 of the deaths were males and 63 fe-
males. The proportion of females was 22 per 
cent, which, seen in a longer-term perspective, 
seems to be within the ‘normal range’. During 
the period 1997 to 2009, the proportion of wom-
en has varied between 18 and 27 per cent, with 
an average close to 22 per cent (Figure 9). During 
the period 1980 to 1990, the average proportion 
of women was also close to 22 per cent.
Figure 9: Drug-related deaths broken down by gen-
der, 1997–2009. Per cent
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Data from Oslo
Oslo is the region with most deaths, and 68 Oslo 
residents died of drug-related causes in 2009. 
However, a detailed study of drug-related deaths 
(Gjersing et al., 2011) from 2006 to 2008 revealed 
that one-third of all drug-related deaths in Oslo 
involved non-residents. The non-residents who 
died from drug-related causes in Oslo differed 
from the Oslo residents by being younger and 
more often intoxicated by heroin, as well as often 
being found dead outdoors or in public spaces.
A total of 232 persons under 70 years of age died 
from a fatal overdose in Oslo between 2006 and 
2008. Approximately one-fifth were women and 
the average age of those who died was 36 years. 
Among those who died from a fatal overdose, 67 
per cent were found at a residential address, 
whereas 18 per cent died outdoors. Heroin was 
judged to be the main intoxicant in 66 per cent of 
the fatal overdoses. Among those between 46 
and 70 years of age, strong pain medication was 
the main intoxicant in one out of every three fa-
tal overdoses. Methadone was the main intoxi-
cant in 10 per cent of the deaths. The number of 
different substances per case was between three 
and four on average. The most common combi-
nations of substances were heroin and benzodi-
azepines, and central stimulants in combination 
with benzodiazepines or heroin. See also Chapter 
7.1.1.
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Main features
As mentioned in Chapter 6.3, a total of 232 per-
sons under 70 years of age died from a fatal over-
dose in Oslo between 2006 and 2008. The major-
ity of those that died (186) had contact with 
health and/ or social welfare services in the year 
prior to the fatal overdose. On average, the per-
sons had contact with three to four different ser-
vices. Many (57 %) had contact with health ser-
vices and social welfare services within three 
weeks of the death. Oslo residents had used so-
cial welfare services most compared to other ser-
vices. Non-residents had mostly been in contact 
with ambulance services.
According to the study, there was an accumula-
tion of deaths within the first weeks after release 
from prisons, and after completed abstinence-
oriented in-patient drug treatment. There was no 
similar accumulation of deaths in the first weeks 
after concluding OST for various reasons.
Drug users, next of kin and professionals in the 
health, social welfare and criminal justice fields 
described different types of fatal overdoses, such 
as ‘accidental’ and ‘exhaustion’. The drug users 
believed the ‘exhaustion’ overdoses were related 
to their general living conditions. The experience 
of social isolation, recent breakdown(s) of 
relationship(s) and many subsequent overdoses 
were described as risk factors for new overdoses. 
At the same time. it appeared as though profes-
sionals in the social welfare services and public 
(municipal) drug services did not generally ask 
about experiences with overdoses and/or suicid-
al intentions. This investigation has shown that 
there are many different factors related to fatal 
overdoses and that these are complex matters.
Health and social welfare services in Oslo were 
described as fragmented and lacking in written 
7. 1  Prevention of drug-related 
emergencies and reduction 
of drug-related deaths
See also information in Structured Questionnaire 
23.
7.1.1  Fatal overdoses in Oslo, Norway 
between 2006 and 2008. A new study
Both historically and at present, Oslo has a high 
number of fatal overdoses. In March 2009, the 
city council therefore decided to investigate pos-
sible causes for these high numbers. The 
Norwegian Centre for Addiction Research 
(SERAF) at the University of Oslo conducted the 
investigation The report was published in March 
2011 (Gjersing et al., 2011). It also proposes a 
number of measures to prevent overdose fatali-
ties. The report has so far not been the subject of 
political consideration.
Methods
Three different methods of investigation were 
employed:
• An assessment of different registers and 
patient records, including data from the 
National Register of Deaths for patients who 
died in Oslo from a fatal overdose between 
2006 and 2008.
• Interviews and focus groups with persons 
who used or had used illegal and legal 
substances, next-of-kin of persons who had 
died from a fatal overdose and professionals 
from the health, social welfare and criminal 
justice fields.
• An investigation into how five European 
cities (Vienna, Frankfurt, Amsterdam, 
Lisbon, Zurich) had handled the issue of 
open drug scenes and overdoses.
7.  Responses to health correlates and 
consequences
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substances. Thus, a reduction in the number of 
fatal overdoses will be possible if the number of 
persons who inject is reduced. This can be 
achieved by facilitating smoking instead of in-
jecting through the distribution of smoking 
equipment and allocated areas (‘user rooms’) 
where the substances can be smoked. In addi-
tion, it is necessary to make sufficient health and 
social welfare services available to persons with 
problem drug use.
The majority of those who died from fatal over-
doses in Oslo had been in contact with several 
services. However, the services appeared to be 
fragmented and no single individual or service 
appeared to be capable of taking charge when 
there was a crisis situation. There appears to be a 
lack of critical assessment of each fatal overdose 
aimed at improving health and social welfare 
services. One of the proposed measures to im-
prove the lack of critical assessment is for the 
municipality to employ an ‘overdose physician’ 
with responsibility for reviewing each fatal over-
dose. This would make improved coordination 
and collaboration possible between services and 
help to develop services related to prevention, 
follow-up and treatment of overdoses (Gjersing 
et al,2011).
7.1.2  Overdoses in Bergen. A survey 
report
A recent survey report from Bergen on the risk 
of overdoses and protective factors (Gerdts and 
Grung, 2011) also points to inadequacies in the 
help services and calls for better coordination 
and more cooperation between services across 
agency boundaries. The report is based on stan-
dardised telephone interviews with 24 agencies 
in Bergen, seven interviews with key informants, 
i.e. persons who are considered to possess ‘expert 
knowledge’ in the drugs and alcohol field, and 
five interviews with users with long-term drug 
dependency dominated by opioid use. Existing 
data from different local and national sources 
have also been used.
The report states that oral and/or written infor-
mation seems to be the only strategy for the 
procedures for overdoses, and with minimal in-
teraction and flow of information between ser-
vices. Interviewed next-of-kin had to a varying 
degree been informed and participated in the 
treatment and follow-up of the person they were 
related to. They had not experienced being seen, 
followed-up or been supported by health or so-
cial welfare services.
Professionals in the health and social welfare 
services had experienced the principle of confi-
dentiality as an obstacle to collaboration and in-
formation exchange between services. In addi-
tion, they stated that there were various 
interpretations of drug problems and how issues 
related to them should be dealt with. Many felt 
powerless in their work with persons who were 
at risk of overdoses, and high turnover of staff 
was also a challenge. However, they all wanted to 
further develop work on the prevention and 
treatment of overdoses.
All those who were interviewed (drug users, 
next-of-kin, professionals) had different views 
on coercive measures in the treatment of persons 
with problem drug use, but most agreed that it 
could be used in situations with frequent over-
doses. Professionals did not refer to political ob-
jectives when they spoke of their experience of 
fatal overdoses. Political documents from Oslo 
City Council of were assessed, and specific ob-
jectives for the prevention of fatal overdoses were 
not found.
According to the study, it was not possible to as-
sess the risk of fatal overdoses in this study due 
to the study design. A cohort study over a longer 
period could have estimated the risk of fatal 
overdoses and their relationship to different 
factors.
Recommendations for prevention
The study contains several recommendations, 
such as:
The high prevalence of fatal overdoses in Oslo 
can be explained by the high number of persons 
who inject heroin in combination with other 
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not been ensured in the same way, regardless of 
other factors such as age, mental/physical condi-
tion, how many overdoses the patient has experi-
enced etc. Both next-of-kin and representatives of 
treatment institutions emphasise the need for me-
thodical follow-up in the period after an 
overdose.
The report proposes some specific measures:
• Establishing a local notification system to get 
relevant information out to the users.
• Considering/further developing a procedure 
for following up overdose episodes, 
including the use of interdisciplinary 
ambulant teams.
• Establishing a team to map the health, care 
and living situation of the above-30 age 
group.
• Offering guidance to next-of-kin who 
experience overdose episodes in their close 
family, and offering crisis counselling to 
next-of-kin who experience a fatal overdose.
In addition, in line with Oslo: Initiating a com-
mon strategy and targeted efforts to promote 
smoking as an alternative to injecting heroin.
In August 2011, the Commissioner for Health in 
Bergen City Government stated that she would 
immediately appoint a working group that would 
be tasked with preparing and initiating measures 
on the basis of the report.
7.1.3  The health and overdose team in 
Trondheim
The team was established by the City of 
Trondheim in September 2001 after the city had 
experienced many overdose fatalities that sum-
mer. The purpose was to prevent overdoses and 
overdose fatalities, and to follow-up next-of-kin 
and drug users after an overdose/death.
The team reports having had contact with as 
many as around 950 named injecting drug users 
(of around 1,500) in Trondheim. The team con-
sists solely of health personnel. Seven nurses will 
be employed by the team in 2011. They engage 
prevention of overdose fatalities. In many cases, 
the implementation of the information measures 
was reported to be sporadic and unsystematic in 
relation to who received information and the 
contents of the information.
Moreover, the help services seem to focus most 
of their attention on risk associated with the in-
terruption of treatment due to drug use and dis-
charge from institutions. Both treatment person-
nel and people from the drug scene refer to the 
fact that the purpose of leaving treatment is a de-
sire to use drugs, which undoubtedly entails 
great risk. In this connection, next-of-kin, among 
others, call for treatment institutions to maintain 
contact with the person in question to motivate 
him or her to return to treatment.
When asked whether the services have plans for 
new measures to prevent overdose fatalities, the 
treatment institutions in the survey material 
stand out in that they have concrete plans. They 
are largely measures that involve different forms 
of contact with the patients when they are not at 
the institution, such as the use of ambulant ser-
vices, contact via text messages etc. Several of the 
services point out that it should be possible to in-
volve next-of-kin as a resource, but none of the 
services seems to have plans for how this can be 
done or for establishing/maintaining contact 
with patients in connection with interrupted 
treatment.
Both the agencies and the drug users identify the 
period before planned detoxification as a risk pe-
riod. This is explained by the users’ wish for one 
final maximal drug experience before they enter 
treatment, often referred to as a ‘last party’ be-
fore admission to the treatment institution/pris-
on. This phase nonetheless seems to receive less 
attention in the form of preventive information 
measures.
As for measures targeting overdoses and overdose 
fatalities in particular, the conclusion is that the 
chain of measures seems to lack the concluding/
follow-up link. While emergency assistance is re-
ported to work, follow-up after an overdose has 
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if relevant. The team ensures that this one of 
the team members accompanies the person.
• They consciously use the fear of death that 
the patients experience in further 
conversations. The purpose is to make them 
understand how close they came to dying 
and that they would have been dead if the 
antidote had not been administered.
• Examining the options and what the patient 
is willing to do him/herself. Contacting 
next-of-kin, social workers / contact persons 
and offering an emergency bed, if necessary.
• They also attend to the others who witnessed 
the overdose – addressing their experiences, 
thoughts and feelings, and they refer them to 
other agencies in the system, if necessary.
The health and overdose team has three round-
the-clock supervised emergency beds at its dis-
posal in a dedicated building that can be used to 
help persons who have experienced an overdose 
or to help down-at-heel drug users who need 
time to get back on their feet. The team is re-
sponsible for admissions. There is no waiting 
time, as it is for those who need it most there and 
then. Overdoses are always the number one pri-
ority. Stays are voluntary and the maximum du-
ration is 14 days.
In 2002, the year after the team was established, 
the number of overdoses fell by more than fifty 
per cent, from 78 to 36 cases. In the three follow-
ing years, the figure was down to just over 20 
cases. The number has since varied, with an av-
erage of around 45 overdoses per year. As regards 
fatal overdoses, the number of deaths has varied 
between zero and eight a year, compared with 
ten in 2001. The team identifies the success crite-
ria as an absolute duty of confidentiality, being 
present in the milieu and, not least, excellent co-
operation with the specialist health services, am-
bulance personnel and the municipal adminis-
tration/ follow-up personnel in Trondheim 
municipality (personal information from the 
manager).
with the drug user scene on a daily basis, assess 
trends, take the pulse of the milieu and observe 
whether any new drugs are introduced to the 
scene.
Overdose prevention is an important task dealt 
with by providing information to the drug users: 
about the purity of the drug; that several people 
should be together when taking the drug; about 
reduced tolerance after a period of abstention 
from opioid/medication use; about the impor-
tance of splitting the dose into several small ones; 
focus on multiple use issues; calling the emer-
gency telephone number-113 on suspicion of an 
overdose; providing first-aid by keeping the pa-
tient moving and awake, and applying pain stim-
uli until help arrives.
Two members of the team are always called out 
in the event of an overdose after being notified 
by the emergency medical communication cen-
tre that an ambulance has been dispatched to 
perform life-saving first aid. They follow up the 
person who has overdosed and others who are 
present. The overdose team always have narcanti 
(an antidote) with them. Note: The police are not 
contacted.
The team refers the overdose victim for follow-
up by the specialist health service and/or a GP, as 
required. In the event of a fatal overdose, they 
follow up the next-of-kin for as long as they want 
them to. The always arrange a meeting, although 
next-of-kin often say that they are being looked 
after and do not wish to be followed up. The team 
has not yet encountered next-of-kin who do not 
want further follow-up from the team. The fol-
low-up conversation with the patient following 
an overdose involves several steps:
• What has the patient taken, and how much? 
If a new substance or pure heroin is involved, 
the milieu/employees in Trondheim 
municipality are warned directly and 
through the media.
• Parasuicides are referred to the accident and 
emergency service and psychiatric follow-up, 
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• To enable illnesses to be diagnosed and 
treated, thus improving the physical and 
mental health situation of this group.
• To reduce the number of ‘crisis situations’ in 
the participants’ day-to-day lives and 
contribute to improving/maintaining their 
independent living skills.
• To help those who so wish to use the 
ordinary support services.
• To contribute to participants not having to 
obtain and inject illegal drugs through 
criminal activity /prostitution.
Organisation:
• The project is located in one of the Alcohol 
and Drug Addiction Service’s 24-hour 
residential facilities.
• The project personnel are employed by the 
Alcohol and Drug Addiction Service.
• The project manager is a health professional, 
a registered nurse.
• The project also comprises two other nurses 
and a social worker.
• The substitution medication is prescribed by 
a doctor.
• Medication is handed out during the day/
afternoon, and also at weekends and on 
holidays.
Since 1 January 2011, when the project became 
fully operational, the project staff has consisted 
of three nurses. The project is still in the start-up 
phase, but so far (end of August 2011), 87 people 
have been referred to the project. Most have 
come at their own initiative. The doses of 
Suboxone have been stepped up for fifty-four of 
them, 20 women and 34 men. Several of them 
have had their medication stepped up several 
times, and many have periods during which they 
do not pick up their medication. Eight persons 
have chosen not to continue their participation 
in the project.
Seven persons have started ordinary substitution 
treatment since starting treatment in LASSO. 
Three persons have applied for substitution treat-
ment and wish to start ordinary substitution 
7.1.4 The LASSO project, Oslo
In autumn 2010, the Oslo Drug and Alcohol 
Addiction Service and the Norwegian Centre for 
Addiction Research established a new project in-
volving the distribution of buprenorphine 
(Subuxone) to patients, aimed at harm reduction 
and giving them a better life. Experience from a 
similar project, Clinic Motivation, which was 
run by the City of Oslo from 2006 to 2009, 
formed the basis for the start-up of the LASSO 
project (harm-reduction substitution treatment 
in Oslo).
The background to the start-up of the project 
was that experience had shown that many pa-
tients drop out of substitution treatment. For dif-
ferent reasons, some of them are never referred 
to and assessed for substitution treatment, while 
others fail to meet the admission criteria. Many 
of them are visible in public places, they are dif-
ficult for the ordinary health services to reach 
and they are excluded from or drop out of resi-
dential/low-threshold services. For large parts of 
the day, they are busy obtaining drugs through 
crime and prostitution. Many of them have ex-
tensive mental and physical health problems. 
The initiators of the project identified a need for 
a type of substitution treatment that is more 
adapted to opioid addicts in this group, in the 
form of greater availability and less bureaucracy.
The project covers the whole city and is offered 
to everyone in the target group who lives in the 
municipality over time. The substitution treat-
ment is based on the specialist health service.
The participants can refer themselves to LASSO 
or be referred by other services such as the field 
nursing service, the injection room or the ambu-
lance service.
The goal of the use of substitution medication is:
• To reduce the risk of harm to health caused 
by injecting opioids.
• To reduce the risk of excessive drug use and 
overdose fatalities.
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As part of the escalation plan for mental health 
1999–2008, management signals were issued 
stating that ambulant teams should be set up at 
all Psychiatric District Centres. The aim was to 
ensure follow-up of patients with long-term 
needs for complex services, including many peo-
ple with concurrent drug/alcohol problems and 
mental health problems.
A government grant scheme was established in 
2009 for the establishment of ACT teams 
(Assertive Community Treatment teams) for pa-
tients with psychoses, reduced functional level 
and extensive additional problems such as prob-
lem drug or alcohol use. Grant schemes have also 
been established for the development of other 
types of coordinated teams between the munici-
pal and specialist health service levels, targeting 
patients with co-morbidity diagnoses.
Reports from the mental health care service in-
dicate that more outreach-based methods are 
employed at 62 of 75 Psychiatric District Centres 
and that more people with a dual diagnosis are 
receiving treatment in the mental health care 
sector than before. Some municipalities have es-
tablished residential and follow-up projects 
based on the principle of ‘housing first’.
Professional guidelines
The Directorate of Health plans to issue national 
professional guidelines for concurrent drug/al-
cohol problems and mental health problems in 
the course of 2011, in which responsibility for 
treatment of this group of patients will be more 
clearly defined. In brief, the recommendation is 
that, if the drug or alcohol problems are domi-
nant, chief responsibility should rest with spe-
cialised treatment for drug or alcohol use, and 
with the mental health care service if the mental 
illness is serious. Schizophrenia, affective mental 
disorders or serious personality disorders are 
deemed to be serious mental illnesses. In the 
draft guidelines, the Directorate of Health un-
derlines that disagreement about who is respon-
sible must not result in patients not receiving a 
good offer of diagnostics and treatment. It is pro-
posed that assessments and admissions be 
treatment in the longer term. Three persons who 
were affiliated to the project have died; two due 
to illness and one as a result of an overdose. One 
of the three had not yet started taking medica-
tion, while the two others died during a period 
in which they did not collect their medication 
(the Oslo Drug and Alcohol Addiction Service, 
personal correspondence).
7.2  Responses to health 
correlates among drug users
7.2.1 Psychiatric and somatic co-morbidity
Development of the services
As mentioned in chapters 5.3 and 6.2, treatment 
for concurrent drug/alcohol problems and men-
tal health problems is provided by two different 
sectors in Norway, but they are often located in 
the same place. It is a goal for the renewal of the 
health and welfare systems that these patients 
should receive as integrated treatment as possible 
for both problems. Documentation from re-
search and reports suggests, however, that there 
is still some way to go before these challenges are 
resolved. It is a well known fact that many pa-
tients with a co-morbidity diagnosis and other 
‘difficult’ patients can end up being passed back 
and forth in the system or not receive adequate 
help for one of their problems.
Organisational, legal and financial measures 
have been implemented in both mental health 
care and interdisciplinary specialised drug/alco-
hol treatment with a view to boosting and 
strengthening these fields in relation to somatic 
health. In order to prevent patients being passed 
back and forth and to ensure concurrent treat-
ment of mental health problems and drug or al-
cohol problems, several government and munic-
ipal agencies have been organised together in 
recent years. The goal of providing integrated 
treatment, by the same team, by the same group 
of treatment providers or in the same treatment 
programme, is gaining increasing support both 
professionally and politically.
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coordinated between mental health care and 
specialised treatment services in order to pro-
vide patients with a dual diagnosis with coordi-
nated, integrated treatment.
7.2.2 Needle exchange programmes
See the data in Standard table 10.
The primary objective of needle exchange pro-
grammes is to reduce the risk of infectious dis-
eases associated with the sharing of injection 
equipment. Approximately 3.3 million syringes 
were handed out in Norway in 2007, largely 
through low-threshold services. In a follow-up 
survey carried out by SIRUS, 14 towns/munici-
palities reported that almost 3.1 million syringes 
were handed out in 2009. Of these, 85 per cent – 
2,635 million were distributed in the three big-
gest cities, Oslo, Bergen and Trondheim. In 2010, 
these cities reported about the same number, 
2,612 million, 1.9 million of them in Oslo alone. 
Sales through pharmacies come in addition, but 
we lack an overview of sales to drug users in this 
context.
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In 2009, the State Housing Bank established a so-
cial housing development programme, the pur-
pose of which is to enter into binding collabora-
tion with the municipalities with the greatest 
social housing problems. The programme aims 
to encourage the municipalities to develop co-
herent social housing services that enjoy local 
support. This will contribute to a better service 
for people at a disadvantage in the housing mar-
ket by raising competence in the municipalities, 
improving the utilisation of state funding and 
developing methods in the field of social 
housing.
In the period 2007 to 2009, in a collaboration be-
tween the Directorate of Labour and Welfare and 
the State Housing Bank, a project aimed at devel-
oping methods and models was carried out in 
the four biggest cities in Norway and five neigh-
bouring municipalities that had problems relat-
ing to the use of temporary housing arrange-
ments. The purpose of the project was to develop 
methods and measures for following up people 
in temporary housing so that they can be offered 
permanent housing. Ethics, relations building 
and the testing of forms of collaboration have 
been important elements in the development of 
methods. Participating municipalities are re-
ported to have made good progress in testing 
different mapping systems and user participa-
tion. Some municipalities have identified effi-
cient methods for obtaining housing in the pri-
vate rental market.
Housing on release from prison
Efforts to obtain housing for inmates on their re-
lease are dependent on whether the municipality 
has suitable accommodation to offer. At the end 
of 2008, more than half of all inmates had no ac-
commodation upon their release. It was also re-
ported in 2009 that many municipalities had no 
housing to offer these groups.
8.1 Social reintegration
See also information in Structured Questionnaire 
28.11
8.1.1 Housing
A survey from 2008 estimates that the number of 
persons with no fixed abode in Norway is 6,100, 
which is an increase from a corresponding sur-
vey in 2005. It is reported that approximately 60 
per cent of homeless people have drug or alcohol 
problems and that 32 per cent have mental health 
problems. The survey also showed that home-
lessness is mainly a problem in cities. In recent 
years, a range of housing and service models 
have been developed, such as the Homeless peo-
ple project and Obtaining housing for oneself. The 
Action Plan specifies that these initiatives will be 
further developed and that experience from 
them will be spread to more municipalities.
The following four measures in the Action Plan 
aim to strengthen housing services for people 
with drug or alcohol problems:
• Increase efforts to eradicate homelessness 
– with particular focus on homelessness in 
small municipalities.
• Increase efforts to prevent homelessness, 
including reducing the number of evictions 
and temporary housing arrangements.
• Develop methods and procedures for 
following up people in temporary housing so 
that they can be offered permanent housing.
• Introduce a new investment grant for 
nursing homes and sheltered housing.
All four measures were initiated in 2009.
11  All structured questionnaires referred to have been 
submitted to the EMCDDA separately.
8. Social correlates and social reintegration
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tences succeed in finding employment or join a 
qualification programme on their release.
There are eight NAV advisers in Norwegian pris-
ons. They cooperate with the NAV offices in con-
nection with prisoner releases. All the regions 
have entered into agreements with NAV at the 
regional level. A number of local agreements be-
tween prisons and NAV offices are also in place.
In a collaboration between the Directorate of 
Labour and Welfare and the central administra-
tion of the correctional services, a three-year na-
tional trial was initiated in 2009, with the aim of 
identifying good models that ensure continuity, 
integrated services and closer individual follow-
up of inmates in connection with the transition 
from prison to freedom. Methods will be tested 
to motivate inmates in the target group to make 
use of the qualification programme on their re-
lease. In 2009, seven projects were initiated in a 
collaboration between local NAV offices and 
prisons. The municipality in which the prison is 
located will cooperate with inmates’ home mu-
nicipality to ensure that more inmates find 
employment.
Work training etc.
As part of the Government’s efforts to combat 
poverty, the Ministry of Labour awards grants to 
voluntary organisations with the aim of strength-
ening and developing activation and work train-
ing models. The target group consists of people 
who are highly marginalised in relation to the 
employment market and in many ways excluded 
from the social arena. Persons with drug or alco-
hol problems are a prioritised target group. The 
scheme received EUR 1.25 million (NOK 10 mil-
lion) in additional funding in 2009, increasing its 
budget to EUR 2.7 million ( NOK 21.5 million). 
A total of 34 projects received grants in 2009.
The Directorate of Health also allocates grants to 
a number of voluntary and charitable organisa-
tions involved in activation and work training 
for persons with drug or alcohol problems.
The correctional services have been allocated 
funding by the Ministry of Local Government 
and Regional Development via the State Housing 
Bank to provide housing for inmates on their re-
lease from prison. Efforts are being made to es-
tablish agreements with the individual munici-
palities. The number of agreements increased 
from 44 in 2007 to 62 in 2008, and there were ap-
proximately 80 housing agreements between the 
correctional services and municipalities in 2009. 
In addition, the State Housing Bank has funded 
the appointment of seven housing advisers, who 
will work on obtaining accommodation for more 
inmates upon their release.
8.1.2 Employment
A qualification programme aims to strengthen 
the efforts for persons with significantly impaired 
work capacity and earning ability who have lim-
ited or no National Insurance rights.
The qualification programme was described in 
NR 2009 Chapter 8.1.3. The programme, and the 
pertaining benefits, targets persons with signifi-
cantly impaired work capacity and earning abili-
ty, who have limited or no rights to National 
Insurance benefits. The purpose is to help more 
people in the target group to find employment. 
The programme must be individually-adapted 
and work-related, so that it supports and paves 
the way for the transition to employment. 
Persons with drug or alcohol problems are part 
of the target group provided that they meet the 
conditions for participation. There are no figures 
available to indicate how many of the partici-
pants have drug or alcohol problems, but feed-
back from the local NAV12 offices shows that 
they are included among the participants.
Convicted persons’ connection to the 
employment market
It is an express goal of the Action Plan that more 
convicted persons who are serving prison sen-
12  The Norwegian Labour and Welfare Service
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Statistics Norway’s regular crime statistics pro-
vide information about the criminal prosecution 
of:
- Drug offences
These are partly differentiated on the basis of the 
law’s classification of different types of offences 
– including the provisions of the Act relating to 
medicines on use and possession (of user 
doses).
- Offenders with drug offences as their 
primary offence14
As a minimum, these statistics show the number 
of persons who are prosecuted for the different 
types of drug crime.
The statistics do not contain information about 
the types and quantities of narcotic substances 
involved in prosecutions. Nor does Statistics 
Norway have statistics containing a full count of 
persons who are punished for the use and posses-
sion of narcotic substances (irrespective of more 
serious drug offences, other drug offences or 
other crimes). However, Statistics Norway has 
published individual surveys based on the data 
that form the basis for the statistics. They include 
full counts of all persons charged with drug of-
fences (irrespective of the primary offence), the 
progress of the drug offence through the crimi-
nal justice system and descriptions of criminal 
careers and imprisonment.
9.1.2 Statistics
Reported crimes
See data in Standard table 11.
14  Only the primary offence, the most serious crime, is 
registered in the statistics.
9.1 Drug law offences
9.1.1 Legal basis and type of statistics
Norway does not have separate legislation relat-
ing to drugs. Two acts apply in connection with 
the reporting, charging and prosecution of drug 
crimes: the Act related to medicines and the 
General Civil Penal Code.13 Statistics Norway is 
the Norwegian institution responsible for keep-
ing statistics on drugs in the judicial system. 
Four types of crime statistics are published an-
nually (http://www.ssb.no/kriminalitet/):
• Offences reported to the police
• Offences investigated – clear-up rate – 
persons charged – relapse figures
• Penal sanctions – persons convicted – 
previous criminal offences
• Prison sentences – inmates
13  Minor drug offences that involve the use or possession 
of drugs are punished pursuant to the Act relating to 
medicines (Act No 132 of 4 December 1992) section 24, 
for which the maximum sentence is up to two years’ im-
prisonment. Other drug crimes are punishable pursuant 
to section 162 of the General Civil Penal Code (Act No 
10 of 22 May 1902 with subsequent amendments). The 
General Civil Penal Code section 162 distinguishes bet-
ween four degrees of gravity, depending on the drug and 
amount involved and the nature of the offence in other 
respects. If a small quantity is involved, the offence is 
punishable by fines or imprisonment for up to two years. 
Aggravated drug crimes include the three other degrees 
of gravity. If a somewhat larger quantity is involved, the 
offence is punishable by imprisonment for up to ten 
years; if a substantial quantity is involved, the offence is 
punishable by imprisonment for between three and 15 
years, and under particularly aggravating circumstances 
the punishment can be up to 21 years’ imprisonment, 
which is the maximum punishment under Norwegian 
criminal law.
9.  Drug-related crime, prevention of drug-
related crime and prison
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Medicines was 18,854. Charges were brought in 
6,597 (35  %) cases, while fines were issued in 
8,535 (45 %) cases.
The proportion of those charged with drug of-
fences who are foreign citizens has increased 
steadily in the last few years – from around 11 
per cent in 2002 to 18 per cent in 2009.
Penal sanctions
Statistics for penal sanctions are not yet available 
for 2010. As regards penal sanctions in 2009 drug 
crime was the primary offence in 43 per cent of 
all types of criminal cases, a slight reduction 
from 2008 (Figure 10). However, this percentage 
can result in a skewed picture of the prevalence 
of this type of crime. The clear-up rate for drug 
crimes is higher than for all other types of crime, 
which means that drug crimes account for a far 
bigger proportion of crimes among convicted 
persons. On the other hand, many judgments 
may serve to conceal drug crimes, also relatively 
serious ones, because only the primary offence, 
i.e. the most serious offence, is identified in the 
statistics.
In 2009, 12,862 penal sanctions were imposed 
with drug crime as the primary offence. Of these, 
7,279 were penal sanctions imposed pursuant to 
the General Civil Penal Code while 5,583 were 
imposed pursuant to the Act relating to medi-
cines. The latter mainly relate to the use and pos-
session of small quantities of drugs. It is worth 
noting that only 1,191 were convictions by a 
court resulting in unconditional prison 
In 2010, nearly 45,000 drug crimes were regis-
tered, which is on a par with the record levels in 
2001/2002(Table 7). The number of reported ag-
gravated drug crimes pursuant to the General 
Civil Penal Code section 162, second and third 
paragraphs, was 1,312, which is 250 more than in 
2008 and 2009. The number of reported drug 
crimes pursuant to the General Civil Penal Code 
is higher than ever, but that the number of viola-
tions of the provisions of the Act relating to 
Medicines concerning the possession of small 
amounts of drugs is still lower than in 
2001–2002.
Investigated crimes
Statistics Norway has updated the statistics for 
investigated offences up to and including 2009. 
The number of investigated drug crimes pursu-
ant to the General Civil Penal Code section 162 
was just over 18,000 in 2009, which is roughly 
the same as the average for the years 2005–2008. 
However, the number of investigated offences re-
lating to use and possession pursuant to the Act 
relating to Medicines is down by eight per cent 
since 2008 and 14 per cent since 2007. The de-
cline is probably partly related to an internal po-
lice conflict in autumn 2009.
In 2009, 16,385 investigations were completed 
pursuant to the General Civil Penal Code section 
162 first and fourth paragraphs, which concern 
less serious offences. Charges were brought in 
8,243 (50 %) cases, while 4,532 (28 %) such cases 
were settled by a fine. The number of investigat-
ed cases for violations of the Act relating to 
Table 7: Number of reported drug crimes 2001–2010.
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Total number of drug crimes  
reported
45,904 44,616 36,133 36,818 37,178 41,165 40,113 36,738 38,515 44,741
Total pursuant to the General Civil 
Penal Code section 162 
19,945 19,294 16,152 16,814 17,118 19,156 19,086 17,547 18,616 21,954
Total pursuant to the Act related to 
medicines 
25,959 25,322 19,981 20,004 20,060 22,009 21,027 19,191 19,899 22,787
- Drugs, use 14,520 13,377 10, 547 10,925 11,259 12,635 12,806 11,585 12,040 13,819
- Drugs, possession 10,410 10,930 8,533 8,364 8,070 8,627 7,562 7,005 7,100 8,242
- Drugs, miscellaneous 1,029 1,015 901 715 731 747 659 601 759 726
Source: Statistics Norway.
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among inmates at the start of the year was less 
than seven per cent. Drug crimes, on the other 
hand, were the primary offence among far fewer 
of the new imprisonments (16 %) than among 
those who were in prison at the start of the year.
Although the figure must be treated with caution 
due to the large number of persons serving sen-
tences in lieu of payment of a fine, for whom no 
information about the primary offence is avail-
able, we see an increase of three and four per 
cent, respectively, in new imprisonments from 
2008 to 2009 for both crimes against property 
and drug crimes.
9.2 Driving offences
Alcohol is still the most commonly detected drug 
in blood samples from motorists and motorcy-
clists who are suspected of driving while intoxi-
cated. The second most common is amphetamine, 
followed by THC (the active ingredient in canna-
bis) and methamphetamine. In the benzodiaze-
pine group of sedative drugs there was also an in-
crease in the detection of clonazepam last year, 
which indicates increasing illegal sales of the drug.
In 2010, drug analysis was carried out by the 
Norwegian Institute of Public Health (NIPH) in 
9,537 cases where drivers were suspected of driv-
ing while intoxicated. Of these, 1,637 breath tests 
were taken by the police locally, about 3,178 
blood samples were analysed by the NIPH for al-
cohol only, and about 4,722 blood samples were 
analysed for alcohol, intoxicating drugs and nar-
cotic substances. The NIPH routinely looks for 
over 30 different intoxicating drugs and narcotic 
substances, and detects an average of two or 
three drugs in the same blood sample.
Table 8 shows the most frequently detected nar-
cotic substances / intoxicating drugs. Both the 
illegal drugs (e.g. methamphetamine and co-
caine) and prescription medicines (e.g. codeine 
and diazepam) are included. The analysis find-
ings do not necessarily indicate whether the sub-
stance taken is illegal or not. As a rule, several 
sentences, while 335 convictions resulted in 
partly unconditional and partly suspended sen-
tences. The total number of fines was 9,212, 
while community sentences were imposed in 
463 cases, almost all of them pursuant to the 
General Civil Penal Code. Other sanctions in-
cluded conditional waivers of prosecution (293), 
court-imposed fines (173), suspended prison 
sentences (381) and suspended prison sentences 
and a fine (813) (Statistics Norway).
Figure 10: Number of penal sanctions for drug 
crime as the primary offence 1999–2009.
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Drugs as the main reason for prison 
sentences and remand
As of 1 January 2009, a drug crime was the pri-
mary offence for 29 per cent of prisoners in 
Norwegian prisons. By comparison, crimes 
against property and crimes of violence each ac-
counted for 21 per cent. If we only look at those 
who were held on remand, drug crime was the 
primary offence for 31 per cent, while it was theft 
or other crimes against property for 28 per cent.
The crimes committed by those who are impris-
oned in the course of a year differ considerably 
from the distribution of crimes among the prison 
population at any given time. One of the reasons 
for this is that short sentences and minor offenc-
es account for a larger proportion of new impris-
onments. For example, 20 per cent of new im-
prisonments in 2009 were primarily due to traffic 
offences, while the proportion of such crimes 
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substances are usually detected in blood 
samples.
Amphetamine is detected in blood samples after 
use of both amphetamine and meth amphetamine. 
Two-thirds of amphetamine findings are probably 
due to the taking of methamphetamine. Some of 
the methamphetamine taken is converted into 
amphetamine in the body. Many of the blood 
samples that contain methamphetamine will 
therefore also contain amphetamine, even though 
the person in question has not actually used both 
drugs. The number of cases where amphetamine 
was found will therefore include both amphet-
amine used alone and amphetamine as a bi-prod-
uct of methamphetamine. If we wish to say some-
thing about the use of amphetamine and 
methamphetamine combined, it is therefore mis-
leading to simply add up the figures for amphet-
amine and methamphetamine.
The number of cases in which THC is found has 
been relatively stable in recent years, at just 
around 30 per cent. The fact that THC is found 
in a blood sample means that cannabis has been 
taken (usually smoked) shortly before the sam-
ple was taken, usually during the last few hours 
before driving (Norwegian Institute of Public 
Health).
9.3  Interventions in the criminal 
justice system
9.3.1 Alternatives to prison
Serving of sentences outside institutions 
pursuant to the Execution of Sentences Act 
section 12.15
In 2010, 511 persons were serving sentences un-
der this system, 13 per cent of whom were wom-
en (Table 9). A total of 287 persons started serv-
ing their sentence in prison and were later 
transferred to an institution. The other 224 start-
ed serving their sentence in a treatment 
institution.
In 2010, 40,777 days were served in an institu-
tion pursuant to section 12, which is a reduction 
in relation to the previous three years (Table 10).
15 Section 12 states that ‘A sentence may in special cases be 
wholly or partly executed by 24-hour detention in an 
institution if such detention is necessary for improving 
the convicted person’s capacity to function socially and 
law-abidingly, or there are other weighty reasons for do-
ing so. The convicted person may be restrained against 
his or her will and brought back in case of escape, if 
necessary by force and with the aid of public authori-
ties. The Correctional Services shall not decide on such 
execution if it is opposed to security reasons or there is 
reason to assume that the convicted person will evade 
the execution.’
Table 8: Some finds of substances other than alcohol in blood samples from drivers suspected of driving 
under the influence in 2010. The number and percentage of blood samples on which a broad analysis was 
carried out.
Name of substance Example of name of medicine Explanation Number Percentage  
(of N=4,722)
Amphetamine  1,513 32 %
THC Active agent in cannabis 1,454 31 %
Methamphetamine  1,433 30 %
Diazepam Valium ® Vival ® Stesolid ® 1,148 24 % 
Clonazepam Rivotril ® 1,077 23 % 
Morphine Heroin Dolcontin® 276 6 % 
Codeine Paralgin forte® Pinex forte® 158 3 % 
GHB 133 3 %
Methadone Methadone® 127 3 %
Zopliclone Imovane Zopliclone® 121 3 %
Buprenorphine Subutex® Temgesic® Subuxone® 95 2 %
Source: Norwegian Institute of Public Health
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Community sentences
Community sentences are often imposed for less 
serious offences. In 2009, community sentences 
were imposed for 463 drug crimes. It is worth 
noting that 86 of the sentences concerned aggra-
vated drug crimes pursuant to the General Civil 
Penal Code section 162 second and third 
paragraph.
9.4  Drug use and problem drug 
use in prison
Drug-related health policies and services in pris-
on are discussed in Chapter 11.
Finds of drugs/user equipment
Reports received by the central administration of 
the correctional services for 2010 from regions/
prisons show that the number of seizures of drugs 
has decreased somewhat compared with 2009. 
There was a decline in seizures of narcotic sub-
stances, from 1,095 in 2009 to 773 in 2010. At the 
same time, the proportion of cases involving ille-
gal drug use uncovered by urine samples has de-
clined from 10.1 per cent in 2009 to 9.4 per cent in 
2010. The correctional service took 2,703 fewer 
urine samples in prisons in 2010 than in 2009.
Cannabis is still the drug most often found in 
urine samples, followed by illegal tablets, and 
then by amphetamine and methamphetamine. 
The use of heroin does not appear to be wide-
spread in Norwegian prisons. There has been a 
decline in the number of positive samples, from 
144 in 2009 to 68 in 2010. There are also few sei-
zures of syringes and needles.
The number of seizures of user equipment has 
declined from 1,042 seizures in 2009 to 933 in 
2010. Based on reports received, there are great 
variations between the regions as regards uncov-
ering illegal drug use through urine tests and sei-
zures of drugs/user equipment. The number of 
seizures also varies greatly between the regions 
(the central administration of the correctional 
service, 2011).
Table 9: Number of sentences started pursuant to 
section 12, 2004–2010.
Year 2004 2005 2006 2007 2008 2009 2010
Men 297 379 388 396 431 457 443
Women 32 59 51 61 74 84 68
Total 329 438 439 457 505 541 511
Source: The central administration of the correctional services
Table 10: Number of days served pursuant to 
section 12, 2004–2010.
Year 2004 2005 2006 2007 2008 2009 2010
Men 26,302 34,474 37,137 37,835 40,150 35,651 35,981
Women 2,235 3,786 4,347 4,224 4,841 5,963 4,796
Total 28,537 38,260 41,484 42,059 44,991 41,614 40,777
Source: The central administration of the correctional services
Suspended sentence with a programme for 
driving under the influence
This sanction replaces the previous alcohol treat-
ment programme. In the course of 2010, a total 
of 531 suspended sentences were imposed on 
condition of a programme for driving under the 
influence. Eighty-five per cent of the sentences 
were completed and 82 per cent were completed 
without the conditions being breached or new 
crimes being committed.
Suspended sentence with Drug Courts
Drug Courts are an alternative to prison for peo-
ple with drug and/or alcohol dependency who 
have been convicted of drug-related crimes. The 
participants regularly attend a day centre where 
rehabilitation is offered by an interdisciplinary 
service team. The programme was originally a 
three-year trial project started in 2006 in the cit-
ies of Oslo and Bergen. The project has been pro-
longed until end of 2014 and will be evaluated by 
SIRUS. In 2010, 21 new sentences were imple-
mented; seven in Oslo and 14 in Bergen. Twenty-
two suspended sentences were completed during 
2010. Seven sentences were completed without 
the conditions being breached, while the rest, 15 
sentences, were interrupted, mostly because of 
new crimes being committed.
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For cocaine and heroin, the seizures are often 
small. For example, the amount of heroin seized 
varied between 0.5 and 10 grams in six of the po-
lice districts, while seven districts made seizures 
of between 10 and 80 grams. The biggest markets 
are still the Oslo area and the regions that include 
the biggest towns and cities. Moreover, the cus-
toms authorities in Østfold county make many 
large seizures, which can largely be explained by 
the proximity to the most important border 
crossings to Sweden, where large parts of the 
drug trafficking to Norway take place by road 
and by train.
It nonetheless appears to be relatively easy to ob-
tain drugs also outside the big towns and cities. 
In the latest population study from 2009, respon-
dents were asked whether they could obtain vari-
ous substances within the space of 24 hours. 
Figure 11 shows the results for the illegal sub-
stances concerned. The proportion of ‘yes’ an-
swers seems high considering that the survey 
also includes small places with, presumably, 
poorer access to narcotic substances.
Figure 11: Percentage ‘yes’ answers in 2009 to the 
question: Do you believe that you could obtain any of 
the following substances in the space of 24 hours?
Source: SIRUS
10.1 Availability
Several factors must be emphasised when de-
scribing any changes in availability. Seizures of 
illegal substances by the police and customs au-
thorities are an important parameter in this con-
text. However, the number of actual seizures and 
the quantities involved are affected by the inter-
nal priorities of and resources available to the 
police and customs authorities, and by surveil-
lance methods and international cooperation. 
Big seizures in particular can be the result of sur-
veillance and investigations carried out over 
time. The statistics can therefore show significant 
fluctuations from one year to the next, without 
this necessarily meaning that corresponding 
changes have occurred in terms of actual avail-
ability. It is therefore a matter for debate to what 
extent seizure statistics are a good tool in con-
nection with such assessments.
The police comments that, for drugs that are 
widespread in Norway, the changes in the num-
ber of seizures correspond well with changes in 
use as reported by social science research. The 
situation is probably more complex than that, 
however. Cannabis can be used to illustrate this. 
Different surveys among the population show 
that there has been a decline in the use of can-
nabis in recent years (see Chapter 2). On the 
other hand, however, the number of seizures of 
cannabis has increased. For the period 2006–
2010, the average increase was nine per cent 
compared with the previous five-year period, 
and the increase from 2009 to 2010 was as much 
as 13 per cent (Chapter 10.3).
Measured by seizures, the most common illegal 
substances are geographically widespread. In 
2010, all the 27 police districts made seizures of 
cannabis, BZD and amphetamines, whereas co-
caine and heroin were seized in 25 districts. It 
must be emphasised, however, that the quantities 
vary greatly between the different police districts. 
10. Drug markets
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far in 2011, the customs service has registered a 
sharp decline in seizures of drugs dispatched by 
post and sent by courier. It is assumed that con-
siderable quantities are smuggled in other ways, 
as there is nothing to indicate that sales have 
been reduced.
Heroin sold in Norway mainly comes from 
Afghanistan via Turkey along the so-called 
Balkan route to Western Europe. It is smuggled 
to Norway by plane, bus, train and car. So far in 
2011, the customs service has registered a marked 
decline in the amount of heroin seized. This is 
due to the fact that no major seizures have been 
made so far. Part of the reason could be changes 
in smuggling routes and major seizures in other 
countries of heroin destined for Norway. The 
number of couriers who smuggle heroin inside 
their bodies and in their hand luggage remains at 
a stable, high level.
Khat is transported from production areas in 
Africa to Europe. It is smuggled on to Norway 
from the Netherlands and the UK by plane and 
car. Cargo planes carrying large amounts of khat 
arrive in the Netherlands daily. The khat destined 
for the Nordic market is distributed from there. 
Large quantities are also transported by road in 
cars from the Netherlands via Germany, 
Denmark and Sweden.
Cocaine sold in Norway comes from production 
areas in South America. It is then transported via 
West Africa or directly to ports and airports in 
Europe. Cocaine is smuggled to Norway using 
various means of transport and couriers. So far 
in 2011, the customs service has registered a de-
cline in the amount of cocaine seized. This is due 
to the fact that no large seizures have been made 
so far. Part of the reason could be that large sei-
zures were made in other countries of cocaine 
destined for Norway. The proportion of couriers 
who smuggle cocaine inside their bodies and in 
their hand luggage remains at a stable, high level. 
So far this year, the customs service has regis-
tered an increasing amount of cocaine being 
smuggled via Poland. A challenge seen in other 
countries is an increase in the smuggling 
10.2 Supply
10.2.1 Smuggling routes to Norway
According to the customs service, most of the 
amphetamine/methamphetamine on the 
Norwegian market comes from illegal laborato-
ries in the Netherlands, Poland and Lithuania. 
Lithuanian criminals still have a dominant role 
as suppliers of synthetic drugs to Norway. 
Although a decrease was registered in the quan-
tity seized during the first six months, the pro-
portion of seized methamphetamine from 
Lithuania is considerable. The travel route varies. 
At the national border, most seizures are made 
from means of transport from the Netherlands 
and Belgium, but seizures are also made from 
passenger cars that travel by ferry from the con-
tinent. Passenger cars with concealed cavities 
and regular bus services seem to be the most fre-
quent methods used.
Hash seized in Norway mainly comes from 
Morocco via Spain and the Netherlands. So far 
this year, the customs service has registered a 
significant increase in seizures of hash. From the 
Netherlands, the drug is transported via 
Denmark to Norway by car, bus, train or plane. 
During the first six months of 2011, the customs 
service uncovered large quantities of hash smug-
gled in goods transport across the border and by 
ferry. At the same time, there has also been an 
increase in the smuggling of smaller quantities 
by plane, bus and passenger car. The number of 
couriers who have attempted to smuggle hash 
inside their bodies has increased so far in 2011.
There are also many indications that the smug-
gling of marijuana to Norway has increased sig-
nificantly. The customs service has registered 
many seizures on trains, buses and in passenger 
cars. Substantial seizures have also been made in 
connection with goods transport. There are 
many indications that much of the marijuana 
seized by the customs service comes from Poland 
and the Czech Republic.
GHB and GBL are smuggled to Norway from the 
Netherlands, Poland, Germany and China. So 
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high, while there has been a decrease in cases of 
this type involving amphetamine and cannabis.
GHB/ GBL, benzodiazepines, amphetamine/
methamphetamine and, not least, other stimu-
lants seem to have become more prevalent in the 
user market, with increases in the number of sei-
zures of 36 per cent, 30 per cent, 24 per cent and 
58 per cent, respectively, from 2009 to 2010. The 
number of seizures of heroin is the highest since 
2003. The number is far lower, however, than in 
the period 1995–2003. Moreover, the purity of 
heroin base has sunk to a historically low level, 
21 per cent in 2010 on average, declining further 
to 17 per cent in first half of 2011. The total 
seized amount of all cannabis products is not 
particularly high, which can be explained by the 
relatively small amount of hash seized. On the 
other hand, the number of cultivation cases and 
the number of seizures of marijuana have yet 
again increased strongly. Both the quantities and 
the number of seizures substantially exceed 
those in the years 2007 and 2008, which were 
registered as record years until 2010.
Although far bigger quantities of both amphet-
amine and methamphetamine have been seized 
in previous years, 290 kg is nonetheless regarded 
as a considerable quantity. In total, the number 
of seizures of these two drugs has increased rela-
tively strongly in 2010 compared with the period 
2006–2009.
If we look at the total amount of seizures of stim-
ulants, including drugs that were classified as 
narcotic substances in 2010 (see NR 2010 
Chapter 1.1), the statistics show a greater in-
crease for this class of drugs than for depressants 
seen as a whole.
Of the new stimulants that were introduced to 
the user market in 2010, it is mainly parame-
thoxymethamphetamine (PMMA) that stands 
out, 24 kg of which was seized in the second 
half-year 2010 in 81 seizures. According to the 
National Institute of Public Health, PMMA has 
so far (end of September 2011) been linked to 20 
overdose cases with fatal outcomes. Although 
of liquid cocaine from South America. Liquid 
cocaine is difficult to uncover, whether smuggled 
inside the body or in luggage.
The customs service is uncovering an increasing 
amount of drugs sent in the post and by courier. 
This applies in particular to narcotic tablets or-
dered online. As regards tranquillising narcotic 
tablets, the smuggling of Rivotril and Subutex 
appears to have increased in particular. Towards 
the end of 2010 and in spring 2011, the customs 
service registered a significant increase in the 
smuggling of Rivotril tablets from Hungary.
The customs service has also registered an in-
crease in the smuggling of new drugs (legal highs). 
New versions of synthetic cannabinoids and oth-
er synthetic substances are being uncovered all 
the time. The challenge is that many of these 
substances are difficult to stop as they are not yet 
on the list of narcotic substances (personal com-
munication, Directorate of Customs and Excise 
Enforcement Department, Anti Smuggling 
Section).
10.3 Seizure statistics
See also the data in Standard table 13.
Main features
The number of cases and seizures has increased 
to record levels in 2010. However, with the ex-
ception of GHB and GBL, the big increase in 
cases has not led to seizures of record amounts of 
drugs. For heroin, however, it is only in 2004 and 
2009 that greater quantities have been seized, for 
cocaine only in 2005 and 2007, for benzodiaze-
pines (BZD) in 2002 and 2006, and for amphet-
amine/methamphetamine the three preceding 
years.
There has been a decline in the number of cases 
involving the most aggravated drug crimes that 
fall under the General Civil Penal Code section 
162 third paragraph, from 64 cases in 2009 to 46 
in 2010. The number of cases pursuant to the 
third paragraph involving heroin has remained 
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Data basis and sources of error
The annual report from the National Criminal 
Investigation Service (Kripos) on the status of 
and developments in drug trafficking contains 
national data that include all seizures by the po-
lice, the customs service, the prisons and the 
Armed Forces. The data are based on verified 
analysis results for use in ordinary criminal cas-
es, as well as on information from the police dis-
tricts when drug offences are decided locally 
through fines or by summary trial based on a 
plea of guilty. The latter categories are decided 
without the seizures being tested at the Kripos 
laboratory. In these cases, relevant information is 
usually given about what the seizures probably 
contain. The sources of error are not deemed to 
have a significant bearing on the main trends, 
but experience indicates that some of the minor 
seizures may include other types of drugs than 
those stated in statements to the authorities. This 
may apply in particular to the ratio between am-
2007 is the only year in which more seizures of 
cocaine were made than in 2010, cocaine none-
theless appears to have a somewhat smaller mar-
ket share during the last three years compared 
with seizures of other drugs.
The seizure figures are very low for ecstasy, both 
in terms of the amount seized and the number of 
seizures. We have to go back to 1994 to find a 
lower figure. Among tablets with logos, MDMA 
has largely been replaced by other drugs, pri-
marily mCPP (1,3-chlorphenylpiperazine).
Both the number of seizures and the number of 
tablets of benzodiazepines (BZD) have increased 
since 2008, a trend that was reinforced in 2010. 
Only in two previous years have greater quanti-
ties been found and more seizures made than in 
2010. It is clonazepam (Rivotril) and diazepam 
(e.g. Valium) in particular that dominate the 
user market.
Table 11: Amounts seized for the most relevant drugs 2006–2010*
Year 2006 2007 2008 2009 2010
Cannabis (kg) 1,544 853 1,732 2,588 1,184
Amp/methamphetamine (kg) 386 559 362 431 290
Other stimulants(units) 1,603 1,979 2,796 3,469 6,149+24 kg
Heroin (kg) 93.0 8.0 55.2 130.1 102.3
BZB (units) 1,006,400 729,082 308,582 668,995 881,800
Opioids (units) 15,685 11,906 11,193 15,186 18,800
Cocaine (kg) 40.5 95.0 76.8 61.1 94.2
Ecstasy (units) 28,636 78,725 30,678 22,700 6,250
Psilocybe mushrooms (kg) 0.84 1.36 0.5 1.66 2.0
LSD (units) 226 26 245 510 174
GHB (ltr) 31.3 58.6 36.5 83.6 83.4
GBL (ltr) 14.2 42.3 220.8 129.8 397.0
*The figures from 2009 and previous years have been revised for some drugs
Source: Kripos
Table 12: Large drug seizures pursuant to General Civil Penal Code section 162, third paragraph in 
2008–2010.
Drug type Number 2008 Number 2009 Number 2010
Amphetamine/ methamphetamine (threshold: seizures> 3 kg ) 14 21 12
Cocaine (threshold: seizures > 3 kg 4 4 3
Ecstasy (threshold: seizures > 15,000 tablets) 0 1 0
Cannabis (threshold: seizures > 80 kg 3 6 2
Heroin (threshold: seizures > 0.75 kg ) 16 32 29
Benzodiazepines 1 0 0
Total 38 64 46
Source: Kripos
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Figure 12: Market share for different drugs in 2010. 
Number of seizures. Percentage.
Cannabis
BZD
Heroin
Amph/methamphetamine
Cocaine
Ecstasy
GHB/GBL
Painkillers
Other stimulants 
Others 
42,0
16,05,0
23,0
3,0
0,2
1,0
4,0
1,0
4,8
Source: Kripos
Comments on the individual drugs
Cannabis
Following a marked decline in 2007 both with 
regard to the quantity and the number of sei-
zures of cannabis, both these parameters in-
creased significantly in 2008 and 2009, mainly 
because hash increased strongly. In 2010, the 
situation was roughly the same as in 2007, rela-
tively small amounts of hash and considerably 
more marijuana and cannabis plants. The most 
striking development in 2010, however, is that 
the number of ‘cannabis plantations’ has in-
creased strongly, and it is now far higher than in 
2007 and 2008.
phetamine and methamphetamine or to so-
called ‘ecstasy tablets’ that no longer always con-
tain MDMA or analogues.
10.3.1 Statistics for 2010
In 2010, 26,087 drug cases were registered. Of 
the total number of drug cases, 10,749 were anal-
ysed, while 15,338 were fixed-penalty cases. The 
increase in the number of cases since 2009 is 19 
per cent – an increase of 21 per cent for the anal-
ysis cases and 18 per cent for fixed-penalty 
cases.
Table 11 shows that the quantities seized (natu-
rally) vary considerably from one year to the 
next. As an indicator of the size of individual sei-
zures, based on quantitative criteria for prosecu-
tion that meet the definition of aggravated drug 
crime in the General Civil Penal Code section 
162, third paragraph, 46 such large drug seizures 
were made in 2010 (Table 12).
Table 13 shows the changes in the number of sei-
zures during the period 2006 to 2010, while 
Figure 12 shows the market share in 2010 for the 
most common substances.
Table 13: Number of seizures in the period 2006–2010 broken down by some types of drugs*.
Drug type 2006 2007 2008 2009 2010  % changes 
2009–2010
Cannabis 11,221 9,952 10,599 11,754 13,326 +13
Amph./methamph. 5,819 5,507 5,153 5,775 7,167 +25 
Heroin 1,087 1,204 1,145 1,430 1,582 +11
Benzodiazepines 4,500 4,058 3,451 3,796 4,945 +30
Painkillers/ opioids 1,161 959 936 1,078 1,184 +10
Cocaine 726 909 854 804 868 +8
Ecstasy 411 421 309 110 71 -35
LSD 28 13 15 26 30 +15
GHB 111 163 133 218 308 +41
GBL 11 25 40 103 132 +28
Psilocybe mushrooms 82 77 54 75 92 +23
*The figures from 2009 and previous years have been revised for some drugs
Source: Kripos
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Heroin
Although the number of seizures of heroin is far 
lower than at the turn of the millennium, there 
has been an increase since 2006. The proportion 
of heroin seizures in relation to seizures of other 
drugs has also increased somewhat, from 4.2 to 5 
per cent in the same period. By comparison, her-
oin seizures accounted for 20 per cent of the total 
number of drug seizures in 1998. As before, most 
heroin seizures are made in the biggest towns 
and cities in Norway. Together, Oslo Police 
District and Hordaland Police District (Bergen) 
made 64per cent of all the seizures of heroin in 
2010.
Other opioids
Both the quantity and the number of seizures of 
painkillers classified as narcotics are higher than 
in recent years. No particularly large seizures of 
these medicinal drugs were made in 2010, how-
ever. Several of the cases concerned illegal im-
portation via internet shopping, but the number 
of tablets in each seizure is relatively small. It is 
once again buprenorphine (Temgesic, Subutex 
and Subuxone) and codeine (e.g. Paralgin forte) 
that dominate the statistics. Together with meth-
adone, buprenorphine accounted for almost 60 
per cent of all seizures in this class of medicines 
in 2010.
Cocaine
Following a strong increase in the number of co-
caine seizures after the turn of the millennium, 
especially from 2005, the number of seizures cul-
minated in 2007. Although the number of sei-
zures and the quantities seized were almost as 
high in 2010 as in 2007, the number of cocaine 
seizures has increased less than the overall in-
crease in cases. From accounting for approxi-
mately 1.5–2 per cent of drug seizures at the start 
of the 2000s, the proportion of cocaine seizures 
increased to four per cent in 2007. The propor-
tion has fallen somewhat again since then, but it 
was back at three per cent in 2010, the same as in 
2006.
The amount of cannabis seized, 1,186 kg, breaks 
down as follows: approximately 822 kg of hash 
(69 %), 209 kg of marijuana (18 %), 156 kg of 
cannabis plants (13 %) and 0.016 kg of cannabis 
extract. This distribution is very different from 
2009, when the proportion of hash was as high as 
93 per cent.
The number of cannabis seizures breaks down as 
follows: 76 per cent hash, 22 per cent marijuana 
and two per cent cannabis plants. Seen in rela-
tion to the number of seizures, the proportion of 
hash is also lower than in 2009 (82 %). As regards 
cannabis plants, 400 seizures were made in 2010. 
By comparison, 243 seizures were made during 
the period 1 July 2007 – 30 June 2008, when the 
police uncovered particularly many ‘cannabis 
plantations’. The growing cultivation activity also 
coincides with a significant increase in marijua-
na seizures, both in terms of absolute figures and 
in relation to other cannabis products. It is rea-
sonable to assume that domestic production is a 
significant cause of the spread of marijuana.
Amphetamine and methamphetamine
Approximately 150 kg of amphetamine was 
seized in 2010, divided between 3,490 seizures, 
and 140 kg of methamphetamine, divided be-
tween 3,677 seizures. For both drugs, the seized 
amount is lower than in 2009, while the number 
of seizures of amphetamine has increased by 
more than 50 per cent. The proportion of meth-
amphetamine compared with amphetamine cul-
minated in 2009, and it was estimated to be 45 
per cent in the second half-year 2010 (Table 14). 
The whole increase in the total number of sei-
zures, 25 per cent from 2009, can be ascribed to 
amphetamine, while the number of seizures of 
methamphetamine is about the same as the year 
before.
Table 14: Proportion of seizures of methamphet-
amine in relation to amphetamine.
Year 2006 2007 2008 2009 2010
 % Meth. 26.0 35.3 43.5 64.3 56
Source: Kripos
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medicinal drug on 1 August 2004. All seizures of 
Rohypnol must therefore come from illegal 
imports.
Phenazepam is a Russian benzodiazepine that is 
not in medicinal use in Norway. Even though 
this drug has never been very common on the 
illegal market in Norway, it nonetheless attracted 
a lot of attention in both 2008 and 2009. 
Phenazepam was formally classified as a narcotic 
substance on 24 March 2010. This drug has had a 
limited spread, but in 2008, relatively large quan-
tities were seized in Nord-Trøndelag Police 
District, both illegally manufactured tablets and 
technically pure active agents. A similar case was 
uncovered in Agder Police District in 2010, 
where approx. 9.9 kg of tablets and about 600 
grams of technically pure phenazepam were 
seized.
10.4  Price of illicit drugs at retail 
level
The latest overview of estimated drug prices from 
Oslo police district of May 2010 was presented in 
the National report for 2010. Compared with the 
previous overview from October 2008, the nom-
inal price of a typical user dose in the Oslo area 
has remained relatively stable: EUR 25 (NOK 
200) for 0.2g of heroin, EUR 12.5 (NOK 100) for 
0.2g of amphetamine, EUR 37.5–50 (NOK 300–
400) for 0.5g of cocaine, and EUR 12.5 (NOK 
100) for 0.7g of hash.16
However, there seems to have been a marked 
drop in price for quantities of up to five grams 
for both heroin and cocaine in the same period. 
The price of one gram of heroin is now estimated 
to be EUR 87.5–100 (NOK 700–800), compared 
with EUR 125 in 2008, and the price of five 
grams is now EUR 225–375 (NOK 1,800–3,000) 
(2008: EUR 313–438). For cocaine, the price of 
five grams has dropped from EUR 438 to EUR 
16  Conversion rate: 1 EUR=8 NOK
Ecstasy
The market is primarily characterised by a sharp 
decline in both the quantity and number of sei-
zures of ecstasy tablets. Moreover, the active 
agent MDMA has largely been replaced by other 
drugs, mainly mCPP (1,3-chlorphenylpipera-
zine), a drug with a mild hallucinogenic affect 
(Chapter 10.5). mCPP was included on the list of 
narcotic substances in March 2010. The decline 
can be explained by more stringent regulation 
and thereby increasing scarcity of the raw mate-
rials used to manufacture traditional ecstasy tab-
lets containing MDMA.
LSD has probably never been very widespread in 
Norway. Since LSD is easy to conceal, however, 
we cannot exclude the possibility that the seizure 
statistics fail to give an accurate picture of the ac-
tual situation.
GHB, GBL and 1,4-butandiol
In 2010, the total number of seizures of these 
three drugs exceeded 400 for the first time. 
Compared with 2009, the increase was particu-
larly great for GHB. Overall, these drugs none-
theless only account for just over one per cent of 
all seizures of substances classified as narcotics. 
However, we cannot exclude the possibility that 
the chances of GHB/GBL being detected is lower 
than for other drugs, since the appearance and 
effect of GHB/GBL and alcoholic beverages are 
very similar. This could mean that the seizure 
statistics fail to reflect the actual prevalence.
Benzodiazepines-BZD
From 2009, both the quantities seized and the 
number of seizures have increased significantly. 
Based on the seizures, the illegal trafficking ap-
pears to mainly involve diazepam (Valium, 
Stesolid) and clonazepam, mainly Rivotril. 
Rohypnol (flunitrazepam) and Flunipam (fluni-
trazepam), which dominated this tablet market 
at the start of the 2000s, have declined strongly. 
This is probably related to both a strong reduc-
tion in illegal imports and more stringent pre-
scription rules. From 1 January 2003, both these 
medicinal drugs were reclassified as class A 
drugs, and Rohypnol was de-registered as a 
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Table 15: Average purity of heroin 2005–2010.
Year 2005 2006 2007 2008 2009 2010
Purity percentage 26 30 36 31 25 21
Source: Kripos
The average purity of amphetamine was about 25 
per cent, and 44 per cent for methamphetamine. 
For amphetamine, this is lower than in 2009 
(29 %). As in previous years, the purity varied 
greatly in 2010, from less than one per cent to as 
much as 97 per cent.
As reported for several years now, the purity of 
seized cocaine has been declining steadily, from 
more than 70 per cent more than 20 years ago to 
25 per cent in 2009. In 2010, however, the purity 
increased again to 28 per cent. There are still 
great variations in the individual seizures. 
Fenacetine, xylocain and caffeine are often found 
as additives.
Experience shows that the THC content of can-
nabis products can vary a great deal. Whole 
plants usually contain three to seven per cent 
THC, and isolated top shoots usually contain 11 
to 22 per cent. For hash, which dominates the 
Norwegian market, the average THC content has 
remained at around seven per cent for several 
years, but analyses for 2010 show that this aver-
age has increased to nine per cent.
For more than 20 years, MDMA has completely 
dominated in seizures of ecstasy tablets. Until 
2008, no other substance accounted for a signifi-
cant part of this tablet market. In 2010, however, 
the proportion of seizures of MDMA only ac-
counted for 19 per cent, while it accounted for 
between 87 and 98 per cent in the period 2004–
2007. The proportion of mCPP was as much as 
69 per cent of tablet seizures in 2010. 2C-B ac-
counted for eleven per cent, while the proportion 
of methamphetamine was less than one per 
cent.
313. For hash and amphetamine, the changes are 
only marginal.
The price also seems to have dropped for pur-
chases of 10 grams. The estimated price of 10 
grams of heroin is between EUR 450 and EUR 
688 in 2010 (NOK 3,600 and NOK 5,500). In 
2008, the price level was EUR 625–750. The price 
of 10 grams of cocaine and amphetamine is also 
markedly lower, approximately 18 per cent lower 
for cocaine and as much as 25 per cent for am-
phetamine. There are no such changes in relation 
to hash.
As regards ecstasy, the price level as a whole has 
remained stable. The price per tablet is around 
EUR 12.5 (NOK 100), while a certain reduction 
can be seen in the price of 100 tablets.
Naturally, a price list of this kind must be treated 
with considerable caution. However, since the 
data have been collected from the same source 
for several years, some comparison is possible.
10.5  Purity/potency/composition 
of illegal drugs and tablets
See data in Standard tables 14 and 15.
Table 15 shows that the average purity of heroin 
base continues to fall. An average purity of 21 
per cent is the lowest ever measured, and none of 
the seizures made in 2010 had a heroin content 
of more than 48 per cent. As in previous years, 
paracetamol and caffeine were found in a num-
ber of seizures, in addition to depressants such as 
benzodiazepines, primarily alprazolam. A typi-
cal mixture can contain 8–10 per cent heroin and 
a large proportion of alprazolam, which causes 
stronger and more untraditional intoxication 
symptoms. Such mixtures are registered both in 
heroin seized at the border and in seizures made 
in the user milieus.
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Selected issues
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of Norway, Staff Academy
11.1  Prison systems and prison 
population: contextual 
information
11.1.1  Characteristics of the population, 
health and social status
The average number of inmates in Norwegian 
prisons was just over 3,700 in 2010.1 This is an 
increase of almost 400 from the year before. The 
total number of inmates during the year was 
14,606, which is slightly fewer than the year be-
fore. The number of new inmates in 2010 was 
11,700, 3,900 of whom were held on remand.
Of the sentences imposed in 2009, sentences for 
crimes of violence accounted for 25 per cent, fol-
lowed by driving under the influence (22 %) and 
drug crimes (15  %). Three per cent were sen-
tenced for sexual offences. Around ten per cent 
were between the ages of 16 and 20, while 17 
prisoners were below the age of 16 in 2010. Most 
stays in prison are relatively short: In 2010, four 
out of ten were released within 30 days, while 75 
per cent were released within three months.
The proportion of foreign inmates (both on re-
mand and serving sentences) has increased 
strongly in recent years, from 18 to 32 per cent of 
the average number of inmates in Norwegian 
prison from 2006 to 2011. Foreign inmates also 
1 Annual statistics 2010. The central administration 
of the correctional services. http://img3.custom-
publish.com/getfile.php/1640752.823. befyrrrfee/
årsstatistikk+2010+bruk.pdf?return=www.kriminalom-
sorgen.no
serve longer sentences than Norwegian inmates, 
most often for drug crimes (about 40 %). Foreign 
inmates are a complex group. Most of them are 
from countries in Eastern Europe and North 
Africa. Inmates in this group are entitled to nec-
essary medical help in prison, but they will nor-
mally not be returned to Norwegian society after 
serving their sentences.
Several surveys show that the level of morbidity 
among inmates is generally higher than among 
the population at large.2 This applies to drug and 
alcohol addiction, mental health problems and 
somatic illnesses. A survey conducted by the re-
search foundation Fafo on the basis of interviews 
with 260 inmates shows that four out of ten have 
chronic illnesses that affect their everyday lives 
(Friestad & Skog Hansen, 2004). The corre-
sponding figure in the general population is 25 
per cent. Two out of ten inmates have financial 
problems. Outside prison, this was the case for 
around six per cent of the general population. 
Four out of ten inmates have no education after 
lower secondary school, while the same applies 
to fewer than one in ten of the general popula-
tion. This may say something about an accumu-
lation of several living-condition problems, and 
it shows that there is a connection between a 
high number of previous prison sentences and 
several problem areas (Ibid).
11.1.2  The extent of drug and alcohol use 
in Norwegian prisons
The three biggest surveys available on drug and 
alcohol use and prisons are all based on figures 
from the early 2000s:
2 Bjorngaard et al. 2009. The prisoner as patient – a health 
services satisfaction survey. BMC Health Services 
Research 2009, 9:176.: http://www.biomedcentral.
com/1472-6963/9/176#B3
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Several things can be said about whether the re-
sults of the surveys are representative of the situ-
ation in prisons today. This applies in particular 
to the proportion of inmates serving short sen-
tences. On an average day in 2003, 20 per cent8 
of all inmates were serving a sentence shorter 
than three months. In Friestad and Skog Hansen’s 
survey, this group was eleven per cent.9 Over the 
whole year, 75 per cent of those who were re-
leased had served less than three months. The 
proportion of inmates who serve short sentences 
in the course of a year is therefore higher as a 
proportion of all inmates than figures based on 
measurements taken on a single day. This is a 
weakness of sample surveys, which are often 
based on the proportion of inmates on a given 
day. Moreover, Friestad and Skog Hansen only 
include inmates serving sentences, not those 
held on remand. The number of persons held on 
remand has increased in recent years and it now 
accounts for almost 30 per cent of the number of 
days served in prison. There are no good studies 
of drug use among persons held on remand, but 
this group of inmates is challenging in relation to 
systematic follow-up of possible drug or alcohol 
problems. Skardhamar found no differences in 
drug/alcohol use between inmates serving sen-
tences and inmates held on remand.10
11.2  Organisation of prison 
health policies and service 
delivery
11.2.1  Drug-related health policies 
targeting prisoners
The white paper on the correctional service, 
Punishment that works – less crime – a safer soci-
ety (Report no 37 (2007–2008) to the Storting), 
8 Length of sentences for inmates serving sentences of 
less than three months as of 16 May 2003. Taken from 
Kompis KIA report v-02-10a as of 19 September 2011.
9 Length of sentences for inmates taken from Table 2.2, 
Friestad and Skog Hansen 2004 p. 17.
10 Skardhamar, T, 2002. Op. cit. p. 86
• Skardhamar (2002)3 has interviewed 247 
inmates from a cluster sample of some 
prisons in a region (the Eastern Norway 
prison district) since the year 2000.
• Friestad and Skog Hansen (2004)4 have data 
from 260 interviews of convicted persons 
from all prisons in 2003.
• Ødegård (2008)5uses data from a questionnaire 
survey of all convicted persons in 2002.
All the surveys ask about drug and alcohol use dur-
ing a period of two to three months prior to impris-
onment. The results vary from almost 60 per cent 
to 76 per cent reporting that they had used drugs in 
the period prior to imprisonment. The first two 
surveys focus on living conditions in general, while 
Ødegård focuses more specifically on the differ-
ence between alcohol and drugs. Ødegård also dif-
ferentiates the results by type of use, i.e. the type of 
drug used, the frequency and the method of taking 
the drug (e.g. by injection). Here, the proportion of 
inmates displaying serious problem drug use6 prior 
to imprisonment was estimated to be 45 per cent, 
while 23 per cent had less serious drug use.7Another 
finding in this survey concerns the consumption of 
alcohol prior to imprisonment. The findings stand 
out from the rest of the population, both in that a 
greater proportion report high-frequency alcohol 
consumption and in that more people abstain from 
alcohol than in the general population.
3 Skardhamar, T. 2002. Levekår og livssituasjon blant 
innsatte i norske fengsler (‘Living conditions and life 
situation among inmates in Norwegian prisons’ – in 
Norwegian only). Master’s degree thesis in criminology. 
The Department of Criminology and Sociology of Law, 
the University of Oslo.
4 Friestad, C. and Skog Hansen, I.L. 2004. Levekår blant 
innsatte (‘Living conditions among inmates’ – in Norwe-
gian only) in Fafo report 429. Oslo http://www.fafo.no/
pub/rapp/429/429.pdf
5 Ødegård, E. 2008. Narkotika- og alkoholproblemer blant 
innsatte i norske fengsler (‘Drug and alcohol problems 
among inmates in Norwegian prisons’ – in Norwegian 
only). Published in the Nordic Alcohol and Drugs Jour-
nal (NAT) no 3 2008: p. 169-185.
6 By serious problem drug use is meant the reporting of 
frequent use of heavy drugs.
7 By less serious drug use is meant the reporting of sporadic 
use of heavy drugs or frequent or sporadic use of cannabis.
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When the Administrative Alcohol and Drugs 
Treatment Reform transferred responsibility for 
detoxification, assessment and specialised treat-
ment for drug and alcohol use to the public 
health service, drug and alcohol dependency be-
came a more limited category. The health ser-
vice’s assessment of drug and alcohol dependen-
cy and of treatment needs became a medical 
assessment (the ICD-10 and DSM IV classifica-
tion systems). It is an important point that it is 
this assessment of the patient’s condition/situa-
tion that constitutes the treatment order, which 
in turn triggers a right to treatment.
One of the sub-goals of the Action Plan is to im-
prove accessibility of services for prisoners and 
convicts. It lists six measures that are also fol-
lowed up in the correctional service’s strategies:
• Improve collaboration between the 
municipal health service, the specialist 
health services, the municipal social services 
and the Norwegian Correctional Services.
• Increase the number of prison days served in 
an institution pursuant to section 12 of the 
Norwegian Execution of Sentences Act.
• Establish units for people with problem 
drug/alcohol use in prisons.
• Improve the services for prisoners about to 
be released.
• Evaluate the trial scheme Drug Rehab 
Programme under Court Supervision and 
assess continuation and expansion.
• Develop a coordinated strategy to combat 
substance use in the Norwegian Correctional 
Services.
11.3  Provision of drug-related 
health services in prison
11.3.1 Treatment in the health service
From a social service and health perspective, 
prison is a good arena for starting change pro-
cesses, since inmates are available and motivated 
for change. All inmates are entitled to the same 
medical treatment in prison as other users. This 
also applies to the right to an individual plan, a 
sets the direction for work on drug and alcohol 
problems in prison. The correctional service 
shall execute sentences while at the same time fa-
cilitating changes in the individual inmates and 
preparing their return to society in collaboration 
with ‘imported services’11 and external partners. 
The correctional service has developed a drug 
and alcohol strategy (2008–2011) that contains 
three sub-goals for this work: 1) Motivate and fa-
cilitate, 2) Reduce the use of drugs and alcohol 
during prison sentences and 3) Strengthen the 
cooperation between drug and alcohol measures 
and collaborative partners.
Inmates have the same rights as the general pop-
ulation. This is particularly the case in relation to 
health, and drug and alcohol users in prison are 
entitled to treatment and follow-up by the health 
service. The municipal health service is present 
in all prisons. It is the municipality in which a 
prison is located that is responsible for health 
services in the prison. GPs are the most impor-
tant resource for those serving sentences under 
the supervision of the probation service. The 
Administrative Alcohol and Drugs Treatment 
Reform in 2004 (see more details in Chapter 
5.3)12 and the Norwegian Action Plan on Alcohol 
and Drugs (2008–2012)13 emphasised in particu-
lar the health service’s responsibility for collabo-
rating with the correctional service during the 
serving of sentences and for following up in-
mates upon release.
11 Imported services are services provided in prison by 
persons/agencies not employed by the prison. Teaching, 
health services, library and other services are examples 
of such services. The health service has been an im-
ported service in prisons since 1988, and the municipali-
ties took over this responsibility in 1994.
12  Information about the Administrative Alcohol and 
Drugs Treatment Reform is available on the Directorate 
of Health’s website: http://www.helsedirektoratet.no/
rusmidler/behandling/rusreformen/
13  Information about the Government’s escalation plan for 
the drugs and alcohol field is available on the Directorate 
of Health’s website: http://www.helsedirektoratet.no/
rusmidler/opptrappingsplanen/
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In the health service’s report for 2007, 15 out of a 
total of 45 prison units express concern about ca-
pacity. Several units are also concerned about in-
adequate provision of specialist health services. 
The Directorate of Health’s assessment points out 
that the need for health services in prison is prob-
ably much greater than in the rest of the popula-
tion… and that the provision varies so much that 
a survey of the coverage of health personnel in 
prisons should be considered.15 In a survey con-
ducted by Synovate Norge on assignment for the 
Directorate of Health in 2010, eight of out ten 
health departments report that the prison health 
service provides adequate health services, while 
one out of ten disagree. The health departments 
were also asked whether the prison health ser-
vice had sufficient resources to provide the nec-
essary health services. More than half agreed 
that they did.
Collaboration with the prison health service is 
one of the most important measures in the cor-
rectional service’s drug and alcohol strategy. It is 
regulated in a separate circular,16 which is in-
tended to contribute to improving coordination 
and strengthening local and regional coopera-
tion. The circular has also been important in col-
laboration on the Action Plan, which also focus-
es on measures aimed at drug and alcohol users 
during and after the serving of sentences. Among 
other things, it emphasises follow-up of individ-
ual plans, which are the users’ own plans, in or-
der to coordinate treatment and rehabilitation, 
and collaboration between the prison health ser-
vice and the specialist health service in order to 
offer treatment during the serving of sentences. 
15  The Directorate of Health 2009. Helsetjenester til 
innsatte i fengsel (‘Health services for inmates in prison’ 
– in Norwegian only). Report 2007. 
16  Rundskriv G-8 2006 om Samarbeid mellom kommune-
helsetjenesten, spesialisthelsetjenesten, kommunenes 
sosialtjeneste og kriminalomsorgen overfor innsatte 
og domfelte rusmiddelavhengige (‘Circular G-8 2006 
concerning collaboration between the municipal health 
service, the specialist health service, the municipal 
social service and the correctional service in relation to 
inmates and convicted problem drug or alcohol users’ – 
in Norwegian only).
right to participation and a right to information, 
the informed consent requirement and the right 
to referral to the specialist health service, if 
relevant.
The correctional service carries out basic assess-
ment of inmates on arrival in prison. This assess-
ment is intended to provide information about 
matters with a bearing on the prison term and to 
form the basis for referral to collaborative part-
ners for a more detailed assessment. In spring 
2012, the correctional service will start testing an 
electronic assessment form. Participation in this 
assessment will be voluntary for the individual 
inmate.
Inmates who are in opioid substitution treat-
ment and/or have been prescribed other addic-
tive medicinal drugs (class A and B drugs) will 
be able to continue this treatment in prison. For 
persons held on remand, it is their GP who has 
medical responsibility, if relevant in collabora-
tion with the prison health service. The prison 
health service and the prison doctor take over 
responsibility for convicted persons and consid-
er continuation of the treatment during the stay 
in prison.
Although the prison health service is part of the 
municipal health service, the extent to which it is 
integrated with the municipality’s other health 
care varies. The prison health service staff are 
mainly nurses and doctors, while some units also 
have a physiotherapist and a psychologist. The 
average time health services are available per in-
mate in all prisons in Norway is one hour and 
ten minutes per week, but there are great varia-
tions between prisons. There has been an in-
crease in the number of nurses and doctors from 
2007 to 2010, but not as great as the increase in 
the number of inmates during the same 
period.14
14  Kartlegging av fengselshelsetjenesten i Norge 2010 (‘Sur-
vey of the prison health service in Norway 2010’ – in 
Norwegian only). Synovate Norge. 21 March 2011.
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have been established in high-security prisons, 
and five in prisons with lower levels of security. 
The precursor to the units for mastering drug and 
alcohol problems was the collaboration on the 
Pathfinder Programme between Oslo prison and 
the Tyrili foundation. In the units for mastering 
drug and alcohol problems, prison staff work to-
gether with health professionals from the specialist 
health service on a treatment-enhancing measure 
aimed at further treatment in prison, either pursu-
ant to the Execution of Sentences Act section 12 or 
by the specialist health service after release.
A separate circular is being prepared on the organi-
sation of the collaboration in the units for master-
ing drug and alcohol problems. It will contain 
guidelines and procedures for reporting on the col-
laboration and the development of the units.
Suspended sentence with drug courts
Suspended sentence with drug courts is a sepa-
rate penal sanction based on the model of Drug 
Courts in Ireland and Scotland. The programme 
was established as a three-year trial scheme from 
2006 with two units in Oslo and Bergen. It has 
since been extended until the end of 2014 (see 
Chapter 9.3.3). The correctional service’s educa-
tion centre has completed a follow-up evaluation 
of the start-up of the project.18 SIRUS is now col-
lecting data from two years’ follow-up of 115 
persons who have been included in the project. 
Admission to the programme has taken more 
time than expected, which will delay the evalua-
tion by up to two years.19
Serving of sentences pursuant to section 12
The Execution of Sentences Act section 12 gives in-
mates who have drug or alcohol problems and/or 
mental health problems the possibility of serving 
their sentence in a treatment or care institution (see 
18  Johnsen, B. and Svendsen, M. Narkotikaprogram med 
domstolskontroll (‘Suspended sentence with drug 
courts’ – in Norwegian only). Start-up of the teams and 
centres 2006. http://img3.custompublish.com/getfile.
php/502689.823.wcquuyytdf/dok22007.pdf
19 Personal correspondence, Astrid Skretting, SIRUS 19 
September 2011.
The units for mastering drug and alcohol prob-
lems, which are also part of the correctional ser-
vice’s drug and alcohol strategy, are one such col-
laboration measure (see Chapter 11.3.2).
A proposed new health and care act (expected in 
2012) will transfer responsibility for more health 
tasks from the specialist health service to the 
municipalities. The consultative paper discusses 
in particular services relating to people with 
mental illnesses and people with drug/alcohol 
dependency.17 The municipalities will also be as-
signed clearer responsibility for following up in-
dividual plans and for coordinating the measures 
before, during and after treatment. This also ap-
plies to the prison health service’s responsibility 
for providing health care for convicted persons.
11.3.2  Measures and treatment provision 
for inmates
A description of the most important measures 
for drug prevention, information and education-
al activities follows below. They are part of the 
correctional service’s overall drug and alcohol 
strategy and aim to motivate and facilitate absti-
nence from drugs and alcohol by convicted per-
sons/persons on remand during imprisonment 
and better control of drug and alcohol use after 
release.
Units for mastering drug and alcohol 
problems
The units for mastering drug and alcohol prob-
lems are a rehabilitation service for inmates who 
are being assessed for entitlement to interdisciplin-
ary specialised drug or alcohol treatment. 
Entitlement to such treatment may confer a right 
to treatment beyond the duration of the sentence. 
In the course of 2011, 13 units for mastering drug 
and alcohol problems will be established in 
Norway, in addition to two corresponding units 
that have already been established. Eight units 
17 Consultative paper; draft new municipal health and 
care act. http://www.regjeringen.no/nb/dep/hod/dok/
hoeringer/hoeringsdok/2010/horing2/horingsbrev.
html?id=621193
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prisons are included in this programme to test 
the collaboration between NAV and the correc-
tional service. It is the NAV office in the munici-
pality in which a prison is located that takes part 
in the collaboration instead of the office in the 
inmate’s home municipality. This is modelled on 
the collaboration with the health service. Of the 
seven prisons taking part in the qualification 
programme, five are establishing units for mas-
tering drug and alcohol problems.
11.3.3  The correctional service’s overall 
drug and alcohol strategy
The correctional service is implementing several 
measures as part of its drug and alcohol strategy. 
The prison officer, acting as contact officer, is the 
most important resource in this context. All per-
manently employed prison officers in Norway 
act as contact officers. The contact officer has 
day-to-day contact with the inmate and is re-
sponsible for motivating and facilitating contact 
and follow-up of plans with the inmate. 
Interviewing methods such as motivational in-
terviewing, assessment and sentence planning 
are tools used in this process. The contact officer 
usually participates in the inmate’s individual 
plan or other plans for the period in which the 
convicted person is serving his/her sentence.
The drug and alcohol coordinator or the prison’s 
social counsellor shall contribute to coordinat-
ing collaboration between the inmate, the con-
tact officer and collaborative partners that work 
in or outside the prison. In connection with the 
implementation of the return-to-society guaran-
tee, dedicated reintegration coordinators have 
been appointed who will assist in planning rein-
tegration after sentences are served.
A substance abuse interview is an alternative to 
sanctions for violation of the prohibition on drug 
and alcohol use in prison. It can also be used as a 
rehabilitation measure to create motivation to 
change drug and alcohol habits. The interview 
consists of three structured conversations based 
on motivational interviewing and cognitive meth-
odology. All prisons shall offer such interviews as 
an alternative to sanctions for violating the 
Chapter 9.3.1). Many of those who are transferred 
pursuant to section 12 are under assessment for en-
titlement to interdisciplinary specialised drug and 
alcohol treatment in the specialist health service. 
The number of convicted persons who are trans-
ferred has remained stable at around 500 per year, 
following an increase since the early 2000s.20 More 
measures are now being initiated to increase the 
number of convicted persons serving their sen-
tence this way. In order to achieve this, collabora-
tion with the health service must start as early as 
possible. In April 2010, the correctional service 
took over responsibility for summoning convicted 
persons to serve their sentences. One of the advan-
tages of this is the opportunity it offers to include 
information about measures such as serving sen-
tences pursuant to section 12. It is also important 
that the health service and the municipalities make 
use of this opportunity to continue or start treat-
ment in prison.
The return-to-society guarantee
The Government’s return-to-society guarantee 
was launched in Report no 37 (2007–2008) to 
the Storting. It entails that all inmates who lack 
housing, employment or training, who need so-
cial services, treatment for drug or alcohol de-
pendency or other health services, shall be of-
fered this when they are released from prison. It 
is a goal that all agencies with which the correc-
tional service cooperates shall offer their services 
in all large prisons. Today, schools and health 
services are established in all prisons, while so-
cial services, labour and other welfare services 
that are organised under the Norwegian Labour 
and Welfare Service (NAV), and the specialist 
health service, are only present in a few prisons.
The qualification programme is a measure or-
ganised by NAV that aims to help more people to 
find employment and engage in activity through 
closer and more binding collaboration. Seven 
20  An evaluation of the section 12 scheme by Ploeg, G. 
2006. Straff i institusjon (‘Punishment in institutions’). 
(English http://img3.custompublish.com/getfile.
php/327910.823.aqavswtdyu/rapport32006.pdf)
The Drug Situation in Norway 201172
11.3.4 Quality and scope of the services
There are two important questions relating to the 
collaboration between the correctional service 
and the health services: How extensive services 
must be offered in order to ensure equal right to 
treatment in and outside prison, and how shall 
the services be adapted to ensure that the indi-
vidual inmates can make use of this service?
Most prisons have procedures for basic assess-
ment on arrival, and several of them involve the 
health and school departments. There is no uni-
form system for such assessments today, but a 
trial project aimed at identifying inmates and 
convicted persons’ needs is scheduled to start-up 
in Halden prison and at Østfold probation office 
in 2012. The assessment is intended to identify 
needs relating to the person’s housing situation, 
education, work, finances, health and other fac-
tors that are important in the rehabilitation con-
text. Participation in the assessment is voluntary, 
and it will not replace the collaborating agencies’ 
own mapping or evaluations.
Subject to the patient’s consent, the prison health 
service will obtain information from the patient’s 
GP and from any treatment facilities by which 
the inmate was being treated prior to imprison-
ment. Subject to the client’s consent, the munici-
pal social services will contact the correctional 
service to establish contact with the prison and 
maintain contact with the inmate during his/her 
stay in prison. A right to specialised interdisci-
plinary drug or alcohol treatment is conferred 
following a medical assessment.
11.3.5 Adaptation of the services
It is the inmate/convicted person who, together 
with the health service, decides how much and 
to what extent the prison shall be informed about 
his/her health situation and treatment. Persons 
held on remand can continue to use their GP 
outside the prison. For convicted persons, this 
responsibility is transferred to the prison doctor 
during the serving of the sentence. The health 
service shall continue work on individual plans 
or start such work for those who wish and are 
entitled to such a plan.
prohibition on drug and alcohol use. This entails 
closely linking control and rehabilitation 
measures.
Measures and cognitive programmes in 
prison
The purpose of measures and cognitive pro-
grammes carried out under the auspices of the 
correctional service is to motivate or prepare the 
inmate for treatment or follow-up. Some pro-
grammes are offered as a result of criminal of-
fences, such as the most comprehensive pro-
gramme Trafikk og rus (‘Driving under the 
influence’), which is a cognitive programme tar-
geting persons convicted of driving under the 
influence who are serving their sentences in 
prisons with a lower level of security. In 2010, 
350 inmates completed this programme. More 
specific programmes are offered to inmates with 
an acknowledged drug or alcohol problem, such 
as the Canadian National Substance Abuse 
Programme (NSAP).21 To ensure quality, pro-
grammes that are organised under the auspices 
of the Norwegian correctional service must be 
approved following an assessment by a dedicated 
accreditation committee. Following a trial peri-
od of three years, NSAP is now being imple-
mented in several prisons on a permanent basis. 
In several prisons, NSAP is part of the service of-
fered by the units for mastering drug and alcohol 
problems. Up to 100 inmates took part in such 
programmes in 2010.
A special penal sanction is being implemented 
under the auspices of the probation service as an 
alternative to prison for persons convicted of 
driving under the influence. The penal sanction 
includes participation in a cognitive programme 
over a period of ten months and it entails the 
convicted person being referred to an assess-
ment for drug and/or alcohol treatment in the 
specialist health service. The number of partici-
pants per year is approximately 500.
21 Correctional Service Canada, SubstanceAbusePro-
grammes, NSAP. http://www.csc-scc.gc.ca/text/prgrm/
sub-eng.shtml
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work on the plan and at meetings about the plan, 
so that it can facilitate meetings and implementa-
tion of the plans during the serving of sentences.
An evaluation was carried out in the period 
2006–2008 following a trial involving the coordi-
nation of planwork at eleven correctional service 
units.23 The units that succeeded in finding solu-
tions were the ones that started by holding a 
meeting with the inmate at which all the relevant 
parties were present and involved in the infor-
mation that was given.24
11.4 Control in prisons
The fundamental principle underlying the cor-
rectional service’s overall drug and alcohol strat-
egy is to see control measures in conjunction 
with motivational/rehabilitation measures. It 
shall always be possible to follow up control 
measures with motivational and rehabilitation 
measures. The substance abuse interview (cf. 
Chapter 11.3.3) is an alternative to a sanction 
following violation of the prohibition on drug 
and alcohol use for inmates with drug or alcohol 
problems. Other sanctions can include loss of 
privileges such as watching TV or participation 
in social activities.
Control measures such as urine tests, breathalys-
er tests (alcohol) and searches are carried out on 
a regular basis with a view to discovering drugs 
and user equipment. There has been a slight 
downward tendency in the use of drugs and ille-
gal medicinal drugs uncovered by urine tests in 
recent years. There are great difference between 
the units and regions, however, in the proportion 
of positive tests.
23  Rokkan, T. 2006. Samordning av planarbeid: Fra kaos til 
orden (‘Coordination of plan work: From chaos to order’ 
– in Norwegian only). Final report with comments and 
recommendations. KRUS. http://www.krus.no/upload/
Samordning%20av%20planarbeid_evaluering.pdf
24  Often called a ‘responsibility group meeting’, but is has 
no legal basis in legislation or regulations.
A survey of the prison health service from 2011 
shows that procedures have been established for 
collaboration with the specialist health service in 
all prisons. This applies in particular to collabo-
ration on psychiatric treatment and treatment 
for drug or alcohol problems, but also to somatic 
treatment to some extent. There is also extensive 
collaboration with the correctional service dur-
ing the serving of sentences, but to a lesser extent 
after the transfer of inmates to another prison or 
upon their release. Procedures for collaboration 
with the home municipality (GP) upon impris-
onment and release have only been established 
to a small extent. The prison health service has to 
some extent established collaboration with NAV 
during imprisonment, but to a lesser extent upon 
release.22
In some prisons, the specialist health service also 
offers outpatient treatment for inmates with 
mental illnesses. The goal is that convicted per-
sons who are included in the units for mastering 
drug and alcohol problems will be transferred to 
treatment in an institution during serving of 
their sentence pursuant to section 12, or to treat-
ment in an institution or outpatient clinic upon 
their release.
As mentioned above, both NAV and the correc-
tional service contribute to the qualification pro-
gramme in the form of staff and facilitating col-
laboration in prison. The health service and, if 
relevant, the unit for mastering drug and alcohol 
problems, are also part of this collaboration.
11.3.6 Coordination of planwork
Individual plans are the most important tool for 
coordinating planwork in the health and social 
services. The legal basis for them is set out in both 
health and social services legislation. Problem 
drug and alcohol users in prison will usually be 
entitled to have an individual plan prepared if 
they do not already have one. It is expedient that 
the prison (the contact officer) participates in the 
22 Synovate 2011. Survey of the prison health service in 
Norway 2010. 
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the support system and treatment available to 
drug addicts and alcoholics.
This comprehensive goal is linked to a two-year 
basic education and/or further education for all 
correctional service staff. The goal is that all staff 
shall be able to evaluate and implement mea-
sures as a reaction to finds or suspicion of drug 
or alcohol use during the serving of prison sen-
tences. This also includes specialised control 
functions, such as the drug service dog handlers, 
who also need skills in motivation, assessment 
and change work.
KRUS also offers training to partners in the pris-
ons: the health service, the social services and 
the municipalities. This training is currently fo-
cused in particular on training in substance 
abuse interviews, the training and certification 
of programme leaders in the National Substance 
Abuse Programme (NSAP), the training of staff 
at the units for mastering drug and alcohol prob-
lems and professional conferences aimed at 
strengthening the collaboration on reintegra-
tion, collaboration at the units for mastering 
drug and alcohol problems, with the focus on in-
mates with mental illnesses.
11.6 Further issues
There are several challenges relating to the coor-
dination of plan work between collaborative 
partners and the correctional service. Many pris-
ons are small and have limited capacity. In the 
smallest prisons (15–25 inmates), there are only 
one or two permanent staff members at work 
during daytime due to work rotas. Work rotas 
may also be an obstacle to continuity of collabo-
ration in larger prison units.
The difference of approach between the correc-
tional service’s vision of fully drug-free prisons 
and the health service’s treatment and harm-re-
duction measures is a challenge in relation to 
collaboration. This applies to substitution treat-
ment, the distribution and use of other addictive 
medicinal drugs and to the use of needles. As 
Over the last three years, 75,588 urine tests have 
been carried out, and illegal drug use was found 
in 8,857 samples, including those who refused 
give samples (11.7 %).25 The ten prisons with the 
most finds of illegal use are mainly large prisons 
(more than 50 inmates), and high-security pris-
ons. Prisons with few finds of illegal use are often 
small prisons and prisons with lower security 
levels.
11.5 Training of prison staff
Competence-raising is an important tool in the 
correctional service’s drug and alcohol strategy. 
This applies in particular to the sub-goal of moti-
vating and facilitating abstinence from drugs/al-
cohol by convicted persons during imprisonment 
and better control of drug/alcohol use after re-
lease. It includes the development and use of new 
mapping tools that combine mapping on a broad 
basis with knowledge about finds from controls 
and observations to form a complete picture of 
convicted persons/prisoners on remand. 
Training in planwork is also crucial for all cor-
rectional service staff if they are to be able to co-
operate with the health service and other part-
ners on the convicted person’s own plan during 
and after the stay in prison.
The correctional service’s education centre 
(KRUS) provides staff training. All correctional 
service staff must be conscious of their own use 
of drugs/alcohol, they must be knowledgeable 
about drug and alcohol dependency, have the 
ability to identify drug and alcohol problems, 
and be able to asses motivation, motivate for 
change using motivational interviewing (MI), 
carry out controls and recognise signs and symp-
toms of drug and alcohol use, be aware of the 
connection between drug and alcohol depen-
dency and mental illness, and be familiar with 
25 Calculated on the basis of statistics from controls carried 
out using urine tests (drugs and medication) or breatha-
lyser tests (alcohol) in all prisons in Norway for the years 
2008, 2009 and 2010.
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In several prisons, the prison health service de-
scribes the increasing number of foreign inmates 
as a major challenge, both in relation to access to 
interpreting services and in relation to the provi-
sion of necessary help. This emerges from a qual-
itative survey of the prison health service in four 
selected prisons (Synovate, 2011).28
Some prisons have better health resources than 
others, and they also seem to be allocated new 
resources through the focus on units for master-
ing drug and alcohol problems, collaboration 
with NAV and the correctional service’s own 
drug and alcohol strategy. However, if we com-
pare the location of the units for mastering drug 
and alcohol problems with the overview of finds 
of illegal drug use in connection with control 
measures, there is little correlation between units 
with a high proportion of finds of illegal use and 
the establishment of units for mastering drug 
and alcohol problems. There does not seem to be 
a connection between prison health services and 
the prevalence of illegal use detected through 
controls. There are as many units with extensive 
resources as units with few resources that have a 
high proportion of finds of illegal use.
Equal right to treatment is an important princi-
ple in the Norwegian health service. The basis 
for such equal treatment is an individual assess-
ment of needs. It is therefore important that the 
health departments in all prisons have the re-
sources they require to be able to refer inmates 
for assessment, and that the prison is capable of 
facilitating any necessary treatment in collabora-
tion with the specialist health service and NAV. 
In order to plan such collaboration, a common 
knowledge base is required of the scope of drug 
and alcohol dependency among inmates and 
convicted persons. In a consultative paper on 
new national professional guidelines for the as-
sessment, treatment and follow-up of persons 
with concurrent drug and/or alcohol problems 
28  Synovate 2011. Op. cit.
regards treatment with methadone, Subuxone 
and Subutex, which is permitted, the distribu-
tion and administering of the medicines could 
be a challenge, especially in prisons with few 
prison health service staff.
This conflict of interest is most apparent in the 
discussion about the use of needles in prison. In 
a report from 2009, the Directorate of Health 
recommended giving inmates access to clean 
needles.26 Previous practice has been to grant ac-
cess to chorine for sterilisation purposes. The 
Norwegian Board of Health and the Norwegian 
Medical Association endorsed the recommenda-
tion, while the prison officers’ unions, the prison 
health service and the police were against it. In 
2010, the Ministry of Health and Care Services 
decided to reject the proposal, stating that there 
was little need to change the current practice, 
that the safety of prison staff was important and 
that the distribution of needles in prisons could 
undermine work on motivating inmates for 
change and treatment.27
Another critical factor in connection with col-
laboration is the fact that many inmates serve 
relatively short sentences. Three out of four con-
victed persons released in 2010 had served up to 
90 days. The average duration of sentences was 
123 days. Almost half were released after 30 days 
on remand and one of three after 60 days. The 
average time spent on remand was 79 days. This 
means a high turnover and a short time frame in 
which to implement measures during the serv-
ing of sentences.
26  Ekeid, S.E. 2009. Tilgjengelighet i norske fengsler 
til sterile sprøyter og spisser for injiserende rusmid-
delavhengige. Forslag til en ny tilnærming. (‘Access to 
sterile needles and syringes for injecting drug addicts in 
Norwegian prisons. Proposal for a new approach’ – in 
Norwegian only). The Directorate of Health
27  The Ministry of Health and Care Services. Press release 
28 July 2010: Nei til utdeling av sprøyter i fengslene (‘No 
to the distribution of needles in prison’ – in Norwegian 
only). http://www.regjeringen.no/nb/dep/hod/aktuelt/
nyheter/2010/nei-til-utdeling-av-sproyter-i-fengslene.
html?id=611770
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prison. Such screening, both in prisons and in 
the probation service, would be a good starting 
point for designing appropriate measures.
and mental health problems,29 it is proposed that 
the prison health departments be given respon-
sibility for screening all inmates on admission to 
29   The national professional guidelines for assessment, 
treatment and follow-up of persons with concurrent 
drug or alcohol problems and mental health problems 
are available online: http://www.helsedirektoratet.
no/vp/multimedia/archive/00316/H_ringsversjon_
av_r_316179a.pdf
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per cent had custody of children. At the outpa-
tient clinics 21 per cent had children and 5 per 
cent had daily custody, whereas 70 per cent of 
the patients receiving opioid substitution treat-
ment (OST) had one or more children and 4 per 
cent had daily custody (Lauritzen, 2010).
As regards OST patients, in the period 1996–
2009 some 250 children were registered as born 
by mothers who had used methadone or bu-
prenorphine during their pregnancy. Only an es-
timated 10–15 per cent of these children were 
living with their mothers. About 60 per cent of 
the mothers reported having prior children 
(Welle Strand, 2011).
In 2010, 8,750 new patients with drug diagnoses 
were accounted for at the Norwegian Patient 
Register (NPR). The share they represent of the 
total number of patients being treated with a 
drug diagnosis cannot be estimated yet, as the 
individual-based registry is new and reporting is 
still deficient. The uncertainty here applies par-
ticularly to patients undergoing outpatient treat-
ment. In future registrations the NPR will rou-
tinely receive information on the number of 
children for each patient, their ages, and their 
custody and care situation at the time when par-
ents are admitted to treatment.
12.2  Health-related risks among 
children living with alcohol 
and drug abusing parents.
In the past decade Norwegian health authorities 
have become more alerted to the issue of preg-
nancy combined with substance use. The report 
Pregnancy, children and substance use (The 
Directorate of Health, 2000) addressed the 
Grethe Lauritzen senior advisor/researcher, 
SIRUS
12.1 Size of the problem
12.1.1 Epidemiological characteristics
Norway lacks the data sources needed to esti-
mate the number of pregnant women or parents 
of young children who use narcotics. However, 
some relevant data is available from studies of 
patients under treatment for drug problems.
Among 2,325 patients in a national cross-section 
study of substance abusers in treatment in 1992–
1993, 35 per cent reported having children 
(Lauritzen et al., 1997). In the age group 20 years 
or younger, 6 per cent reported having one or 
more children. In the age bracket 21–30 the 
share was 34 per cent, whereas 58 per cent of 
those who were aged 31 and upwards had chil-
dren. Upon admittance for treatment, 11 per 
cent informed that they had daily custody of 
children. The share of women confirming to 
have children in their care was significantly 
higher than the share of men reporting these re-
sponsibilities. In an earlier study from Oslo in 
the years 1990–1991, which comprised 697 per-
sons admitted to treatment, 39 per cent answered 
that they had children and 14 per cent said they 
had daily responsibility and custody of children 
under the age of 15 (Arner et al., 1995).
Also available is a prospective cohort study of 
481 drug users who were admitted to treatment 
in 1998/1999 and who were followed up for 10 
years. The material here was analyzed in relation 
to the type of treatment patients were admitted 
to. This reveals that 50 per cent of the patients at 
residential units for adults had children and 11 
12.  Drug users with children  
(addicted parents, parenting, child care 
and related issues)
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in a control group with regard to certain mea-
surements used as indicators of regulation diffi-
culties. However, a study at ages six months and 
one year does show differences in parent-child 
interplay variables between the OST group and 
the control group, particularly regarding sensi-
tivity and distraction. It could appear that chil-
dren whose mothers are in OST have a higher 
degree of reported behavioural problems at ages 
two and three than children in the control group. 
But very few had problems requiring clinical in-
tervention. As many as 95 per cent of the chil-
dren live with their mothers at ages two as well as 
age five. These families have been intensively fol-
lowed up.
A study from Bergen (Sandtorv et al., 2009) of 
pregnant patients in OST showed that more than 
half the children (N= 13) were exposed prena-
tally to substances other than substitution medi-
cations. During the follow-up period five of the 
13 children displayed a sub-average psychomo-
toric development and two had symptoms of hy-
perkinetic behaviour disorder.
There are also prospective studies of children 
born by drug using women who have not been in 
OST. Sundfær (1992, 1999, 2001, 2004, 2009) has 
followed children of 40 such women from their 
birth to age 25. In a long-term follow-up of 
Norwegian children exposed to drugs in utero 
Moe (Moe, 2002; Slinning et al., 2007; Walhovd 
et al., 2009; Moe et al., 2010) and Slinning 
(Slinning, 2003; Slinning, 2004; Slinning & Moe, 
2007; Walhovd et al., 2007, Walhovd et al., 2009) 
have contributed valuable information about at-
tention and self-regulation and the effects of pre-
natal opiate exposure on brain development.
The consequences of growing up with parents 
with harmful use of substances will pivot on a 
wide range of factors. However, some common 
denominators for substance use and parenting 
are apparent which span all types of substances. 
Alcohol or drug use can undermine alertness to 
the daily needs of children, it can destabilize life 
rhythms, lead to wide swings in humour and be-
haviour that are bewildering for children. To 
primary health care service, social services and 
child care services. It provides information about 
the harm of substance use on the foetus and in-
cludes birth parameters assessed by types of sub-
stances. As a vital preventive strategy, clear 
warnings were given to abstain from alcohol and 
other substances during pregnancies. However, 
for pregnant patients undergoing OST it is rec-
ommended to continue their use of substitute 
medication. A few Norwegian studies have been 
conducted on pregnant patients in OST and 
their children. Not many patients were involved 
in the studies, however, so the findings have to 
be interpreted prudently.
Research on OST patients and their children has 
been carried out in Oslo since 2002. (Bakstad et 
al., 2009; Welle Strand, 2011). A diminishing 
number of patients have partaken in substitution 
treatment during pregnancy in recent years, and 
most of them had been in OST for some time be-
fore pregnancy. These women have often left 
their drug use behind and are undergoing reha-
bilitation. Pregnant women in OST in Norway 
use relatively high doses of OST medication 
compared to what is given in other countries, de-
spite some of them decreasing dosages during 
pregnancy. In the studies by Bakstad and Welle-
Strand the methadone dosages averaged 90mg or 
more, both during initiation and at the time of 
birth. About half of the newborns exposed to 
OST medications required medication for neo-
natal withdrawal syndrome (NAS) with an aver-
age treatment period of just over 40 days, where-
as the duration for infants exposed to 
buprenorpohine was a little shorter. No statisti-
cally significant connection was found between 
the mothers’ dosages of methadone/ buprenor-
phine during pregnancy and the frequency or 
duration of NAS. Nearly all the women smoked 
tobacco during their pregnancy.
We have insufficient knowledge in Norway about 
the development of children exposed prenatally 
to methadone or buprenorphine, but studies are 
underway. A prospective study (Sarfi et al., 2009) 
found that infants aged three months in the OST 
group displayed no difference from peer infants 
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harmful substance use in a generational 
perspective.
12.3 Policy and legal framework
12.3.1 Policy
In 2003, the then Ministry of Children and 
Family Affairs took the initiative for a study 
charting provisions for children whose parents 
had substance use problems. Special attention 
was to be given to children who accompanied 
their parents in the residential treatment. 
Additional focus was given to obtaining a na-
tionwide overview of specific provisions that had 
been established for the children. Documentation 
from the study was published in two reports 
(Solbakken et al., 2005, Solbakken & Lauritzen, 
2006). In parallel, equivalent studies were made 
regarding children whose parents suffered from 
mental disorders (Åmodt & Åmodt, 2005).
The recommendations of these reports coalesced 
on a call to view the needs of both groups of chil-
dren in a similar context. In keeping with this 
advice, the Government passed an inter-ministe-
rial initiative in 2007 to follow up children from 
these two parental groups.
A national network of competence «Barns Beste» 
[In the interests of children] was established for 
prevention and treatment of problems encoun-
tered by the children. The objective is to facilitate 
the spread of expertise by gathering, systemizing 
and disseminating knowledge and experience to 
a widespread and often decentralized profession-
al field. The scope of responsibility has later been 
extended to include children whose parents suf-
fer serious somatic illnesses and children with 
incarcerated parents. A reference group for the 
network has been established as well as a group 
of researchers on a national level focusing on 
children at risk.
In the 1990s seven regional centres of compe-
tence regarding substance use were established 
in Norway. One of them, Borgestadklinikken, 
specializes in pregnant substance users and their 
various degrees it can pan out in a deficit of pa-
rental care.
Children of substance abusers are not a homog-
enous group. Substance use problems in families 
express themselves in a variety of ways, in inten-
sity and duration, and children will exhibit dif-
ferent degrees of vulnerability and capabilities 
for tackling the stresses they are exposed to. The 
problematic use of substances in families will 
nevertheless often lead to economic difficulties, 
transience and a lack of security for affected 
children.
Knowledge about these conditions has been ac-
crued in many ways. Children’s own accounts are 
rich sources for understanding the conditions in 
which they grew up and their developmental 
problems. The offspring of substance abusers 
have written biographies after coming of age. 
Therapeutic work with adult offspring represents 
a source that has provided essential phenomeno-
logical knowledge about how daily life is impact-
ed and can continue to affect lives into adult-
hood (Hansen, 1990, 1994). A state of alert is 
often high among children in families where 
drugs or alcohol play a dominant role − a pre-
paredness against both unfamiliar and familiar 
scares. Their efforts to gain control can have 
large consequences on a child. It can lead to in-
troversion, difficulties in concentrating, physical 
ailments, anxiety and depression. Help toward 
validation of feelings and understanding of inci-
dents and experiences can be important in vari-
ous phases of the child’s life.
Follow-up studies in Norway show that over 50 
per cent of drug users in treatment report having 
had parents with a serious alcohol problem 
(Arner et al., 1995, Lauritzen et al., 1997). The 
share who relate serious mental disorders among 
their parents is also considerable and we see that 
alcohol abuse and mental problems are largely 
concurrent. Also a very high share of the young-
est patients are the offspring of drug using par-
ents. These studies concur with international re-
search and show how important it is to evaluate 
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Act (§25 third paragraph). The provision allows 
confidential information to be given to partners 
in cooperation as required in attending to the 
needs of a patient’s children, as long as the pa-
tient does not object. To bolster the position of 
children when their parents are seriously ill, a 
provision has been made in the Specialist Health 
Services Act (§3–7a) that health institutions cov-
ered by the specialist health services are to have 
personnel responsible for children (www.lovda-
ta.no). The regulation channels responsibility to 
these persons so they can promote and coordi-
nate health personnel’s supervision and atten-
dance to minors whose parents suffer from men-
tal disorders, somatic illnesses, are seriously 
injured or have substance use problems.
Treatment of substance abuse in Norway is to be 
an interdisciplinary, specialised health service. 
Municipalities that have a coordinating and fol-
low-up responsibility for these patients are not 
encompassed by this legal provision. However, 
they are free to adopt such a system.
12.3.3 Plans related to substance users 
and their children
Plans of action against substance use pro-
blems:
Three plans of action for 2003–2005, 2006–2008 
and 2008–2012, have all aimed at placing pre-
vention work in focus for children and youth 
and sought to be goal-oriented with regard to 
children and youth in risk relationships.
Relationship between mental health and 
substance use:
Escalation plan for mental health
The escalation plan (1998–2006) presupposes an 
overall approach and a broad spectrum of initia-
tives across sector lines. It also counts on consid-
erable expansion, competence boosting and in-
creases in efficiency in the specialist health 
services. As regards earmarked funding for mu-
nicipal mental health care, the Directorate of 
Health has issued a circular that at least 20per 
cent of the funds should be targeted for children 
and youth.
children. Another, Rogaland A-senter, has a spe-
cial focus on children at school age. Annual na-
tional conferences are held with the theme 
«Barnet og rusen» [The child and substance use] 
and these make bountiful use of international 
expertise.
Mental health care for children and adolescents 
is required by national guidelines to give priority 
to bolstering competence about alcohol and drug 
use and addiction. This is vastly important for 
improving identification of parents’ substance 
use problems where the child is the primary pa-
tient and to reach out with early interventions to 
children and youngsters. A national network of 
competence for infants’ and young children’s 
mental health care has been formed with the aim 
of offering education and conducting pertinent 
research about infants. Infants and young chil-
dren who have been exposed to harmful sub-
stance use are included as an important target 
group.
Comparably, expertise about substance use is a 
priority area for the child care services. One of 
the ways this is being attended to is by imple-
menting screening tools, among them Adolescent 
Assessment Dialogue (Friedman et al. 2001), 
which monitors the use of substances in a broad-
er behavioural perspective. The instrument also 
includes questions about parents’ use of drugs 
and alcohol.
12.3.2 Legal framework
Amendments have been made in the Health 
Personnel Act and the Specialist Health Services 
Act to ensure that personnel in health care ser-
vices identify and attend to the underage child’s 
needs of information and follow-ups as next of 
kin. The goal is to ensure that these children are 
getting early help and that processes are estab-
lished to make children and their parents more 
suited to tackle the situation in cases of severe 
illness and substance use problems.
To enable health personnel to assist children as 
involved parties in their parents’ problems, a 
new provision was made in the Health Personnel 
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ferences in living conditions among children and 
youth are the main concern.
White Paper no. 6 (2002–2003) Plan of action 
against poverty.
This maintains that parents’ employment is the 
major prerequisite for counteracting poverty and 
for improving the conditions in which children 
are raised. Goal-oriented improvements are 
stressed in the welfare services and in initiatives 
aimed at promoting social inclusion of children 
and youth.
The Child Care Act of 1994.
The purpose of this act is to ensure that children 
and youth who live under conditions that could 
be detrimental to their health and development 
are given timely and necessary help and care and 
to contribute to secure conditions for children 
and youth to grow up in. Several of the provi-
sions in the act impose the child care services to 
offer services and carry out necessary measures 
when conditions call for such action.
Policy documents and legal regulations, along 
with rather large budget allocations have sharp-
ened the demand for vigilance and action with 
regard to children of substance abusers in 
Norway.
Other public documents that have an 
impact on children whose parents have 
substance use problems:
UN Convention on the Rights of the Child
The UN Convention on the Rights of the Child 
was incorporated into Norwegian law in 2003. In 
accordance with article 12 regarding respect for 
the views of children, children are to be given the 
right to express their views on judicial and ad-
ministrative proceedings that concern them.
White Paper No. 40 (2001–2002) About Child 
and Youth Care
This Government white paper concerns preven-
tive help to children and families. Child Welfare 
should be a central player in efforts to help par-
ticularly vulnerable children and adolescents. 
Measures taken must be considered in an overall 
context in accordance with the needs of children 
and youth.
White Paper no. 39 (2001–2002) About growing 
up and living conditions for children and youth in 
Norway.
The main perspective is on children and youth as 
a resource. Another key issue is the bolstering of 
parental responsibility. Efforts to counteract 
marginalization and contribute to levelling dif-
Parents’ substance use problem IS known Parents’ substance use problem IS NOT known
The child HAS signs of 
maladjustment 
A: These children are easiest to identify. 
They display clear signs of maladjustment/ 
developmental difficulties and their parents’ 
drug/alcohol problem is known.
The children often have comprehensive needs for 
help and child welfare is involved with many of 
the families. 
B: These children display clear signs of 
maladjustment/developmental difficulties.
Because the parents’ substance use problem 
is unknown, the children’s symptoms and 
difficulties are treated without being related 
to the drug or alcohol problem as a cause or 
burden.
The child DOES NOT 
have signs of  
maladjustment
C: The parents’ substance use problem is known 
but the children appear to be resourceful, 
capable and well functioning. Compensational 
strategies that that can overburden the child and 
create developmental difficulties later are not 
dealt with.
D: These children are hardest to identify and 
provide interventions for. They often go unnoticed 
and catching on to a difficult childhood requires 
a professional eye and a sensitive approach. 
In such cases, schools and kindergartens are 
important arenas for observation and prevention 
and vital bases for care. 
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children and to pregnant patients as early in 
their pregnancy as possible.
Therapeutic work in these facilities is particular-
ly demanding. The parents’ treatment and reha-
bilitation process has to be ensured while an on-
going evaluation needs to be made regarding 
optimal care of the children. This requires a high 
degree of competence in observation and inter-
vention with regard to the interplay between 
parents and children, attachment issues, parental 
duties and possible development disturbances 
among the children. It calls for systematic and 
professional assessments and access to external 
specialists in child psychiatry and neurology, 
and sufficient monitoring and diagnostic tools. 
The Directorate of Health has put a lot of effort 
into gathering and evaluating instruments for 
various purposes and age groups in this context 
and these have been integrated in the Norwegian 
Electronic Health Library. Very few of the resi-
dential institutions have been evaluated so far.
As a link in the Government’s initiatives (2007–
2014), a systematic training programme lasting 
two years has been given to employees at this 
type of treatment centres (Killen, 2010). Its eval-
uations have been uplifting (Klette, 2011). A net-
work for all of the country’s treatment units that 
admit patients who are pregnant or parents with 
young children meets twice a year to share expe-
riences and strengthen mutual competence.
Following a Danish model, so-called family ambu-
latories are being tried out (Olofsson, 2006 ). These 
are linked to somatic hospitals and are intended to 
provide preventive health assistance to pregnant 
substance abusers and follow-ups of their children 
until they reach school age. Preventive health as-
sistance is safeguarded through contact with the 
pregnant woman and her family as early in preg-
nancy as possible. Focus is on prevention of drug 
and alcohol related developmental harm to the 
child. The provision has a family prospective with 
focus on psychosocial conditions and socioeco-
nomic matters. The family ambulatory is a low-
threshold measure requiring interdisciplinary col-
laboration among post-natal wards, mental health 
12.4  Specific responses for drug 
users with children
12.4.1 Availability of specific responses
The background material for the Government’s 
initiatives for 2007–2014 indicated that the help 
offered to especially vulnerable children has 
been incidental and not comprehensive enough. 
Impressive individual efforts have been made 
but no general strategy has been implemented 
for detecting and reaching children who suffer 
from their parents’ use of drugs and alcohol.
In the report «Tilbud til barn av rusmiddelmis-
brukere» [Responses to children of substance us-
ers] (Solbakken & Lauritzen, 2006), the table be-
low was used to illustrate the need to identify 
various groups of children needing help, de-
pending on whether their parents’ substance use 
problem is known or not, and whether the chil-
dren themselves display maladjustment or devel-
opmental difficulties.
The division shows that diverse categories of 
children and parents will pose different challeng-
es on the public and private facilities that provide 
assistance and treatment. Such challenges will 
link to awareness of parental substance abuse 
and the children’s behavioural development and 
display of problems.
Early intervention for pregnant patients and 
for young children and their parents
Family wards or mother/child units have been 
established at several of the Norwegian residen-
tial institutions. These are meant to receive 
mothers (or both parents) with children in situa-
tions where parents require treatment and well-
founded, professionally assessed reasons are 
present for bringing their children along. In a 
study from these units we learned that 93 per 
cent of the children were under the age of three 
and 64 per cent under the age of one (Solbakken 
et al., 2005). Twenty-five per cent of these infants 
were born during their mother’s stay at the insti-
tutions and priority was given to the youngest 
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preschool children can also participate. Central 
elements in this programme are:
• Alcohol and pregnancy, how alcohol harms 
the foetus. Use of the monitoring tool 
TWEAK (Tolerance, Worried, Eye opener, 
Amnesia, K(c)ut down)
• Mental problems during pregnancy and 
when children are young. Use of Edinburgh 
Postnatal Depression Score (EPDS). (Holden 
et al., 1989, Wickborg & Hwang, 1996)
• Violence during pregnancy and when 
children are young. Use of Abuse Assessment 
Screen (AAS) (www.Nktvs.no)
• Teaching the Motivational Interviewing 
(MI), (Barth et al., 2001, Prescott et al., 2004, 
Rollnick et al., 2007).
The instructional programme is under evalua-
tion to be presented in 2012.
Children at school age
School age is often a critical period for children 
of substance users. New expectations and exten-
sive socialization with peers and spare time ac-
tivities make it harder to hide alcohol and drug 
use in the family. Schools can be important are-
nas for identifying children’s care situation and 
applying appropriate help. Teachers are often in 
need of assistance and cooperation from other 
professionals. It was revealed (Solbakken & 
Lauritzen, 2005) that many of the provisions 
made for school-aged children of substance 
abusers are group-based and under the supervi-
sion of local public health centres for primary 
schools or public mental health care agencies for 
children and adolescents. Little has been done so 
far to evaluate these measures. In general, a high 
degree of expertise is required to deal with a 
child’s role as participant in a therapeutic group. 
The study pointed out the importance of viewing 
group interventions within a systemic and cul-
tural psychological/sociological perspective. The 
need for individual provisions for support and 
treatment of children and youth was also 
stressed.
care services and various municipal agencies and 
programmes which offer help. An ongoing coordi-
nation and adjustment of efforts is required to help 
these patients and their family’s situation. Family 
ambulatories call for long-term monitoring and 
coordinated efforts.
Another of these initiatives is the so-called mod-
el municipality experiment. The intention here 
has been to evolve functional models for early 
interventions and systematic follow-ups of chil-
dren. Twenty-six municipalities participate and 
they annually receive extra state funding. These 
municipalities must establish and develop inter-
departmental cooperation among various mu-
nicipal services and their services and special 
initiatives for children, youth and adults. 
Regional coordinators have been employed and 
the model municipalities are regularly given op-
portunities to improve their expertise and share 
their experiences in regional and national net-
work gatherings. Emphasis is given to use of 
monitoring tools to detect and prevent early de-
velopments of problems among children. The ac-
tivities of the model municipalities have been 
documented and the report for 2010 states that 
they have come a long way towards identifying 
the target group. Municipalities have started to 
use monitoring tools and are working systemati-
cally toward their implementation. The reports 
also show that they have initiated their develop-
ment of tangible assistance measures.
A project affiliated with the model municipality 
experiment is the Instruction programme for 
screening tools and clinical advice approaches in 
encounters with pregnant women and parents of 
young children. The programme spreads knowl-
edge to professionals working on a daily basis 
with pregnant women and parents with young-
sters, such as GPs, midwifes and public health 
nurses. The programme is also directed at rele-
vant professionals in municipal child welfare, 
employees who work specially with substance 
abuse problems, deal with violence and mental 
health, family welfare offices, etc. Representatives 
from kindergartens and others who work with 
The Drug Situation in Norway 201184
that worked out these guidelines concurred on 
all recommendations with the exception of how 
methadone and buprenorphine should be used 
during pregnancies. This is a difficult and con-
troversial issue. The Directorate of Health’s pri-
mary recommendation is that female patients 
should not scale down their use of substitute 
medications during pregnancies, unless they 
choose to do so. A guide on early intervention in 
substance abuse cases, Fra bekymring til handling 
(2009), [From concern to action] spells out re-
sponsibilities and alternative reaction and treat-
ment forms. This guide was discussed in the na-
tional report for 2009, Chapter 3.3.1.
12.5 Concluding comments
As shown in recent years some rather intensive 
and comprehensive initiatives have been made 
for children whose parents have severe health 
problems, the children of drug users inclusive. 
The strategy that has been followed involves the 
creation of all-embracing structures that are ca-
pable of spotting children who are burdened by 
special family conditions and developing specific 
measures for sub-groups that are adapted to the 
children’s age and needs as well as the parents’ 
problems. The child’s own voice, as part of a user 
perspective is included as a key principle.
It has been pointed out that such an initiative re-
quires an overall plan to maximise the utilisation 
of resources and ensure their direct benefit to 
children. No conclusive summaries of the 
Government’s initiatives have been carried out, 
but a number of measures have been launched 
and a willingness to act is clearly evident.
Treatment measures for substance abusers
When parents with harmful use of substances 
are admitted to treatment it should be obvious 
that attention also must be given to their chil-
dren’s situation. This applies to the specialised 
treatment centres for the patient group and for 
somatic and psychiatric health services. Since 
2010 these specialised treatment centres are 
obliged to ask patients about their children, how 
old they are and what their care situation is. The 
data is reported to the Norwegian Patient 
Registry. Treatment units should also be respon-
sible for ensuring that the child’s situation is both 
looked into and attended to. Some treatment 
centres work according to family therapy princi-
ples and have plenty of experience with analyz-
ing a family system and focusing on the children. 
Others have a long way to go. Another major 
challenge involves creating continuity in treat-
ment and follow-up measures for the family 
members when their basis is rooted in different 
governmental levels and an array of services.
Knowledge development
In connection with the Government’s plan of ac-
tion an overall strategy is being sought for devel-
oping expertise about drug and alcohol prob-
lems in families. This is directed toward the child 
welfare services, mental health care, kindergar-
tens, schools, public health centres, and GPs. 
Efforts are underway to integrate expertise about 
substance abuse in relevant curriculums at col-
leges and universities.
12.4  Availability of specific 
guidelines and guides
The national guidelines for pregnant patients in 
OST rehabilitation and follow-ups of families with 
young children until the kids reach school were 
completed in 2011. See also Chapter 5.2. The 
goal for the guidelines is the provision of clear, 
knowledge-based recommendations for treat-
ment and follow-ups of OST patients during 
pregnancy and at post-natal hospital wards. 
Children of OST patients are to receive system-
atic attention until school age. The project group 
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